Prevalence, Characteristics and Correlates of Prediabetes in Al Ain and Dubai, the UAE: Cross Sectional Study by Ali Al Marzooqi, Layla Mohamed Hassan
United Arab Emirates University 
Scholarworks@UAEU 
Health and Physical Education Dissertations Health and Physical Education 
1-2018 
Prevalence, Characteristics and Correlates of Prediabetes in Al 
Ain and Dubai, the UAE: Cross Sectional Study 
Layla Mohamed Hassan Ali Al Marzooqi 
Follow this and additional works at: https://scholarworks.uaeu.ac.ae/health_dissertations 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Ali Al Marzooqi, Layla Mohamed Hassan, "Prevalence, Characteristics and Correlates of Prediabetes in Al 
Ain and Dubai, the UAE: Cross Sectional Study" (2018). Health and Physical Education Dissertations. 1. 
https://scholarworks.uaeu.ac.ae/health_dissertations/1 
This Dissertation is brought to you for free and open access by the Health and Physical Education at 
Scholarworks@UAEU. It has been accepted for inclusion in Health and Physical Education Dissertations by an 
authorized administrator of Scholarworks@UAEU. For more information, please contact fadl.musa@uaeu.ac.ae. 




iii 
 
 
 
 
Copyright 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © 2018 Layla Mohamed Hassan Ali Al Marzooqi 
  All Rights Reserved 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
 
 
 
Advisory Committee 
1) Advisor: Syed M. Shah 
Title: Professor 
Institute of Public Health  
College of Medicine and Health Sciences 
 
2) Co-advisor: Ian Blair 
Title: Associate Professor 
Institute of Public Health  
College of Medicine and Health Sciences 
 
3) Member: Abderrahim Oulhaj 
Title: Assistant Professor 
Institute of Public Health  
College of Medicine and Health Sciences 
 
vii 
 
 
 
 
Abstract 
The United Arab Emirates (UAE) has one of the highest rates of type 2 diabetes 
mellitus in the world. Prior to the onset of type 2 diabetes mellitus, a period of 
moderate hyperglycemia is often present, referred to as prediabetes. This is associated 
with a significant loss of pancreatic beta cells, an increased risk of cardiovascular 
disease and other serious health issues. There are gaps in the literature concerning the 
prevalence of prediabetes and its associated correlates, as well as correlations between 
the conversion rates from prediabetes to type 2 diabetes mellitus. 
The primary objective of this study was to determine the prevalence of prediabetes and 
its correlates in adults. The secondary objective was to identify the proportion of 
conversions of prediabetes to type 2 diabetes mellitus and the major correlates.  
This research was based on secondary data collected during prediabetes interventions 
in Al Ain and Dubai, two cities in the UAE. In Al Ain, a random sample (n=605) of 
parents participated in type 2 diabetes mellitus screening in a family-based study. In 
Dubai, 700 Emirati adults diagnosed with prediabetes, at five primary health care 
centers, were invited to take part in the intervention study. After ethical approval and 
gaining informed consent, socio-demographic, anthropometric, lifestyle and clinical 
data were then collected. Prediabetes and type 2 diabetes mellitus were defined in 
accordance with the American Diabetes Association’s guidelines: based on fasting 
plasma glucose (FPG ≥126 mg/dl (≥7 mmol/l) for type 2 diabetes, 110-125 mg/dl (6.1-
7 mmol/l) for prediabetes, (HbA1c ≥6.5%) for type 2 diabetes and (HbA1c 5.7-6.4%) 
for prediabetes. 
We used a multivariable multinomial logistic regression analysis to identify the 
independent correlates for prediabetes and type 2 diabetes mellitus in comparison to 
people with normal glucose levels in Al Ain. In Dubai we used logistic regression 
analysis to identify the correlates of the transition from prediabetes to DM in the data 
from the various health centers. 
The overall prevalence of prediabetes and type 2 diabetes mellitus was 37.7% and 
18.7%, respectively, in Al Ain. Ageing, being overweight and obesity were positive 
correlates for prediabetes. A secondary school, or higher, level of education correlated 
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negatively for prediabetes. Ageing, obesity, central obesity, a lack of vigorous physical 
activity and a family history of diabetes were positively correlated for diabetes, while 
a secondary school, or higher, level of education, were negative correlates for diabetes. 
In Dubai, a significant proportion (23%) of participants with prediabetes suffered from 
DM within a two-year period. Low HDL-cholesterol was significantly (<0.05) 
correlated with a deterioration from prediabetes to type 2 diabetes mellitus.  Subjects 
who reported vigorous physical activity at least once a week were less likely to acquire 
type 2 diabetes mellitus. 
Prediabetes is a significant public health problem in the UAE. Old age, being 
overweight, obesity and educational levels were all found to be significant correlates 
for prediabetes. A high proportion of people with prediabetes acquired type 2 diabetes 
mellitus within a relatively brief period. This highlights the importance of both 
screening and intervention in the case of prediabetes. Our findings were consistent 
with previous studies carried out in other countries. 
Keywords: Prediabetes, type 2 diabetes mellitus, obesity, prediabetes screening, 
physical activity, prediabetes-to-type 2 diabetes, UAE.   
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 )cibarA ni( tcartsbA dna eltiT
السكري  ما قبلوالعوامل المؤدية إلى مرض  والخصائص معدل الانتشارحول دراسة مقطعية 
  مارات العربية المتحدةفي مدينتي العين ودبي، دولة الإ
 الملخص
 بير فيك تعاني من ارتفاعالإمارات العربية المتحدة  دولة ر العالمية إلى أنتشير التقاري المقدمة:
بة في نسارتفاع  ما يعاني الأشخاص من غالبا  . الثانيالسكري من النوع  مرضمعدلات انتشار 
 تسمى ،الثانيل تشخيص مرض السكري من النوع قبوذلك السكر في الدم عن المعدل الطبيعي 
 بيتالاكبير من خلايا  دحيث ترتبط هذه المرحلة بفقدان عد .هذه المرحلة بمرض ما قبل السكري
الإصابة بأمراض القلب والأوعية الدموية وغيرها من  في نسبةزيادة ب، والمتواجدة في البنكرياس
يت التي أجرالدراسات عدد في  نقص كبيرهناك بالرغم من ذلك فالصحية الخطيرة.  التداعيات
 إلى مرضتطوره  ومسببات العوامل المرتبطة بهوالسكري ما قبل انتشار مرض أسباب  حول
 من النوع الثاني. السكري
السكري ما قبل و تحديد مدى انتشار مرض ه من هذه الدراسة اسيالهدف الأس هدف الدراسة:
ن مرحلة م لتطور المرضالمسببات الرئيسية  فهو تحديد ي. أما الهدف الثانالعوامل المسببة لهو
 .ونسبة هذا التحول الثانيما قبل السكري إلى مرض السكري من النوع 
عها خلال دراسة أخرى يجمتبيانات ثانوية، تم  علىاستند هذا البحث  المنهج المتبع للدراسة:
ري. من خطر مرحلة ما قبل السك للحد في مدينتي العين ودبي في الإمارات العربية المتحدةأجريت 
 الذين شاركوا في الدراسةطلاب المدارس أولياء أمور  من )506عينة عشوائية (عدد=تمت دعوة 
دعوة  تتمفدبي مدينة في أما . في مدينة العين السكريما قبل مرض نسبة انتشار  المعنية بفحص
في خمسة مراكز للرعاية  ،بمرض ما قبل السكريهم سابقا  شخص إماراتي تم تشخيص 007
ة بهم خاصبيانات تم جمع  .في الدراسة للمشاركةالتابعة لهيئة الصحة بدبي الصحية الأولية 
نقطاع ابمرض  إصابتهمخطر قياس مدى الاجتماعية والبدانة والنشاط البدني و الحالةومتعلقة ب
تم  علما  بأنه .لقياس توقف التنفس أثناء النوم استبيان برليناستخدام عن طريق التنفس أثناء النوم 
مريكية الأ الجمعية لتعريف وفقا   الثاني السكري والسكري من النوعما قبل مرض  نسبة تحديد
ما قبل ديسيلتر لمرض ملغ/ 121-111في حالة الصيام ( نسبة السكر على استنادا  وذلك ، للسكري
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-7.5( ومعدل السكر التراكمي )من النوع الثاني ديسيلتر لمرض السكريملغ/ 121≥ السكري و
 .)من النوع الثاني لمرض السكري ٪5.6≥و  لمرحلة ما قبل السكري ٪4.6
لسكري ا العوامل المرتبطة بمرض ما قبلالانحدار اللوجستي المتعدد لتحديد نموذج  تم استخدام
العين.  دينةم في طبيعي سكرمستوى ب يتمتعون أشخاصبالمقارنة عبر من النوع الثاني والسكري 
 الانحدارنموذج  ليلها باستخدامتم تحف الصحة في دبيهيئة كز امرالمأخوذة من بيانات الأما 
 سكريالسكري إلى مرض ال من مرحلة ما قبل التطور مسبباتلتحديد  ثنائي الاستجابة اللوجستي
 دبي. مدينة فيمن النوع الثاني 
ي مدينة ف ما قبل السكري والسكري من النوع الثاني ينسبة انتشار مرض بلغت نتائج الدراسة:
بل مرض ما قإيجابيا  بين  ا  أظهرت نتائج الدراسة ارتباط على التوالي. كما ٪3..1و ٪3.37 العين
مرض ما قبل  كما ارتبط) 50.0<P، وزيادة الوزن والبدانة (العمرالتقدم في  وكل من السكري
 .)العاليالتعليم الثانوي وسلبا  بمستوى التعليم (السكري 
 ين الذين كانوا يعانون منالمشارك من )32%(أظهرت أن نسبة كبيرة أما بيانات مدينة دبي فقد 
كما . ةمن المتابع السنتين خلالمن النوع الثاني مرض السكري ب أصيبواالسكري قبل ما مرض 
) 50.0<P( الكوليسترول عالي الكثافةنسبة  انخفاضبين  يجابيإلى ارتباط إ نتائج الدراسة شارتأ
ارتباط إلى . ومن النوع الثاني السكري إلى مرض السكريما قبل مرض بخطر التحول من 
عالي الجهد النشاط البدني  أظهرت الدراسة ارتباط كما). 450.0=P(السمنة مع معدل هامشي 
 .من النوع الثاني السكري إلىقبل السكري  من مرحلة ما التحولخطر مع 
في دولة الإمارات العربية  من أهم التحديات الصحيةمرض ما قبل السكري  يعد خلاصة الدراسة:
ما قبل لمرض  مسببة عوامل ،التقدم في العمرو ،زيادة الوزن والسمنة تشكلحيث المتحدة. 
بة ى نسلى مرض السكري من النوع الثاني لدتطور مرض ما قبل السكري إوقد لوحظ . السكري
 لدوريا يسلط الضوء على أهمية الفحص مما .قصيرة نسبيا   زمنية فترةخلال  كبيرة من الأشخاص
ة الدراسات السابقا أجمعت عليه العديد من وهذا م. المبكر لمعالجة مرض ما قبل السكريوالتدخل 
 في بلدان أخرى.
اط البدني، النشالبدانة، ، من النوع الثاني السكري، السكريما قبل مرض  مفاهيم البحث الرئيسية:
الإمارات العربية دولة ، من النوع الثاني السكريمرض ما قبل السكري إلى من مرض تحول ال
 .السكر التراكمي في الدم معدل، المتحدة
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Chapter 1: Review of Literature 
1.1 Overview of Prediabetes 
Prediabetes is a stage of intermediate hyperglycemia between normal glucose 
tolerance and type 2 diabetes mellitus (DM), that is observed in the fasting and/ or 
postprandial stage1. Prediabetes not only correlates for future incidences of DM, but 
also prefigures other non-communicable diseases (NCD). 
The concept of prediabetes has been around since the 1950s. From 2000 onwards, 
the term prediabetes started to be commonly used2. Both the World Health Organization 
(WHO) and the American Diabetes Association (ADA) have used the term ‘Intermediate 
Hyperglycemia’ and ‘High Risk State of Developing DM’ respectively, rather than 
prediabetes. The term prediabetes has been criticized for many reasons. One of these is 
that many people with the condition may not eventually develop DM. Furthermore, the 
term prediabetes could indicate that people with the condition are actually healthy (with 
no disease currently present) and imply that no intervention is required, despite the fact 
that prediabetes is a major public health concern and requires early intervention3. 
1.1.1 Pathophysiology of Prediabetes 
An important metabolic concern is the disturbance of glucose-insulin 
homeostasis. Impaired fasting glucose (IFG) or glycaemia refers to elevated glucose 
levels in a fasting state that are not yet at the level of diabetes. Impaired glucose 
tolerance (IGT) can be defined by elevated postprandial glucose levels, indicating an 
impairment in the capacity of the human body to handle consumed carbohydrates. It 
is evaluated by administering an oral glucose tolerance test (OGTT). 
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Insulin resistance is where a normal amount of insulin is not enough to yield a 
predictable glucose response in muscles, the liver, and adipose tissues. A study has 
shown that genetics plays a role in insulin resistance and this can be worsened by 
environmental factors, such as obesity (especially central obesity and related visceral 
fat) and PA4. Therefore, interventions that improve insulin resistance and limit the 
secretary load on beta cells has been proven to prevent prediabetes progressing as far 
as DM. 
The mechanisms for IGT and IFG are different depending on where exactly the 
body is failing to respond to insulin5. For IFG, insulin resistance is mainly located in 
the liver, while for IGT it is in the muscle6. The patterns of insulin resistance for both 
disorders (IFG and IGT) also differ. Insulin is usually secreted in two stages following 
a meal, the early and late phases. The early phase occurs 30 to 60 minutes after 
consumption, while the late phase occurs from 60-120 minutes. Abnormalities in 
insulin secretion in the early phase lead to IFG and in the later phase they lead to IGT. 
In people with IGT, muscle tissues are resistant to insulin. Therefore, glucose blood 
levels remains high for two hours after the meal, despite the fact that they remains 
normal after fasting overnight and between meals. In people with IFG, blood glucose 
levels are elevated in the morning and for half an hour after they have eaten food, as 
the liver will secrete because it is resistant to the insulin. Therefore, in people with 
IFG, an early insulin response is abnormal while a late insulin response is the norm7. 
Impaired Beta Cells Function 
The pancreas is a vital organ consisting of the pancreatic islet, or the islet of 
Langerhans. These islets are scattered throughout the pancreas. They consist of 
different cell types, including insulin secreting beta cells, glucagon producing alpha 
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cells and pancreatic polypeptide producing delta cells8. An appropriate beta cell 
function requires there to be a normal beta cell anatomy, which is essential for an 
appropriate response to a changeable metabolic need for insulin. Beta cell dysfunction 
results from there being inadequate glucose sensing that would stimulate insulin 
secretion. Therefore, elevated glucose concentrations prevail. A constant elevation in 
the level of glucose above the normal range results in prediabetes. At least a 60% 
decrease in beta cells is required to develop DM4. Beta cell dysfunction is more serious 
than insulin resistance, as is found in beta cell dysfunction. Insulin secretion is reduced, 
but can still be secreted even when there is insulin resistance. 
Beta cell dysfunction is correlated to the 2-hour plasma glucose level during 
OGTT in normal glucose tolerant individuals. It is also a correlate for people with 
normal glucose level becoming IGT and, thus, eventually transitioning to DM. In 
people with IGT, there is a 70%-80% decline in beta cell function4. Therefore, 
interventions that stop, or delay, the dysfunction of beta cells are valuable tools in 
fighting DM. 
1.1.2 Diagnosis and Screening of Prediabetes 
The WHO proposed the term prediabetes as early as 1980, but later 
discouraged people from using it because slightly increased glucose levels do not 
always translate into DM. In 2005, the ADA proposed the term prediabetes for 
impaired glucose tolerance (IGT) and impaired fasting glucose (IFG). However, 
different cut-off values were used for IFG – 5.6 mmol/l by the ADA9 and 6.1 mmol/l 
by the WHO10. Thus, different criteria were used in parallel to define prediabetes as 
an intermediate phase of altered blood glucose concentration between normal glucose 
levels and DM that was not yet serious enough to be diagnosed as DM comprising of 
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IFG and IGT11. FBG and OGTT were used for the diagnosis of prediabetes by the 
ADA and the WHO, and lately HbA1c has been added to these criteria12. HbA1c refers 
to glycated hemoglobin, which mirrors overall blood glucose levels present two to 
three months prior to laboratory testing. A consensus on the diagnostic criteria that 
defines prediabetes has not yet been agreed13. 
Although the ADA has recommended HbA1c as a diagnostic tool for 
identifying prediabetic adults at risk of developing DM, several points need to be taken 
into consideration. Firstly, the ADA considered HbA1c to be a poor diagnostic tool for 
prediabetes, due to low sensitivity and specificity14. Secondly, the accuracy of the 
HbA1c test to diagnose prediabetes in adults, and its correlation to mean serum glucose 
concentrations, requires more work to identify how several covariates can influence 
the HbA1c level in adults. These covariates are age, race/ ethnicity and mineral 
deficiencies among others)15. 
The ADA recommends that if a diagnostic test needs to be repeated, it is 
preferable to repeat the same test as there is greater likelihood of an agreement with 
the initial test result1. However, if two different tests have been performed and the 
results are in conflict regarding a diagnosis of DM, it is the test that yielded the positive 
result that should be repeated.  
In contrast to previous recommendations specifying FBG as the preferred test, 
new criteria leave the choice of diagnostic test to the physician. In total 19,182 
participants, aged ≥12 years, were interviewed in the United States to identify the 
prevalence of prediabetes. This study utilized HbA1c 5.7-6.4% or FBG 100 to 125 
mg/dl: OGTT was not used. Overall, there was an increase in the prevalence of age-
adjusted prediabetes from 27.4% in 1999-2002 to 34.1% in 2007-2010 according to 
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the HbA1c criterion. However, the prevalence of prediabetes, when using IFG with 
the same population, remained fundamentally unchanged (23.8-25.9%) over the same 
period16. 
a) Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) 
IFG and IGT are types of prediabetes where the patient’s blood sugar level is 
constantly greater than normal levels, but not high enough for a diagnosis of DM to be 
made. The ADA’s most recent (2010) definition of IFG is a fasting blood sugar level 
of 5.6-6.9 mmol/l (100 mg/dl to 125 mg/dl - a measurement of 2-hour post load glucose 
is not recommended). This cut-off point is lower than the one set by the WHO, where 
the fasting blood sugar is ≥6.1 and <7.0 mmol/l and the 2-hour post load is  <7.8 
mmol/l (if measured)16. The reason the ADA set a lower fasting glucose level is to 
make the prevalence of IGT and IFG consistent. However, this did not achieve its 
target and instead led to an approximately three to four-fold increase in the overall 
prevalence of IFG17. In most populations, IFT is more common than IGT. Data from 
the United States indicates that the prevalence of IFG and IGT is around 26% and 15% 
respectively18. It is predicted that both will rise in the future. Furthermore, the 
prevalence varies considerably according to a person’s age and sex. 
The prevalence of IFG, compared to IGT, is higher in older people and among 
men than it is in women for some unknown reasons3. The IFG level tends to incline to 
a plateau in middle age, while the prevalence of IGT increases in old age. The 
European Diabetes Epidemiology, a collaborative analysis of diagnostic criteria in 
Europe, showed a prevalence of IGT that was 2.9% in men aged 30-39 and 15.1% in 
those aged 70-7919. Both IFG and IGT are related to a substantially increased risk of 
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developing DM, with the highest risk being in people who have combined IFG and 
IGT20. 
b) Glycated hemoglobin HbA1c 
Glycated hemoglobin (also called hemoglobin A1c, HbA1c, A1C or Hb1c) is 
the product of non-enzymatic glycosylation of hemoglobin β-chains and the measure 
of glucose bound to the hemoglobin. It is equivalent to the overall level of glucose in 
the blood over the previous two to three months (which is the lifespan of red blood 
cells)21. Poor glycemic control leads to the elevation of HbA1c levels and vice versa. 
It has been used to assess glycemic control since 197622.  
The ADA recommended using the HbA1c 5.7-6.4% test as a method of to 
diagnose prediabetes in 201523. However, it did not establish firm guidelines for the 
use of the HbA1c test in adolescents, as their study did not validate thresholds for this 
group. Research has shown that HbA1c results are affected by a variety of factors 
influencing glycemic control. These factors are classified as non-modifiable. 
Modifiable factors include BMI, vitamin D/ iron/ magnesium levels, PA, red cell 
lifespan, renal and liver function and pregnancy. Non-modifiable factors are age, 
ethnicity/ race, genetic factors, family history, infection, hormonal and autoimmune 
conditions. Consequently, the HbA1c test has not been used consistently by clinicians 
to identify individuals with prediabetes24. 
Using HbA1c for the diagnosis of prediabetes has many advantages. These 
include the convenience of the test with no need to fast beforehand. It exhibits good 
stability after specimen collection and also reproducibility (including less day-to-day 
variability in comparison with either the FBG or 2-hour postprandial glucose level) 
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and can successfully detect adult individuals at a lower risk of developing DM24. The 
International Expert Committee, appointed by the ADA and the European Association 
for the Study of DM, has warned of the tests limitations. These are the fact that the 
HbA1c test is expensive when compared to OGTT, and is not readily available in 
developing countries.  
The committee found that the HbA1c test did not accurately diagnose DM as 
well as other tests, such as the FBG or OGTT. Therefore, use of HbA1c alone to 
diagnose DM, or prediabetes, requires that it be translated into a meaningful clinical 
practice1, or that a combination of the HbA1C and FBG tests is used in the diagnosis 
of prediabetes. This can decrease the risk of any systematic bias inherent when testing 
only with HbA1c25. 
HbA1c has been shown to correlate with the likelihood of diabetic retinopathy 
and microvascular complications. This continuous linear relationship is even stronger 
than that of FBG. The ADA and WHO have set a cut-off point for HbA1c of 6.5% as 
the diagnostic criteria for prediabetes, because retinopathy increases above this level. 
This is in addition to previous criteria that uses IFG and IGT26. 
1.1.3 Classification of Prediabetes and DM 
Current ADA guidelines for the diagnosis of prediabetes and DM27 are as follows: 
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Table 1.1: The ADA guidelines for diagnosis of prediabetes and DM (2017) 
Categories for diagnosis of prediabetes   
FBG  2-hour post prandial glucose  HbA1c  
100-125 mg/dl (5.6-6.9 mmol/l) 
IFG and 
140-199 mg/dl (7.8-11.0 mmol/l) 
IGT Or 
5.7-6.4% 
(39-46 mmol/mol)  
Criteria for DM diagnosis 
≥126 mg/dl (7.0 mmol/l) or 
≥200 mg/dl (11.1 mmol/l) during 
OGTT (75-g) or 
 
≥6.5% (48 mmol/mol) 
or 
 
Random PG ≥200 mg/dl (11.1 mmol/l) 
 
 
Current WHO guidelines for diagnosis of prediabetes and DM28 are as follow: 
Table 1.2: WHO guidelines for diagnosis of prediabetes and DM (2017) 
Categories for diagnosis of prediabetes 
FBG  2-hour post prandial glucose  HbA1c  
110-125 mg/dl (6.1-6.9 
mmol/l) 
IFG 
140 mg/dl (<7.8 mmol/l) 
IFG 
 
126 mg/dl (<7.0 mmol/l) 
IGT 
140-200 mg/dl (7.8-11.0 mmol/l) 
IGT  
Categories for diagnosis of DM   
≥126 mg/dl (7.0 mmol/l) 
 
≥200 mg/dl (11.1 mmol/l) 
≥6.5% 
(48 mmol/mol)  
 
1.1.4 Epidemiology of Prediabetes 
The prevalence of prediabetes is increasing worldwide. It is estimated that 
>470 million people will have prediabetes by 2030, and the highest increase is 
expected to be in South-East Asia and the Western Pacific Region3. The prevalence of 
prediabetes differs, depending on the criteria used for diagnosis16. Studies have shown 
that only using the FBG level for the diagnosis of prediabetes results in an 
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underestimate of the scale of the disorder29. Therefore, HbA1c remains a useful 
complimentary tool alongside FBG for the diagnosis of prediabetes26. 
In the United States (USA), the prevalence and emerging trends of prediabetes 
and DM from 1988-2012 among adults aged 18 and above were described by the 
National Health and Nutrition Examination Survey. The incidence of DM was 
identified by using a self-reported diagnosis of DM, or HbA1c (≥6.5%) or FBG (126 
mg/dl) or a 2-hour PG (200 mg/dl) if DM had not been previously diagnosed. 
Furthermore, prediabetes was defined by HbA1c (5.7-6.4%) and FBG (100-125 
mg/dl), or a 2-hour PG (140-199 mg/dl). In this study, it was reported that the crude 
(unadjusted) tally for DM was 14.3% (95% CI 12.2-16.8%). The age-standardized or 
age-adjusted prevalence of DM increased from 9.8% (95% CI 8.9%-10.6%) in 1988-
1994 to 12.4% (95% CI 10.8%-14.2%) in 2011-2012 (p<0.001 for trend). Furthermore, 
DM in the USA increased in all of the age groups, as well as in both sexes and every 
racial and ethnic group surveyed. In the same study, the crude percentage for 
prediabetes in adults was 36.4% (95% CI 30.5-42.7%). Moreover, the prevalence of 
prediabetes was particularly high in Hispanics in the USA30. 
In Canada, the incidence of prediabetes and DM among adults aged 20 and 
above was estimated using the Canadian Health Measurement Survey (n=3,494)31, a 
national population-based sample. Prediabetes and DM were defined by using the 
Canadian guidelines, based on fasting FBG and HbA1c levels. Prediabetes was defined 
as an FBG level of ≥6.1 and <7.0 mmol/l or an HbA1c level of ≥6.0% and <6.5% (≥42 
and <48 mmol/mol). DM was defined as an FBG level of ≥7.0 mmol/l or an HbA1c 
level of ≥6.5% (≥48 mmol/mol). The prevalence of prediabetes was 4.3% (95% CI 
3.4-5.3) based on FBG criteria [(males 6.4%; (95% CI 4.6-8.8), females 2.2% (95% 
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CI 1.7-3.0)]. The prevalence of prediabetes was 12.5% (95% CI 8.7-17.8) based on 
HbA1c criteria (males 11.8%; 95% CI 8.1-16.8, females 13.3%; 95% CI 8.9-19.5). 
Using both criteria (FBG or HbA1c), the prevalence of prediabetes was 15.2% (95% 
CI 11.4-19.9) on average with 15.8% for males (95% CI 11.8-20.7) and 14.6% for 
females (95% CI 10.4-20.1). The overall prevalence of DM was 5.6% when using the 
FBG criteria, 7.7% with HbA1c criteria and 7.7% with FBG or HbA1c. 
The trend in the incidence of prediabetes in England between 2003 and 2011, 
for individuals aged 16 and above, was investigated by using data from the Health 
Survey for England. Individuals were classified as having prediabetes if the HbA1c 
level was between 5.7% and 6.4%32. According to the findings of this study, the 
prevalence of prediabetes increased from 11.6% in 2003 to 35.3% in 2011. Socio-
economically deprived subjects were found to be at a substantial risk of developing 
prediabetes after controls for age, gender, race/ ethnicity, BMI and BP were all taken 
into account.  
While in developed countries, this increase in prediabetes can be traced to an 
increase in obesity, an ageing population and an increased life expectancy for people 
with prediabetes33, in developing countries it is due to rapid urbanization, increasingly 
sedentary lifestyles and unhealthy eating habits34. A high rate of DM and prediabetes 
has been reported in many developing countries. The prevalence of prediabetes and 
DM was examined in a population-based sample (n=57117) of adults aged 20 years or 
above in 15 Indian states using WHO criteria35. The overall prevalence of prediabetes 
was 10.3% (95% CI 10.0-10.6). This was higher in urban areas (14.7%; 95% CI 13.6-
15.9) when compared to rural ones (6.0%; 95% CI 5.1-6.8). The overall prevalence of 
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DM was 7.3% (95% CI 7.0-7.5). It was higher lowly socio-economic groups, 
particularly in urban settings. 
In China, the prevalence of prediabetes and DM was estimated via a cross-
sectional design in a random nationally representative sample of adults (n=170287). 
DM and prediabetes were identified, based on FBG, HbA1c and a 2-hour OGTT that 
followed the ADA’s classification system. The overall prevalence of prediabetes was 
35.7%, while DM was 10.9% (95% CI 10.4-11.5), and already diagnosed DM stood at 
4.0% (95% CI 3.6-4.3). The incidence of both DM and prediabetes varied by ethnicity. 
There was a lower incidence in Tibetan (31.3%) and Muslim Chinese (31.9%)36.  
The prevalence of prediabetes and DM was estimated in a demographic and 
health survey of 7,541 adults aged 35 or over in Bangladesh in 2011. Prediabetes was 
defined as a FBG level of 6.1 mmol/l to 6.9 mmol/l without DM medication. DM was 
defined as a FPG level ≥7.0 mmol/l with the self-reported use of DM medication. The 
prevalence of prediabetes and DM was estimated to be 22.5% and 10%, respectively. 
The overall age-adjusted prevalence of DM and prediabetes was 9.7% and 22.4%, 
respectively. Among urban inhabitants, the age-adjusted prevalence of DM was 15.2% 
as compared to 8.3% in the rural population. The risk of prediabetes in Bangladesh 
increased with age, and among wealthier and better-educated individuals, as well as in  
those with hypertension37. 
A community-based survey was conducted in Saudi Arabia in 2016 on 18 year-
olds whether Saudi or not living in Jeddah (N=1420)38. DM and prediabetes were 
identified, based on FBG and HbA1c, using the WHO’s classification system. Those 
with FBG of 100-125 mg/dl, and/ or HbA1c 5.7-6.4% were identified as having 
prediabetes. People with FBG of ≥126 mg/dl, and/or HbA1c ≥6.5% were categorized 
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as DM. Also, self-reporting of any previous diagnosis of DM and those taking drug 
treatments for DM were both classified as having DM. The prevalence of prediabetes 
and DM was 11.9% and 18.3%, respectively. The age and sex-standardized incidences 
of prediabetes was 9.0% (95% CI 7.5-10.5): 9.4% (95% CI 7.1-11.8) in men and 8.6% 
(95% CI 6.6-10.6) in women. For DM, it was 12.1% (95% CI 10.7-13.5): 12.9% (95% 
CI 10.7-13.5) in men and 11.4% (95% CI 9.5-13.3) in women. Also of note is that the 
prevalence of prediabetes and DM increased with age.  
The prevalence of prediabetes in Oman in 2011 was estimated by using a cross-
sectional design with an adult sample group aged 18 to 60 (n=1,600)39. Prediabetes 
was identified, based on FBG (100 mg/dl and 126 mg/dl) and OGTT (140 mg/dl and 
200 mg/dl) levels. The overall prevalence of prediabetes in Omani adults was 35% and 
this increased with age. A higher prevalence of prediabetes was found among married, 
divorced, and widowed people, as compared to those who never married. A higher 
prevalence was also found among those with a lower level of education, the 
unemployed, smokers, and people with hypercholesterolemia and dyslipidemia39. 
In the UAE a multi-ethnic expatriate population accounts for 80% of the 
population of the country. The prevalence of prediabetes has previously been 
documented in native Emiratis in two studies. In 2007, a population-based sample was 
obtained from 452 householdsin al Ain. There were 2,455 adult (>18) Emirati citizens 
in this study. Their prediabetic status was based on a fasting venous blood glucose 
concentration of 5.6-6.9 mmol/l or a 2 hour post-OGTT venous blood glucose level of 
7.8-11.0 mmol/l. DM was defined according to WHO criteria. The prevalence of 
prediabetes and DM was 20.2%, and 10.5% respectively. Age-standardized rates for 
prediabetes and DM among 30-64 year olds were 24.2% and 29.0%, respectively40. 
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The Weqaya study conducted in 2010 obtained data from 50,138 Emirati adults aged 
18 or above in 25 primary care screening centers in Abu Dhabi. Participants with 
HbA1c of 5.7%-6.4% were categorized as having prediabetes. Participants with a 
history of adult-onset DM and those on DM medication, an HbA1c of 6.5% or higher, 
or a random glucose level of 11.1 mmole/L were considered to have DM. The 
prevalence of prediabetes and DM was 27% and 18%, respectively41. Correlates for 
prediabetes were not evaluated in either of these studies.  
Shah and his team reported on prediabetes and DM in a random sample 
(n=599) of female expatriates (non-UAE nationals) which included South Asian, Arab 
and Filipino subjects, aged 18 years and above living in Al-Ain (UAE) in 2012-13. 
The ADA guidelines on HbA1c were used to diagnose prediabetes (an HbA1c level of 
5.7-6.4%) and DM (an HbA1c level ≥6.5%). In this cross-sectional study, the 
prevalence of prediabetes and DM was estimated at 18.6% (95% CI 13.9-24.4) and 
10.7% (95% CI 7.2-15.6), respectively. The prevalence of prediabetes was 8.5% in 
Filipinos, 16.7% in Arabs and 30.3% in South Asians. The prevalence of DM was 
1.7% in Filipinos, 12.2% in Arabs and 16.7% in South Asians. The prevalence of DM 
and prediabetes increased with the length of time spent in the UAE even after 
controlling for age. 
Prediabetes is a significant economic burden. Identifying people with 
prediabetes is worthwhile from a clinical, financial and public health point of view1. 
In the last 5 years, the cost of prediabetes has increased by 74% to $44 billion. The 
increase is worrying as it means new cases of DM are not just an existing economic 
burden, but will also pose a potentially greater future burden unless prevention efforts 
are successfully implemented42. In the UAE, the annual medical cost of DM reached 
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$60 million (AED 220 million). The DM prevention program has shown that making 
lifestyle changes, including losing weight, increasing PA and changing one’s diet can 
significantly decrease the risk of developing prediabetes and DM43. 
1.1.5 Correlates of Prediabetes 
As the onset of DM can be prevented or delayed, identifying reversible 
correlates is essential in attempting to control the recent epidemic of DM44. It is 
possible that correlates for prediabetes could mirror those for DM45.  
According to guidelines from the European Society for Cardiology and the 
European Association for the Study of DM, prediabetes is associated with numerous 
conditions, including obesity, central obesity, ageing, physical inactivity, low 
consumption of fruit and vegetable, hypertension and a family history of DM. 
Furthermore, the American College of Endocrinology and the American Association 
of Clinical Endocrinology, have identified correlates for DM and prediabetes. They 
are as follows: a family history of the condition, being overweight or obese, an 
unhealthy lifestyle and hypertension46. Other correlates can include race/ ethnicity47, 
abuse of alcohol, poor sleep patterns and obstructive sleep apnea, smoking, poor eating 
habits and a sedentary lifestyle48,49. 
a) Age 
Age is a correlate for many diseases. According to the European Society for 
Cardiology and the European Association for the Study of Diabetes, age can be 
correlated for both prediabetes and DM. Furthermore, this causal connection has been 
confirmed by a study using secondary data from the Basic Health Research Survey 
conducted by the Ministry of Health in the Republic of Indonesia. This was a cross-
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sectional study of 24,417 adults (aged 18 and above) from 33 provinces across 
Indonesia46. 
b) Family History 
Having a family history of DM in a first degree relative, doubles the risk of 
developing DM and prediabetes, respectively, in the offspring. This correlation is 
evident even in the absence of obesity. Several studies have examined the association 
between a family history of DM and prediabetes. In Germany, 5,400 people with 
normal blood sugar levels and more than 2,600 with prediabetes were examined and it 
was found, after adjusting for sex, age and BMI, that people with a family history of 
DM were 26% more likely to develop prediabetes50. An earlier study in Sweden also 
established a 50% increased risk of prediabetes in people with a family history of 
DM51. 
c) Obstructive Sleep Apnea 
Apnea attacks can occur anywhere from a few times to hundreds of times in 
one night44. Observational studies have identified sleep apnea as a correlate for 
prediabetes and DM52,53. In the UK, a study confirmed that sleep apnea was a correlate 
for DM, and effects the metabolism of glucose. This study involved 1,682 adults with 
DM who answered a questionnaire and it also utilized overnight oximetry53. This 
relationship can be explained by the sympathetic nervous system, the hypothalamic-
pituitary-adrenal stress axis, and pro-inflammatory pathways becoming activated by 
chronic intermittent hypoxia and/ or sleep. Therefore, screening for sleep apnea should 
be standard practice for every patient with DM54. 
 
16 
 
 
 
 
d) Obesity 
Obesity is a reversible correlate for prediabetes and DM55. Men and women with 
abdominal obesity both displayed the strongest association to developing prediabetes. 
This relationship was stronger in men when compared to women56. Adipose tissue 
produces free fatty acids, adipocytokines, hormones, and other substances involved in 
insulin resistance57. Waist circumference (WC) is another proven correlate for 
prediabetes and DM58. These mechanisms are not clear but it might be because of the 
release of fatty acids from excess adipose tissue, inducing resistance to insulin in the 
muscle which, in turn, leads to a rise in plasma glucose levels59. Studies from around 
the world have confirmed that obesity is one of the main correlates for prediabetes and 
DM27,60. A cross-sectional study of 3,494 adults (≥20 years of age) obtained from a 
Canadian Health Measures Survey, showed that a high BMI and WC were associated 
with a higher prevalence of prediabetes and DM31. There was a similar finding in data 
collected from the 2011-2012 in the National Health and Nutrition Examination 
Survey in the USA30. 
e) Physical Inactivity  
PA (including aerobic, resistance, flexibility and balance exercises) is critical for 
an individual’s overall well-being and plays a key role in controlling blood glucose 
levels and BMI61. Adopting and maintaining regular PA (at least 150 minutes a week) 
improves our sensitivity to insulin and protects against prediabetes and DM62. 
According to the Pre-diabetes Consensus issued by the American College of 
Endocrinology and the American Association of Clinical Endocrinology, an unhealthy 
lifestyle and physical inactivity are correlates for prediabetes and DM63. 
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1.1.6 Complications of Prediabetes 
People with prediabetes have a higher risk of heart disease3, nephropathy, 
retinopathy, neuropathies32, strokes26, DM and also higher mortality rates16. The 
reasons prediabetic people develop these complications are not entirely clear. 
However, it may be due to many causes such as the effect of higher blood glucose, the 
presence of other abnormal metabolites, such as free fatty acids, or the occurrance of 
correlates, that include dyslipidemia, hypertension and insulin resistance65. 
Furthermore, studies have shown that glucose levels lower than those that currently 
meet the definition of prediabetes might also be related to similar complications with 
prediabetes, mostly in high-risk individuals64. 
a) Neuropathies 
Diabetic neuropathies are a heterogeneous group of disorders that have a 
variety of clinical signs. Nerve damage, or diabetic neuropathy, results from 
persistently high blood glucose levels. Although, it may take decades to develop, it is 
considered as one of the most incapacitating complications of DM because of the pain 
it causes and the lack of treatments available. The pain is due to the small fibers, which 
cause an unpleasant sensation of burning and tingling. The large fibers can also 
become involved, leading to numbness and the loss of protective sensations. This is 
correlated to diabetic foot ulceration. Although pain or numbness in the legs or feet 
might be the most common way of identifying neuropathy, it can also produce other 
symptoms, such as increased male erectile dysfunction, a higher frequency of 
idiopathic polyneuropathy, painful sensory neuropathy and the dysfunction of cardiac 
autonomic activity. This is manifested in reduced heart rate variability and 
parasympathetic modulation of the heart66. 
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There are four types of diabetic neuropathy: peripheral neuropathy, proximal 
neuropathy, autonomic neuropathy and focal neuropathy. This study has demonstrated 
that subclinical small unmyelinated nerve fiber neuropathy67 and autonomic 
neuropathy are commonly present in prediabetic patients with IGT. It is usually milder 
than the neuropathy suffered by people with DM68. 
b) Nephropathy and Kidney Disease 
Diabetic nephropathy accounts for a significant amount of morbidity and 
mortality and is the principal cause of chronic kidney disease in Western countries 
including the United States69. It can be characterized by structural and functional 
changes in the kidney and is often diagnosed by persistent albuminuria (>300 mg/d or 
>200 μg/min). This must be detected on at least two occasions that are three to six 
months apart. Additionally, there is a progressive deterioration in rate of glomerular 
filtration and  higher arterial BP70. 
Despite the fact that not everyone with DM develops diabetes neuropathy, it is 
a well-known condition amongst such people71. The cause of this is unclear, but 
cardiovascular disease (CVD) may explain much of the relationship between 
prediabetes and the development of chronic kidney disease72. Individuals with 
prediabetes need earlier detection and treatment to prevent the development, 
progression and complications of chronic kidney disease. This includes intensive 
glycemic control where the aim is to reach something close to normoglycemia and 
keep BP (BP) below 140/90 mmHg66. 
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c) Retinopathy 
Diabetic retinopathy is the most common reason for loss of vision in adults 
aged 20-74 years in the USA. The duration of DM and the level of glycemic control is 
the strongest correlate for the progression of diabetic retinopathy. High blood sugar 
damages micro blood vessels in the retina, leading to increased vascular permeability, 
hemorrhage and distortion of vision. In its most advanced stage, this can result in the 
formation of abnormal blood vessels on the surface of the retina and the posterior 
surface of the vitreous (proliferative diabetic retinopathy), causing scarring and cell 
loss in the retina. Macular edema can develop at every stage of retinopathy and is 
characterized by retinal thickening caused by leaky blood vessels73. 
The current study shows that retinopathy, a characteristic of DM, is present in 
people with prediabetes. In the DM prevention study, 7.9% of prediabetes patients had 
retinopathy74. Another study reported that IGT causes a fourfold increase in the 
incidence of retinopathy, when compared to age-matched control subjects65. Screening 
for diabetic retinopathy can prevent blindness by allowing for intervention and 
treatment to take place. Strict blood glucose and blood pressure control and timely 
laser photocoagulation therapy can prevent stop or, at least, delay the progression of 
diabetic retinopathy and thus prevent a loss of vision. 
d) Cardiovascular Disease 
Atherosclerotic CVD is defined as having a history of one of the following: a 
stroke, transient ischemic attack, peripheral arterial disease, stable/ unstable angina, 
acute coronary syndrome, myocardial infarction or arterial revascularization. It is the 
leading cause of mortality and morbidity worldwide. Large epidemiological studies 
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have shown that there is an association between an individual with IFG and IGT and 
an increased incidence of CVD and mortality75. Twigg et al. found that there was a 
two to threefold increased risk of CVD in adults with prediabetes, independent of its 
eventual progression to DM45. Therefore, early intervention at the prediabetes  stage 
can prevent diabetic macrovascular complications76. 
Typical diabetic microvascular complications77 also occur in nearly one tenth 
of prediabetic patients and are improved once restoration of the normoglycemia has 
been achieved4. This relationship may be confounded by other common correlates that 
are present between CVD and prediabetes66. This study indicates that IGT and HbA1c 
are associated with metabolic syndrome and correlate strongly with CVD as compared 
to IFG78. However, there is still an absence of longitudinal follow-up studies that 
compare HbA1c to OGTT in terms of the prediction of CVD. 
1.1.7 Screening and Control of Prediabetes 
In the last decade, the prevalence of DM has increased enormously worldwide. 
The IDF has put forward the idea of early diagnosis of prediabetes via screening and 
intervention as a fundamental strategy required for the accurate identification of people 
with prediabetes. Therefore, a robust and convenient screening test is essential to 
reduce, prevent and control the overall societal costs of DM and to stop prediabetes 
from progressing to DM. Screening for blood glucose has been used to identify 
individuals at high risk of developing DM or asymptomatic DM. Once prediabetes has 
been diagnosed, an aggressive treatment plan must be implemented in order to prevent, 
or slow down, the progression to DM.  
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Several recent randomized trials with adult subjects have confirmed that DM 
can be prevented, or delayed, through lifestyle intervention programs that promote 
improvements in diet, increased PA and weight loss. In the Finish Diabetes Prevention 
Study79, 522 adults with IGT were randomized and received either a brief diet, a brief 
diet or exercise counseling (control group), or intensive individualized instruction on 
weight reduction through dietary control and PA (intervention group). After an average 
follow-up time of 3.2 years, there was a 58% relative reduction in the incidence of DM 
in the intervention group when compared to the control group. Similarly, in a Diabetes 
Prevention Program in the US80, 3,234 subjects were randomized, according to their 
lifestyle, medication (metformin) or received a placebo. Compared with the placebo 
group, there was a 58% reduction in the progression to DM in the lifestyle intervention 
group, and a 31% relative reduction in the progression of DM in the metformin group 
over a period of 2.8 years on average.  
Identifying patients with prediabetes, and then intervening before it has 
progressed to DM, has significant benefits for both individuals and healthcare systems. 
On an individual level, it leads to an improvement in health thanks to early referral to 
specialists and by beginning treatment before the onset of complications. Such 
complications include micro and macro-vascular diseases, as well as other co-
morbidities. Furthermore, studies have shown that prediabetic adults, who are aware 
of their condition are more likely to get involved in DM risk-reducing activities 
compared to people who are unaware81. In addition, the early detection of prediabetes 
is cost-effective, as it leads to a reduction in the demands on the healthcare system and 
gives DM patients a better chance of obtaining higher quality healthcare services82. 
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This study has shown that prediabetic adults, who are aware of their condition 
are more likely to get involved in activities to reduce their risk of developing DM than 
those who are unaware of the issue81. Furthermore, there are no clear and especially 
specific symptoms for prediabetes. Some people with prediabetes might have 
symptoms such as fatigue and an increased appetite, or other complications of DM. 
Therefore, a patient could have prediabetes without knowing it, making screening 
vital80. As such, the ADA has recommended that screening for prediabetes should start 
at age 45 and above for those who have no previous DM correlate1. However, it 
recommends that overweight and obese people with one or more DM correlate should 
be screened regardless of age, even if they are asymptomatic. Normally, testing these 
groups requires repeated measures at a minimum of three-year intervals1. According 
to the WHO, the downturn in the implementation of screening programs for 
prediabetes and DM is down to cost involved and the increasing load on the healthcare 
system. There is a need to not only screen for such cases, but also for treating the 
increasing number of individuals diagnosed with prediabetes and DM28. 
1.2 Overview of Obesity and its Role in Diabetes and Prediabetes 
DM is fast becoming a major cause of illness and premature death worldwide 
and its increase parallels a rise in obesity. With greater economic prosperity in the 
UAE, the population has settled into a sedentary, well-fed lifestyle. Reports from the 
UAE show that it has one of the highest rates of obesity in the world and this might 
result in more DM and prediabetic cases. 
Obesity is a major public health problem. It is principally a social and 
environmental disease. The WHO considers “globesity” to be a growing epidemic, not 
only in developed countries, but also in developing ones. This often neglected yet 
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visible problem leads to a variety of health consequences, ranging from the increased 
risk of premature death through a reduction in quality of life, to chronic diseases, like 
cancer, CVD and DM83. 
1.2.1 Definition and Classifications of Obesity 
a) BMI Classification of Obesity 
 
Obesity is defined as the accumulation of abnormal or excessive fat that puts 
health at risk. There are several ways to the percentage of body fat. Some are used in 
clinical settings and others in research environments. In research, methods include the 
use of magnetic resonance imaging, multi-frequency bioelectrical impedance analysis 
and underwater weighing (densitometry). In a clinical environment, the techniques 
used are less accurate for the percentage of body fat, but are appropriate to identify 
correlates for different diseases. These methods include the use of the body mass index 
(BMI), WC and skin-fold thickness.  
Adult obesity can be classified by using BMI. It uses two body dimensions to 
describe people as being overweight and/ or obese: a person’s weight in kilograms (kg) 
divided by the square of his or her height in meters (m2). The WHO has classified 
people with a BMI (kg/m2) of 18.50-24.99 to be within the normal range, those with a 
BMI (kg/m2) of 25.00−29.99 to be overweight and those with a BMI (kg/m2) that is 
greater than, or equal to, 30 are considered as obese. Obesity can be sub-classified into 
class I (BMI 30.00-34.99), class II (BMI 35.00-39.99) and class III (BMI ≥40)84. 
BMI is the most common screening test for obesity. It is reliable, easy to 
measure and its values are age-independent, and it is similar for both genders85. BMI 
correlates well with the percentage of body fat and vital health outcomes, like coronary 
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heart disease and DM. As it increases, mortality rates increase as well. This makes it a 
good tool for screening, monitoring the effect of treatment and determining 
institutional policies for individuals. BMI is limited, however, because it is unsuitable 
for children due to their growing and changing body shape. It fails to distinguish 
between fat and fat-free mass, like muscle and bone, which can lead to obesity being 
exaggerated in large muscular individuals.  
WHO classifications of being overweight and obese can be used 
internationally. However, Mascie-Taylor and Goto have a different opinion86. They 
have taken into consideration the differences between ethnicities, and concluded that 
a universal BMI cut-off point does not seem appropriate for all ethnic groups. 
Therefore, there is a growing discussion on whether there is a need to develop different 
BMI cut-off points for different ethnic groups, as the current WHO cut-off point does 
not provide an adequate basis for taking action when it is used with the Asian 
population, for example. There are several reasons for this. Firstly, Asian people have 
a higher percentage of body fat than Caucasian people of the same sex, age and BMI. 
Secondly, the proportion of Asian people with correlates for DM and CVD is large, 
even below the WHO cut-off point for being overweight (25 kg/m2). Also, BMI 
grading in relation to the risk of disease may vary for different populations84. For 
example, an obese lady (class one) will have a greater risk of disease if her WC is 
higher than 88 cm, compared with a similar lady with a normal WC (<88 cm).  
In 2002, WHO experts suggested that the international cut-point be used in the 
Asian population for reporting purposes only. However, for public action the cut-off 
points (23.0, 27.5, 32.5, and 37.5 kg/m2) must be lower level than for the European 
population in general. Studies from Singapore and Hong Kong reported that a higher 
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percentage of body fat at a lower BMI reflected an increase in the correlates for chronic 
diseases and death in the Asian population. Likewise, Chinese studies have indicated 
that a prevalence of hypertension, DM and dyslipidemia increases with the increase in 
the BMI, even at indices that are below the current cut-off point for being overweight. 
For many Asian populations, the cut-off point of 18.5-23 kg/m2 represents an 
acceptable risk, 23.0-27.5 kg/m2 represents an increased risk and 27.5 kg/m2 and 
higher represents high risk86.  
Although BMI has usually been the indicator used to measure body size and 
composition, WHO reports have confirmed that using other methods for measuring 
abdominal adiposity, such as WC, waist-hip ratio and waist-height ratio (WHR), are 
superior to BMI for predicting the risk of CVD. BMI and WC combined predict greater 
variants in health risk than just using BMI alone83. The National Heart Lung and Blood 
Institute confirmed that it was the same for WC87. 
b) Central or Abdominal Obesity 
As above, BMI has usually been used to measure body size and composition. 
However, WHO reports suggest that other methods of measuring abdominal adiposity, 
such as WC, WHR and waist-height ratio, are superior to BMI in predicting NCD, 
especially DM. The National Heart Lung and Blood Institute has indicated that adding 
BMI and WC predicts a greater range of health risks than using BMI alone83,87. A 
twelve-year follow-up study of middle-aged men showed that abdominal obesity was 
related to an increased risk of many diseases, including CVD and premature death. In 
women, BMI was associated with an increased risk of these diseases as well: however, 
central obesity was a stronger correlate than BMI83. 
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WC is an accurate and simple measure of abdominal obesity, compared to 
WHR and BMI. It is measured by using a stretch‐resistant tape that provides a constant 
100g tension at the mid-point between the top of the iliac crest and the least palpable 
rib. Hip circumference should be measured around the widest portion of the buttocks, 
with the tape parallel to the floor. Both measurements must be taken while the subject 
is in a relaxed standing position, with their feet close together and arms at the side of 
the body, and at end of normal expiration. The normal range for WC is less than 80 
cm for women and 94 cm for men. The higher the WC, the higher the risk of metabolic 
complications (Table 1.3)83. The WHR is measured by dividing the WC by the hip 
circumference. 
Table 1.3: WHO cut-off points and the risk of metabolic complications  
Indicator Cut-off points Risk of metabolic complications 
WC >94 cm (men); 
>80 cm (women) 
Increased 
WC >102cm (men);  
>88 cm (women) 
Substantially increased 
WHR ≥0.90cm (men);  
≥0.85 cm (women) 
Substantially increased 
 
This study has shown that BMI and WC have a strong positive correlation 
(P<0.0001) with the percentage of body fat in males and females, and are good 
indicators of metabolic syndrome, CVD and DM, compared to WHR88. 
The cut-off points for WC and WHR, which are proposed for general use, are 
based on Caucasian or European populations and so should not be applied uniformly 
to every population and ethnic group. Many studies of populations have recommended 
using cut‐off points that are specific to different ethnic groups. The reasons for this are 
that Asian populations appear to have higher morbidity at lower cut-off points for WC 
than Caucasians. In addition, the prevalence of abdominal obesity among Asian males 
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was higher when using the WC cut-off points for Asian people, compared to the WC 
cut-off points for Caucasians. Below is a table summarizing the WC cut-off points for 
some ethnicities89 (Table 1.4). 
Table 1.4: Cut-off values of WC based on ethnicity and gender 
Country/ethnic group Sex WC 
Europid Men >94 cm 
Women >80 cm 
South Asian Men >90 cm 
Women >80 cm 
Chinese Men >90 cm 
Women >80 cm 
Japanese Men >90 cm 
Women >80 cm 
Ethnic South and Central 
Americans 
Use South Asian recommendations until more 
specific data is available 
Sub-Saharan Africans Use European data until more specific data is 
available 
Eastern Mediterranean and 
Middle East 
Use European data until more specific data is 
available for (Arab) populations 
Source: Alberti, 200690 
1.2.2 Epidemiology of Obesity 
Over the past 30 years, there has been a dramatic increase in the prevalence of 
obesity. In fact, obesity rates almost doubled from 1980-2008. In 2008, 10% of men 
and 14% of women worldwide were obese (BMI ≥30 kg/m2), compared with 5% for 
men and 8% for women in 1980. An estimated 600 million adults were obese in 2014. 
In the same year, an estimated 41 million children under the age of five years were 
overweight or obese91. Obesity has reached epidemic levels worldwide92 and the WHO 
considers it as being one of the most serious health challenges of the early 21st Century 
and a major public health concern in developed and devolving countries93. Eating 
unhealthy food, sedentary lifestyle and a lack of PA are major contributors to these 
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alarming rates that, in turn, can lead to an increase in body fat that has been linked to 
several diseases94. 
The prevalence of obesity has increased at different rates in all of the WHO 
regions. It is most prevalent in the WHO Regions of the Americas (26% obese) and 
least prevalent in the WHO Region of South-East Asia (3% obese). Furthermore, the 
prevalence increases with income level, up to upper middle-income levels. The 
difference in both sexes more than triples from 7% obesity in lower middle-income 
countries to 24% in upper middle-income countries. Women were more likely to be 
obese than men in all of the WHO regions. Female obesity was significantly higher 
than male in low and middle-income countries, but it was similar in high-income 
nations94.  
In the USA, obesity has increased across all age groups. During the past 20 
years, there has been a dramatic rise in obesity rates in the United States92, according 
to the Center for Disease Control and Prevention (CDC). From 2011-2014, the 
prevalence of obesity was 36.5% among USA adults, and it is projected that this figure 
will rise to 47% by 203092. Furthermore, there has been an increase in the number of 
overweight men and women over the last few years. Between 2005 and 2015, the 
proportion of overweight or obese adults rose from 60.5% to 62.9% and the proportion 
of adults who are morbidly obese increased from 1.8% to 2.9%. In England, 27% of 
adults are obese and an additional 36% are overweight, making a total of 63% who are 
either overweight or obese95. The Organization for Economic Co-operation and 
Development (OECD) reported in its Obesity Update for 2017 that more than one in 
two adults is either overweight or obese in OECD countries96. Over the past decade, 
the rate of overweight adults and obesity has increased in Canada, France, Mexico and 
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Switzerland. In 2015, 19.5% of the adult population across the OECD countries were 
obese, and there is no clear indication of a reduction in any country96. OECD 
projections have also shown that obesity levels are expected to be high in Mexico and 
England, where 39% and 35% of the population, respectively, are projected to be obese 
by 203096. On the contrary, it is predicted the rise will be slower in Italy and Korea, 
where obesity rates are expected to be 13% and 9% respectively in 203096. 
Globally, there are more obese people than hungry people, even in developing 
countries. Low and middle-income countries are now facing a double burden. They 
are experiencing a rapid increase in people being overweight or obese, while 
continuing to combat infection, disease and malnutrition. In Bangladesh, there has 
been a dramatic increase in obesity. A secondary data analysis of the National 
Bangladesh Demographic and Health Survey showed that the prevalence of obesity 
stood at 4.6% among the adult population in 2011, compared to only 1.1% in 200897. 
It also showed that the rate of obesity was higher among women, people with a higher 
level of education, the wealthy and those who lived in urban areas98.  
While the incidence of obesity has doubled in some countries in the past 25 
years99, it has tripled in Arab nations100. It has even become a problem in poorer Arab 
states and among low-income groups, creating both health and economic burdens on 
government services. A 2008-2009 national survey in Lebanon showed that the 
prevalence of obesity among adults aged 20 and over was 26.1%101. This figure 
increased to 52.7% in 2016102. 
The WHO has reported that the GCC countries have one of the highest rates of 
obesity worldwide. Kuwait, Bahrain, Saudi Arabia and the UAE are in the top ten most 
obese countries. In Saudi Arabia, obesity has increased on a national level. In 2008, 
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the WHO reported that the prevalence of obesity was 42%, 33.2% and 33% in the adult 
populations of Kuwait, Qatar and Saudi Arabia, respectively. In 2015, those figures 
had risen to 39% in Saudi Arabia, remained stable Qatar and reached 42% in 
Kuwait103. This places Kuwait in the top ten most obese countries globally. The 
increase in obesity in the region is due to the high consumption of fast food and sugar-
dense beverages, as well as technological advances that have reduced activity levels. 
There has also been a reduction in the consumption of traditional, locally grown natural 
food, such as dates, vegetables, and wheat103. 
Over the past four decades, there has been a move from a traditional semi-
nomadic, physically active lifestyle to a modern, urbanized, technology-driven 
lifestyle in the UAE, characterized by low domestic, occupational, leisure time 
physical activity (PA). This is combined with the over consumption of energy-dense 
convenience foods of poor nutritional content. Therefore, there has been a dramatic 
growth in the prevalence of obesity in both the native Emirati and expatriate adult 
population living in the UAE104, which has resulted in an increased in obesity105. The 
UAE’s Ministry of Health and Community Protection (MOH) considers obesity and 
DM to be the biggest health issue facing its people. In 2012, the prevalence of obesity 
among Emirati nationals from Abu Dhabi was 35% (38% women and 32% men)41, 
compared to 32% (39.9% women and 30% men) in 2008106. In 2015, the prevalence 
of obesity in the UAE was estimated to be 34% among adults107. 
1.2.3 Correlates for Obesity 
Obesity is a major problem worldwide and its causes are both complex and 
multifactorial. It results from a long-term imbalance of energy intake and expenditure 
that can lead to a positive energy status resulting in the accumulation of body fat91. 
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The human brain regulates our feeding behavior while the hypothalamus controls long-
term energy balance and body weight. Defects in hormone levels and the 
hypothalamus are thought to cause the pathogenesis of energy imbalance that results 
in obesity.  
Genetic factors also play a role in developing obesity108. Some studies have 
reported that BMI is 25-40% genetic. However, the prevalence of obesity has increased 
in the last two decades, which indicates that the reason is not due to genetic factors. It 
is reasonable to say that this recent increase in both developing and developed 
countries is down to environmental factors. In addition, modern societies have adopted 
a Western diet and time-allocation patterns have changed109, leading to a positive 
energy situation caused by over-nutrition, physical inactivity and a sedentary 
lifestyle110. 
1.2.3.1 Environmental Factors  
Public health experts agree that obesity is best fought by restructuring the 
environment rather than concentrating on an individual’s behavior111. Harvard School 
of Public Health has claimed that the "environment has become toxic to healthy living" 
and it is difficult for an individual to make a healthy choice that is vital for a healthy 
weight. The obesogenic environment has been defined as a sum of the effect that 
surrounds us, and it encourages obesity in individuals and the population. It includes 
schools/ universities, homes, workplaces, community spaces, and the media112. 
Features of this environment include easy accessibility to, and the affordability of, 
highly advertised foods and inactive lifestyles. Spence et al. reported that the proximity 
of the obesogenic environment, where people struggle against unhealthy energy-dense 
food consumption and a sedentary lifestyle, is a vital correlate for obesity. They added 
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that shaping the environment in such a way that it encourages healthy decisions is the 
key feature in the prevention of obesity113. Cities in the UAE are unfortunately not 
designed for walking, making automobiles the first choice. The high temperature of 
450C in the Summer and the dusty conditions restrict people in the UAE and 
discourage and them from exercising, especially women114. 
1.2.3.2 Physical Activity (PA)  
PA is defined as any body movement made by the skeletal muscles that 
involves energy expenditure. Lack of PA is the fourth leading cause of death 
worldwide, and it is a major correlate for several common chronic diseases. Globally, 
31.1% adults are physically inactive. A third of adults do not meet the public health 
guidelines for suggested levels of PA115. 
Between 1977 and 1995, active transportation has dropped for all age groups. 
In the United States, it was estimated that only 21.1% adult and 35.9% children walked 
regularly116. The level of PA among adults is also low in Canada117, the United 
Kingdom and other developed countries118. Al-Hazzaa et al. reported that 71% of 
young people in Saudi Arabia did not engage in PA for a sufficient duration or 
frequency119. 
A significant lack of PA among the UAE population has been documented in 
several research studies120. A cross-sectional study, conducted in 628 randomly-
selected households in all seven emirates, revealed that only 41% of adult Emirati 
women have moderate or high levels of PA and 75% of Emirati girls and adolescents 
spend more time (>5 hours per weekday) sitting, compared to their male counterparts 
(50%)121. Age was a major determinant of the level of PA (negative association) in the 
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UAE. Henry et al. confirmed that PA in childhood and adolescence may affect activity 
patterns in adulthood in the UAE122. 
It is advised that adults take at least 150 minutes of moderate intensity PA or 
75 minutes of vigorous PA every week118. Berger and colleagues examined the barriers 
to physical activity for 600 female students in a women’s college in Fujairah. This 
study identified that important determinants for PA in the UAE were a lack of female 
role models among peers and families, information about the benefits of exercise, 
culture, climate, clothing, make-up, personal motivation, time and opportunity, as well 
as school and government policies120. A qualitative study conducted by Habiba et al., 
demonstrated that environmental barriers, like not having culturally accepted exercise 
facilities for women, hot weather and safety concerns – especially at night – played an 
important role in discouraging Emirati females from exercising123. 
1.2.3.3 Sedentary Lifestyle 
A sedentary lifestyle is defined as the time that people spend sitting, resulting 
in lower metabolic expenditure124. It is one of the key determinants of the growing 
rates of being overweight and obese in Western populations125. Worldwide, the 
proportion of adults who spend 4 or more hours per day being sedentary (watching 
television, driving cars, sitting, sewing, playing board/ computer/ phone games) is 
41.5%126. Owen et al. reported, in a cross-sectional study of 5,078 Australians, that 
sedentary behavior increases with age, and is more common among less educated and 
lower income people127. Similar findings were observed in the USA128. Most Canadian 
adults’ working hours (68% men and 69% women) are sedentary129. They spend an 
average of 10 waking hours per day being sedentary (not including sleep). 
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The time spent in sedentary activity, including watching TV, has increased 
dramatically in almost all the major Arab countries119. For instance, in the UAE, the 
median number of hours that 58 adolescent females aged 11-16 years spent watching 
television was 2.5 per day, and the number of hours increased at the weekend122. 
Musaiger et al. found that watching television occupied significant amounts of 
children’s and young adults’ leisure time in the UAE, and the practice of having meals 
in front of the television was also very common for families in the UAE130. 
1.2.3.4 Nutritional Factors 
Dietary factors have been comprehensively studied for their likely 
contributions to growing obesity rates. These factors are the size of food portions, daily 
consumption of fruit and vegetables, the role of breakfast, consumption of fast food 
and sugary beverages.   
Studies suggest that two vital lifestyle choice factors contribute to the 
increasing rate of being overweight and obese in the UAE. These are dietary (frequent 
snacking, the replacement of traditional food with fast food, replacing water with a 
soft drink, low fruit and vegetable consumption and wealth) and increased physical 
inactivity121. 
a) Food Portion Size 
The size of food portions is the amount of a single food item served in a single 
meal or snack time. For example, the amount of food put on a plate or the quantity 
offered in readymade food packages. The WHO believe that large food portions play 
an important role in the global obesity epidemic84. The propensity towards a rise in 
portion sizes began in the late 1970s and has increased ever since. In the USA, portion 
sizes have risen sharply over the last 30 years, especially those that have a high energy 
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density. This has led to the overconsumption of food and has fueled the growing 
obesity epidemic. The current portion sizes for hamburgers, French fries and soda are 
2-5 times larger than they used to be131. A study shows that, except for sliced white 
bread, all commonly available food portions exceed the USA Department of 
Agriculture and Food and Drug Administration’s standard portions, sometimes to a 
very large extent. In the UAE, there has been a change from traditional food to a more 
Westernized diet leading to the consumption of high-dense energy foods and bigger 
portions. Musaiger et al. have attributed the epidemic of childhood obesity in Dubai 
mainly to these reasons130. 
Ledikwe et al. have attributed the rise in the obesity rate in the last three 
decades to the increase in portion sizes for many foods and the frequency of eating 
outside the home. They emphasize the importance of eating a healthy balance of 
different types of food in order to control obesity132. A study by Rolls et al. examined 
how adults reacted to different portion sizes. They found that the bigger the portion, 
the more the participants ate. Those offered a larger portion consumed 30% more 
energy compared to others who were offered a smaller portion of food132. 
b) Daily Consumption of Fruit and Vegetables 
It has been well established that fruit and vegetables are important components 
of a healthy diet and can help to prevent a wide range of diseases. Fruit intake in most 
Western countries is well below the daily recommended amount (five servings a 
day)133. The WHO recently recommended a minimum intake of 400g or five portions 
of fruit and vegetables per day to prevent obesity and other chronic diseases134. Having 
daily fruit and vegetables leads to good weight management through the replacement 
of energy-dense food with healthier choices that ensure satiety due to eating fiber. This 
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leads to the consumption of fewer calories and modulation of the dietary glycemic load 
which affects postprandial hormonal shifts135. 
Traditional UAE food, which is high in fiber and low in fat, has been largely 
replaced by a Westernized diet with a higher content of fats, sugar, sodium and 
cholesterol. It is also low in fiber-rich foods, such as vegetables, fruit and whole 
grains136. The Bedouin Emirati, who live in rural areas and have maintained their 
traditional food culture, have lower obesity rates than those in urbanized areas137. Daily 
fruit and vegetable consumption is low in the UAE. This has been reported by 
Musaiger and Abuirmeileh, who confirmed low fruit and vegetable consumption in a 
cross-sectional study in all seven Emirates by random sampling of 1,122 men and 
1,090 women138. Zaal et al. reported that fruit and vegetables are less accessible in the 
UAE compared to high-dense energy food, and the consumption of canned fruit is 
higher than fresh fruit and vegetables130. 
c) Role of breakfast  
There is a relatively strong public belief that having breakfast regularly plays 
a role in human health. The frequency of people skipping breakfast has increased over 
the past few years, during which time the obesity epidemic has increased worldwide. 
Thus, there is a strong scientific belief that a causal relationship between obesity and 
breakfast exists (inversely correlated).  
Several clinical studies have demonstrated that regular food consumption 
reduces the risk of obesity. A systemic review of 16 European studies has suggested 
that skipping breakfast increases the correlate for people becoming overweight and 
obese because they tend to overeat at lunch or dinner130. This positive association is 
observed internationally, regardless of the culture in a diversity of countries139. The 
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odds of becoming obese as a result of skipping breakfast is 4.5 times higher, compared 
to people who regularly eat breakfast140. 
Research studies have shown that skipping breakfast is highly prevalent in 
many Arab countries. In the UAE, Musaiger reported that 28% of Emirati boys, aged 
6-7 years, skip breakfast compared to 37% of girls of same age100. Furthermore, 
Kerkadi conducted a study on 400 female students from UAE University. Students 
who had breakfast regularly (72.2%) were less likely to be obese than those who did 
not and were consequently either overweight or obese.141.   
d) Consumption of Fast Food 
Consumption of fast food has been closely associated with obesity in recent 
years. Fast food consumption increased fivefold worldwide from 1977 to 1995 in 2-18 
year olds and nearly one third of youths now eat fast food every day. Studies have 
shown that weekly consumption of fast food by young adults is associated with an 
increase in BMI142. Isganaitis et al. considered fast food to be the primary cause of the 
current obesity epidemic143. 
There is a close association between the proximity of fast restaurants to 
residential areas, exposure to fast food advertisements and an increase in the risk of 
obesity. Fuzhong et al. studied 1,221 residents from 120 neighborhoods. They 
measured their BMI, level of PA, frequency of visits to local fast food restaurants and 
fried food consumption. They reported that an increase in neighborhood fast food 
outlets was associated with an unhealthy lifestyle and an increased risk of obesity 
among adults144. Furthermore, a positive correlation between exposing children to fast 
food advertising and BMI has been established in several studies. It has been shown 
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that banning such advertisements reduces the number of overweight children and 
adolescents by 10% and 12%, respectively. 
The UAE’s economic boom and concomitant Westernization has resulted in a 
greater dependence on fast food130. The easy accessibility of this food is another 
concern.  Studies have revealed that 76% of participants had consumed fast food at 
least once a day during the seven days before the data was gathered145. This was much 
higher than the figure reported by Kerkadi, who found that 34.9% of female students 
at the same university consumed fast food at least once a day141. 
e) Consumption of Sugar Sweetened Drinks 
Many studies have been carried out into the relationship between consuming 
sugary drinks and weight gain. These drinks have repeatedly been found to correlate 
for obesity. Over the last three decades, the consumption of sugar sweetened drinks, 
including soft drinks such as iced tea, fruit drinks and energy and vitamin water drinks, 
has increased noticeably worldwide146. Between 1977 and 1996, there was an upsurge 
in the percentage of people consuming these beverages (from 61.4% to 76%), the 
frequency of consumption (from 1.96 to 2.39 servings per day), the portion size (from 
13.6 to 21 oz/d) and calorie intake (from 70 kcal to 189 kcal per day)143. US studies 
have shown that approximately 50% of Americans aged 4 and above regularly drink 
soft drinks on a daily basis. They have replaced dairy drinks and become a leading 
source of carbohydrates, especially in children and teenagers147. In the UAE, Zaal et 
al. found that high consumption of energy-dense foods, such as carbonated canned 
drinks, during the day and at night was a major reason for gaining weight130. 
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1.2.4 Consequences of Obesity 
Obesity is associated with a large number of health, social and emotional 
problems. The social and emotional effects of obesity include suffering discrimination, 
receiving lower wages, poor quality of life and depression. The health problems start 
when an individual is slightly overweight and they increase as the weight increases, 
causing serious mortality issues (CVD, DM, hypertension, kidney stones, infertility, 
musculoskeletal illnesses), and some types of cancer (endometrial, breast and colon) 
as well as morbidity91. The Nurse Health Study showed the risk of death rose in women 
with a BMI of more than 29 kg/m2 and mortality was lowest among those women 
whose weight had remained unchanged since early adulthood. The American Cancer 
Society’s Cancer Prevention Study 1 and 2 came to the same conclusion. 
1.2.5 Association of Obesity with Prediabetes and DM 
Obesity is a major correlate for DM and prediabetes150. Furthermore, DM and 
prediabetes are closely associated with a high BMI, and visceral fat is an independent 
correlate for insulin resistance. Numerous other measurements of obesity, including 
WC, WHR and waist-to-stature ratio, are associated with DM and prediabetes27,151. 
The relationship between DM and obesity was explored in a National Health 
and Nutrition Examination Survey, where 21,205 adults were examined for DM. 
Among the people with DM (13.6%), 80.3% were overweight and 49.1% were obese, 
and the prevalence of DM rose the more severely obese they were. ‘Diabesity’ is the 
term used to describe the strong epidemiological and pathogenic relationship between 
DM and obesity. Studies have also confirmed the significance of weight loss in 
improving control of DM, which has, in some cases, led to people reverting back to 
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normoglycemic status. “Look AHEAD” was a large multicenter trial where 
overweight/ obese adults with DM randomly selected to participate in a rigorous 
lifestyle intervention (with a reduction in calorie intake and increased PA levels) or 
receive DM support and education only. After a follow-up one year later, it was noticed 
that weight reduction in the intervention group (8.6% weight loss) was significantly 
associated with an improvement in DM control in obese and overweight adults with 
DM, when compared to patients in the control group (0.7% weight loss)149. In spite of 
the close relationship between obesity and DM, the real mechanisms are not 
straightforward, given that not all obese and overweight people develop prediabetes or 
DM, and that there are people of normal weight who develop prediabetes and DM 
regardless. 
Studies have shown that obese people are five to six times more at risk of 
developing prediabetes, compared to normal-weight people57. In addition, people who 
lose 5-10% of their weight through a healthy diet and exercise regime can significantly 
reduce their risk of developing prediabetes4,7. Furthermore, the USA Prevention 
Program’s multicenter clinical research study involved training overweight patients 
with prediabetes to lose weight through dieting and PA, medication or a placebo. After 
both three and ten year follow-ups, it was evident that losing weight (through dietary 
changes and increased PA) had an effect on reducing the incidence of DM when 
compared to the placebo or the use of medication in prediabetic patients. Moreover, 
the observed  reduction in the incidence of DM in this study was 58% in people who 
lost weight through dietary changes and 34% in people who lost weight through 
increasing their level of PA80. 
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1.3 Summary 
The prevalence of prediabetes in every age group is rising exponentially around 
the world causing massive health problems and a significant economic burden. This 
increase is due to population growth, aging, urbanization, and a growing number of 
people who are physically inactivate. Obesity is one of the main correlates for 
developing prediabetes. The ADA and WHO use FBG, OGTT and HbA1c for the 
diagnosis of prediabetes, which is a major correlating factor for many diseases. 
However, people can revert to normoglycemic status through modification of their 
lifestyle.  
This dissertation is based on secondary data. Both sets of data were collected 
during an intervention with prediabetic adults in Al Ain, Abu Dhabi and Dubai, in the 
UAE as part of a National Research Foundation (NRF) funded grant for the 
“prevention of diabetes through population-based strategies”. The data from Al Ain 
was secondary data based on NCD correlates and was obtained from a random sample 
of school children and their parents. In this dissertation we used parental data to 
achieve the primary objective of the esearch i.e. to ascertain the prevalence of 
prediabetes and its identify its correlates (Described in Chapter 2). The Dubai data was 
collected as part of case study where 700 adults were identified with prediabetes in 
five primary health care centers in Dubai in 2015 as part of the Dubai Health Authority 
diabetes screening and prevention program. Participants were re-examined in 2017. 
The data here was used for the secondary objective, that is to determine the correlates 
when prediabetes develops into DM. The total number of participants was 605 in Al 
Ain and 487 in Dubai (Described in Chapter 3).  
42 
 
 
 
 
In the UAE, there is no recent data on the prevalence of prediabetes, and little 
data on the correlates when prediabetes develops into DM. The results of this study 
encourage two-way communication between researchers and decision makers to help 
shape regulations and laws to fight obesity and prediabetes. It will also show evidence 
that can inform policy makers on how to control diabetes in the UAE.  
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Chapter 2: Prevalence of Prediabetes and its Correlates -  Al Ain  
2.1 Aims and Objectives 
2.1.1 Aims 
Prediabetes is a high-risk state for the development of DM. Furthermore, a 
substantial number of people with DM remain undiagnosed and untreated. Our study 
aims is to document the burden of prediabetes and its correlates in the UAE. Also, we 
seek to improve the current understanding of the relationship between prediabetes and 
its correlates in married adults in Al Ain, the UAE.  
2.1.2 Specific Objectives 
- Objective 1: 
o To estimate the prevalence of prediabetes in married adults in Al Ain, 
the UAE 
- Objective 2:  
o Evaluate the relationship between prediabetes and its correlates in 
married UAE nationals/ Arab adults in Al Ain, the UAE 
2.2 Methods 
2.2.1 Study Design 
We used a cross-sectional design to achieve our study objectives. 
2.2.2 Study Site 
This study was conducted at the Al Muwaiji Healthcare Center in Al Ain, Abu 
Dhabi, in the UAE. Al Ain is the 4th largest city in the country. It is located 160 
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kilometers east of the capital Abu Dhabi. The city covers an area of 13,100 Km2 and 
has a population of 650,000 (according to the UAE census 2013). The United Arab 
Emirates University is located in Ali Ain and Abu Dhabi Health Authority provides 
health care through a number of primary healthcare centers. The participants were all 
invited to attend the Al Muwaiji Healthcare Center to be measured and have blood 
tests. This primary healthcare center is affiliated with Ambulatory Healthcare Services 
in Al Ain, Abu Dhabi. 
2.2.3 Study Population 
The Al Ain based data used in this dissertation was secondary data about NCD 
risk factors. Details of the primary study are summarized in Figure 1. For our study 
purposes, every participant was either a married UAE national or an Arab national 
with children in school who lived in Al Ain. Out of 866 participants contacted, 605 
agreed to participate and signed the informed consent form. 
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114 private and public schools in Al Ain with children aged 12-18 years old  
 
 
1,630 students  
 
    
   
 
         1,220 students  
 
 
 
 
     1,186 students1  
 
 
 
 
Parents of 1,120 student 
Figure 1: Summary of primary data collection in Al Ain, Abu Dhabi, the UAE 
1. As part of a previously completed global health study “Developed developing countries partnership for NCDs 
prevention”, a random sample of 1,186 adolescent, aged 12 to 18 years from 114 public and private schools in Al 
Ain completed a school-based NCDs risk factors study. Approval was obtained from Abu Dhabi Education 
Council. Parents of 1,186 students were contacted though telephone by a staff nurse in Al Muwaiji Healthcare 
Center in Al Ain to come and take a blood test (Fasting blood sugar& lipid) conducted by a pediatrician. Contact 
numbers were obtained from the medical file of each student. Nurses from Al Muwaiji Healthcare Center in Al 
completed the measurement of 1,186 students. The measurements were as followis: Self-administered 
Questionnaire, I PAQ, Beck & Rosenberg self-esteem scale II. Weight, height, waist, blood pressure III. Blood 
samples after fasting overnight. 
 
 
 401 students 
refused to 
participate  
 9 were not 
fasting when 
presented in 
clinic 
 
Parents of 60 
students did not 
attend to collect 
the blood test 
results of their 
children despite 
two reminders 
 
34 students were 
excluded – they did not 
meet inclusion criteria. 
Other students were 
from multiple 
ethnicities therefore 
excluded despite 
completing data 
collection 
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2.2.4 Selection of the Study Participants  
2.2.4.1 Inclusion Criteria 
1. The participants were either a father or mother of the adolescents studied. 
2. UAE nationals and Arabs. 
3. Resident in Al Ain. 
4. They were willing to participate and signed the informed consent form. 
2.2.4.2 Exclusion Criteria 
1. Participants who did not fulfill any of the inclusion criteria. 
2. Those who did not sign the informed consent form. 
2.2.5 Sample Size Calculation 
The sample size was determined by using a single population proportion 
formula. It was reached by considering the 27% prediabetic prevalence discovered in 
the Weqaya study41 of the prediabetic Emirati population. We had a 95% confidence 
level with 0.05 margin for error. This came to 302, and by adding 50% for the non-
response rate, the total sample size was 605 participants.  
2.2.6 Study Measurement 
2.2.6.1 The Primary Variable 
The primary variable was the prevalence of prediabetes and DM.  
2.2.6.2 The Study Variable 
Being overweight, obesity and central obesity.  
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2.2.6.3 Other Variables  
Socio-demographic characteristics 
- Age, tobacco use, educational level, smoking, history of chronic diseases and 
family history of chronic conditions. 
Anthropometric measurements 
- Height, weight and BMI  
Blood tests 
- FPG, HbA1c, total cholesterol, TG, HDL and LDL cholesterol 
- The level of PA 
- Diet 
2.2.7 Data Collection Procedure 
Data collection was conducted on secondary data from 1,120 participants in 
2013. Funding was granted by the National Research Foundation (NRF). We selected 
relevant and previously validated questions from the WHO STEP Surveillance 
(STEPS) Questionnaire. The questions were culturally adapted and piloted on a sample 
of the participants (n=12) after being translated into Arabic. We also relied upon a 
shortened version of the International Physical Activity Questionnaire (IPAQ). A copy 
of this questionnaire has been included in the appendix.  
The pilot study was scheduled for two weeks in July 2013 on a randomly 
selected sample of 12 participants form the original 866. Satisfactory results were 
obtained from the pilot study in terms of ensuring that all the nurses understood the 
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questions and in the same way. In addition, the time required to complete the survey 
was determined and respondents were apparently comfortable with the questions.  
Training workshops for the nurses were conducted in August, 2013 (4). These 
sessions informed the nurses of the purpose of the study and trained them in 
standardizing anthropometric methods prior to data collection. The workshop was run 
by qualified trainers. After the workshop, the nurses identified those from the 1,120 
participants who met the inclusion criteria. A total of 254 participants were excluded 
as they did not meet these criteria. 
The 866 participants who met the criteria were invited to take part in the study. 
This number took into account the fact that there would be some who would not agree 
to participate. The invitation was conducted along these lines: every week 50 subjects 
received SMS messages inviting them to attend Al Muwaiji Healthcare Center in Al 
Ain. They were asked to come to the center after fasting in order to do an investigation 
of their blood samples. The SMS messages were followed up by phone calls in order 
to ensure attendance. The invitations were sent out by a coordinator and four staff 
nurses from the center. The invitations were sent out over a six month period and 
resulted in 440 participants agreeing to become involved out of the possible 866. In 
order to increase the number of participants, UAE national medical students (n=5) 
from UAE university were informed of the study protocol and asked to call participants 
who did not respond to the first invitation. As a result, 165 more participants agreed to 
take part in the study, making the final number up to 605.  
The 261 who did not participate in the study did so for a variety of reasons 
including: refusal to participate (71) and no response (186), despite two reminders. 
Four subjects were excluded as they were not fasting when they came to the center. 
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The 605 participants attended Al Muwaiji Healthcare Center for an evaluation 
and a blood test. Thus, the response rate was 54%. The data collection was conducted 
by a coordinator and trained nurses. They administered questionnaires, took 
measurements and collected blood samples. See Figure 2.  
We used a structured questionnaire and selected relevant and valid questions 
from the WHO STEP Surveillance (STEPS) Questionnaire. The questions were 
culturally adapted and piloed on a sample of parents (n=12) after being translated into 
Arabic. We also included a shortened version of the International Physical Activity 
Questionnaire (IPAQ). A copy of this questionnaire has been included in the appendix.  
A SECA adult portable stadiometer was used to measure the participants’ 
height after they had removed shoes, socks, slippers and any headgear. It was measured 
in centimeters to within 0.1 cm. The SECA digital scale was used to measure their 
weight, and the scale was regularly calibrated against a standard weight. The 
participants were asked to remove footwear and socks and their weight was recorded 
in kilograms to within 0.1 kg. BMI (kg/m2) (BMI; calculated as weight in kilograms 
divided by height in meters squared). Subjects were classified as being of a normal 
BMI if less than 25 (BMI <25.0 kg/m2), the overweight category included those with 
a BMI of 25 to 29.9 (BMI 25.0-29.9 kg/m2), and the obese group was those with a 
BMI of 30 or greater (BMI ≥30.0 kg/m2).  
WC was also measured by using a flexible, non-stretch nylon tape measure 
(SECA Hamburg, Germany) while subjects were lightly clothed. It was done in 
centimeters to the nearest 0.1 cm at the midpoint between the inferior margin of the 
last rib and the iliac crest in the mid-axillary plane. Hip measurements were taken 
around the widest portion of the gluteal muscles in centimeters to the nearest 0.1 cm 
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with the tape parallel to the floor. This was done while the individual was standing 
with his or her feet close together, at the end of a normal expiration, with the arms 
relaxed at the sides. Each measurement was repeated twice, and if the measurements 
were within 1 cm of one another, the average was calculated. If the difference between 
the two measurements exceeded 1 cm, then the two measurements were repeated. We 
used a WC of >94 cm for men and >80 cm for women to define central obesity. 
We also measured resting brachial BP. A trained research nurse carried this out 
using a calibrated automated device (Omron HEM-705cp). The subject was in a sitting 
position with an appropriate sized cuff applied to the upper right arm after a five minute 
period of rest. BP was measured trice. The first value was discarded and the average 
of the two subsequent measures was used for analytical purposes. Hypertension was 
defined as a mean systolic ≥BP 140, a mean diastolic BP ≥90 or a if the subject was 
currently undergoing hypertension treatment with prescription medication. 
PA was assessed by using the International Physical Activity Questionnaire 
(IPAQ). The activity level was measured using the intensity level, which is the rate at 
which the activity is performed or the extent of the effort needed to achieve an activity 
or exercise. The PA level can be classified into three levels: vigorous, moderate and 
light. ‘Vigorous-intensity activities’ require hard physical effort and cause a large 
increase in breathing or heart rate, ‘moderate-intensity activities’ require moderate 
physical effort and cause a small increase in breathing or heart rate, and ‘light-intensity 
activities’ do not achieve the aforementioned levels of activity. Participants were 
classified as sufficiently active if they exceeded the minimum recommended duration 
for PA per week according to WHO standards, i.e. 150 minutes of moderate intensity 
PA, or 75 minutes of vigorous intensity PA, or an equivalent combination of moderate 
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and vigorous intensity PA per week, with each activity performed for at least 10 
minutes.  
For biochemical measurements (HbA1c, lipid profile and FPG), venous blood 
samples were taken from individuals, after 10-12 hours of overnight fasting, during 
their visit to the Al Muwaiji Healthcare Center. 5 ml of venous blood was taken while 
in a sitting position. It was then immediately centrifuged to separate the serum, and 
transferred under cold chain conditions within less than three hours from collection, to 
Tawam Hospital Laboratory in Al Ain for analysis. 
Biochemical tests were then conducted to measure fasting blood glucose, total 
cholesterol, TG, HDL and LDL cholesterol. The blood tests results generated an 
electronic medical report at Tawam Hospital. Two different cut-off points were used 
to define prediabetes: FPG ≥100 mg/dl and <126 mg/dl and FPG ≥110 mg/dl and <126 
mg/dl or an HbA1c level of 5.7-6.4%. DM was defined by as a previous diagnosis of 
DM or, if DM had not been diagnosed previously, the ADA guidelines for DM (HbA1c 
= 6.5% or greater, or FPG of 126 mg/dl) were used. The National Cholesterol 
Education Programme guidelines define dyslipidemia in the following way: 
Hypercholesterolemia-serum TG levels of ≥150 mg/dl and/ or a 
Hypercholesterolemia-serum cholesterol level of <200 mg/dl. The optimal HDL 
cholesterol level was <100 mg/dl and the LDL cholesterol level was <40 mg/dl. 
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1120 participants1 
 
 
 
 
 
                                                       866 participants 
 
 
 
 
 
 
 
 
 
 
                         605 agreed to participate in and completed the study 
 
Figure 2: Summary of secondary data collected in Al Ain, Abu Dhabi, the UAE 
(n=605) for this dissertation 
1. The 1,120 participants were parents of students from the previously mentioned study. Their contact numbers 
were noted when they attended Al Muwaiji Healthcare Center in Al Ain to collect blood results for their children. 
When we got further funding (an NRF grant) we invited the parents, via SMS message and a telephone call, to 
come to Al Muwaiji Healthcare Center in Al Ain for their own examination and test. Either the father or mother 
was selected for the study based on whoever came to collect the blood test. If both parents came then both of them 
were involved after obtaining consent. 
 
2.2.8 Ethical Considerations  
2.2.8.1 Ethical Approval of Study 
Ethical approval was obtained from the Human Research Ethics Committee in 
the College of Medicine and Health Sciences, UAE University (13/09, Appendix 1). 
2.2.8.2 Informed Consent 
Every participant who agreed to join the study, provided written informed 
consent before taking part, see Appendix 6. 
261 excluded: 
 71 refused to 
participate 
 186 did not respond 
despite two reminders  
 4 came to clinic 
without fasting 
 
254 excluded- did not 
meet inclusion 
criteria 
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2.2.8.3 Confidentiality 
The data and questionnaires were stored in the Institute of Public Health at 
UAE University with their data protection guaranteed. Thus the confidentiality of this 
data was preserved. To maintain anonymity, unique personal identification numbers 
were assigned to each participant in order to conceal the identities of the participants. 
2.2.9 Data Analysis 
The statistical analysis was carried out by using the STATA version 14.0 in 
order to calculate the prevalence of DM and prediabetes. We used Microsoft Access 
to enter the data before it was imported into STATA version 14.0 (StataCorp LP, 
College Station, TX) for analysis. The categorical variables were summarized by 
proportions, while the continuous variables were summarized by using mean and 
standard error, whichever was most applicable, with 95% confidence intervals. A Chi-
square test compared proportions across groups and an ANOVA test compared the 
means across the groups. We used univariate and multinomial logistic regression 
analysis to determine the correlates for prediabetes. Variables entered into the 
multivariable multinomial logistic regression models were selected according to their 
significance (p<0.2) in the univariate analysis.  
Multivariate analysis was used as our dependent variable had three categories 
(normoglycemia, DM and prediabetes). In addition, we controlled confounding 
information by using a multivariate analysis. We checked the data for interactions but 
could not find any between the variables in our study. 
 Design effect is important in cross sectional study. Therefore, probability 
proportional to size, (when samples from different sized sub-groups are used and 
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sampling is done with the same probability, the chances of selecting a member from a 
large group are less than the chances of selecting a member from a smaller group), 
takes varying sample sizes into account. This was not taken into consideration when 
choosing our target population, therefore our data may be under-representative of the 
general population in the UAE. 
2.2.10 Timeline 
The data was collected in a six-month period, from September 2013 to June 2014. 
2.3 Results 
The demographic and clinical characteristics of the study population are 
presented as a percentage for the categorical variables and as a mean±standard 
deviation for the continuous variables in Table 2.1. 
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Table 2.1: Demographic and clinical characteristics of the study population (n=605) 
in Al Ain, Abu Dhabi, the UAE 
Variables All Male Female 
Emirati 52.6 39.3 60.7 
Arab 47.4 51.9 48.1 
Age (mean±std) 42.9±7.9 45.9±8.2 40.3±6.8 
Married 95.5 98.9 94.8 
Divorced or widowed 4.5 1.1 5.2 
No formal education 7.1 4.4 9.1 
Up to secondary level 47.1 46.1 48.1 
>Secondary level 45.8 49.5 42.8 
Employed 47.8 82.5 72.8 
Unemployed 52.2 17.5 27.2 
BMI (mean±std) 31.1±8.4 30.4±9.8 31.1±8.4 
Height (mean±std) 162.9±10.3 169.9±9.8 157.1±6.3 
Weight in kg (mean±std) 81.1±17.5 86.7±16.7 76.5±16.7 
Waist in cm (mean±std) 91.8±13.2 98.8±10.8 85.9±12.1 
Hip circumference in cm 
(mean±std) 
105.7±10.1 103.9±8.5 107.1±11.1 
Total cholesterol (mg/dl) 88.2±18.0 88.2±19.8 88.2±16.2q 
LDL-cholesterol (mg/dl) 57.6±28.8 59.4±37.8 55.8±14.4 
HDL-cholesterol (mg/dl) 19.8±7.2 7.2±3.6 23.4±7.2 
TGs (mg/dl)  25.2±16.2 30.6±19.8 21.6±14.4 
No 42.9 42.4 43.5 
Yes 57.1 57.6 56.5 
No 74.9 49.6 95.8 
Yes 25.1 50.4 4.2 
No 29.3 29.2 29.3 
Yes 70.7 70.8 70.7 
No 21.2 21.2 21.1 
Yes 78.8 78.8 78.9 
No 41.5 31.4 49.8 
Yes 58.5 68.6 50.2 
Under 25 14.1 14.1 14.1 
25-29.99 35.7 39.1 33.1 
≥30.0 50.2 46.8 52.8 
Normoglycaemia 43.6 37.2 48.9 
Prediabetes 37.7 40.2 35.7 
DM 18.7 22.6 15.4 
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2.3.1 Baseline Demographic Characteristics of the Study Population 
Participants were divided into two groups, based on their nationality – Emirati 
or Arab (52.6% and 47.4%, respectively, P=0.002). The mean age of the study 
population was 42.9±7.9 years, with a range from 35 to 50.8 years. The average age 
of the male participants was significantly olderthan the female ones (45.9 vs. 40.3, 
P<0.001). The percentage of married participants was 95.5%, while 4.5% of the study 
population were divorced or widowed. The level of education varied from no formal 
education, up to secondary level and higher than secondary level (7.1%, 47.1%, and 
45.8%, respectively). The employment status was significantly different between the 
employed and unemployed participants (47.8% and 52.2%, respectively, P<0.001). 
2.3.2 Baseline Clinical Characteristics of the Study Population 
Table 2.1 shows the characteristics of the study population. The mean values 
for total cholesterol (mg/dl), LDL-cholesterol (mg/dl), HDL-cholesterol (mg/dl), and 
TG (mg/dl) were significantly different between the male and female subjects 
(P<0.003). The percentage of participants with no family history of DM was 42.9%, 
whereas the percentage of participants who had never smoked cigarettes was 74.9%. 
Based on the body mass index categories, 14.1% of the participants were found to have 
a BMI of <25, 35.7% had a BMI between 25 and 29.9, whereas 50.2% had a BMI of 
≥30.0 and were classed as obese (Figure 3). Furthermore, females were more often 
obese than males, while more male subjects were classified as overweight than female 
participants (Figure 4). The mean WC (WC >=94cm male >=80 cm female) was 
91.8±13.2 cm. The average WC of the male participants was significantly different 
from that of the females (98.8 vs. 85.9, P<0.001). 
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Figure 3: The percentage of body mass index categories (n=605), in Al Ain, Abu 
Dhabi, the UAE 
 
Figure 4: The percentage of body mass index categories by gender (n=605), in Al 
Ain, Abu Dhabi, the UAE 
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2.3.3 Baseline PA Level  
About 71% of the study participants reported that they did vigorous PA, 78.8% 
stated they practiced moderate PA, and 58.5% reported walking for at least 30 minutes 
once a week. 
2.3.4 Prevalence of DM and Prediabetes 
Overall, the unadjusted prevalence of DM and prediabetes using the HA1c and 
FPG definition was 18.7% (CI 15.7-21.9) and 37.7% (CI 33.9-41.6), respectively. The 
unadjusted prevalence of DM and prediabetes was higher in males than in female 
subjects (22.6% of males had DM and 40.2% had prediabetes). The percentage of 
normoglycaemic participants was 43.6% (Figure 5). 
 
Figure 5: Proportion (%) with normoglycemia, prediabetes and DM by gender 
(n=605), in Al Ain, Abu Dhabi, the UAE 
We further calculated the age-standardized prevalence of DM and prediabetes 
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DM and prediabetes increased significantly as the participants got older. Univariable 
analyses (Table 2.3) showed that the older participants (≥55 years) were 26 times more 
likely to have DM, and three times more likely to have prediabetes than he younger 
participants (P<0.006).  
We have further subdivided the prevalence of prediabetes and DM by BMI 
(using WHO criteria for BMI), and central obesity (WC >=94cm male >=80 cm 
female). The prediabetic participants were more often obese and overweight and had 
a higher percentage of central obesity when compared participants with DM (Figures 
6, 7).   
 
Figure 6: Prevalence of DM and prediabetes (%) by BMI categories (n=605), in Al 
Ain, Abu Dhabi, the UAE 
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Figure 7: Prevalence of prediabetes and DM by central obesity (Waist circumference 
>=94 cm in male >=80 cm in female) (n=605), in Al Ain, Abu Dhabi, the UAE 
2.3.5 Prevalence of Overweight/ Obesity 
The distribution of the population by BMI categories as defined by WHO 
criteria and showed that 14.1% (CI 11.5-17.1) had a BMI of <25 kg/m2; and 35.7% 
(CI 31.9-39.6) were overweight (a BMI between 25.0 and 29.9 kg/m2), while 50% (CI 
46.1-54.1) were obese (MBI ≥30). 
Table 2.2 demonstrates that 50.1% of the study population could be classified 
as obese (≥30.0 kg/m2) according to BMI. However, central obesity was also prevalent 
in 70.4% of the population, based on WC classification (WC >=94cm male >=80 cm 
female). In addition, 50.7% were found to have central obesity when WHR ≥0.90 cm 
for men and ≥0.85.0 cm for women were used as cut-off points.  
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Table 2.2: Distribution of the study population, according to different measures of 
obesity 
Variable N (%) Males Females 
BMI  
Under and Normal weight (<25 
kg/m2) 
84 (14.1) 14.1% 14.1% 
Overweight (25.00-29.99 kg/m2) 213 (35.7) 39.1% 33.1% 
Obese (≥30.0 kg/m2) 299 (50.1) 46.8% 52.8% 
WC  
>94.0 cm (men); >80 cm (women) 426 (70.4) 70.1% 70.7% 
<=94 cm (men); <=80 cm (women) 179(29.6) 29.9% 29.3% 
WHR  
≥0.90 cm (men); ≥0.85.0 cm (women) 307 (50.7) 81.8% 25.1% 
<0.90 cm (men); <0.85 cm (women) 298 (49.3) 18.2% 74.9% 
 
 
We used multinomial logistic regression analysis to determine the association 
between independent variables, such as age, family history, anthropometric measures 
and biochemical measures, and dependent variables to determine the presence of DM 
and prediabetes. Table 2.3 and Table 2.4 show the univariable, and multivariable, 
regression analyses results for the possibility of having DM and prediabetes according 
to potential correlates, respectively. 
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Table 2.3: Univariate analyses− unadjusted odds ratios for DM and prediabetes 
Variable 
All 
DM Prediabetes 
 
N n (%) OR (95% CI) n (%) OR (95% CI) 
Overall prevalence 
(n, %) 
605 113(18.7)  228(37.7)  
Nationality 
Emirati 318 56 (17.6) 1 117(36.8) 1 
Arab 287 57 (19.9) 1.16 (0.81, 1.65) 111(38.7) 1.24 (0.79, 1.93) 
Age (n, %) 
35-54 years 447 83 (18.6) 6.54 (2.29, 18.61) 180(40.3) 2.57 (1.51, 4.39) 
≥55 53 23 (43.4) 25.65 (7.57, 86.92) 17 (32.1) 3.44 (1.44 8.25) 
Sex (n, %) 
Male 274 62 (22.6) 1.93 (1.23, 3.01) 110(40.1) 1.48 (1.03, 2.12) 
Female 331 51 (15.4) 1.0 118(35.6) 1 
Marital status 
Married  578 106 (18.3) 1.0 219(37.9) 1 
Divorced widowed 20 4 (20.0) 1.15 (0.37, 3.52) 9(35.0) 0.89 (0.33, 2.45) 
Family type 
Nuclear family 471 92 (19.5) 1.0 178(37.8)  
Joint family 126 18 (14.3) 0.64 (0.36, 1.15) 47 (37.3) 0.87 (0.56, 1.34) 
Education level (%) 
No formal education 42 14 (33.3) 1.0 20 (47.6) 1 
Up to secondary 
level 
282 55 (19.5) 0.25 (0.10, 0.64.9) 105(19.5) 0.34 (0.14, 0.81) 
>Secondary level 274 41 (14.9) 0.18 (0.07, 0.45) 101(14.9) 0.31 (0.13, 0.72) 
Employment status  
Employed  316 56 (17.7) 0.88 (0.58, 1.37) 121(38.3) 1.01(0.71, 1.45) 
Unemployed 289 57 (19.7) 1.0 107 37.0) 1 
BMI categories  
<25 84 11 (13.1) 1 16 (19.0) 1 
25.0-29.9 213 25 (11.7) 1.23 (0.56, 2.68) 83 (38.9) 2.81 (1.51, 5,26) 
≥30.0 299 75 (25.1) 3.92 (1.92, 7.99) 125(41.8) 4.49 (2.43, 8.33) 
WHR 
≥0.90 cm (men); 
≥0.85.0 cm (women) 
258 80 (26.1) 3.50 (2.18, 5.62) 118(38.6) 1.54 (1.08, 2.21) 
<0.90 cm (men); 
<0.85 cm (women) 
347 33 (11.0) 1 110(36.8)  
Central obesity 
(WC) 
>94.0 cm (men); >80 
cm (women) 
324 63 (26.6) 2.89 (1.83, 4.56) 94 (39.7) 1.64 (1.13, 2.37) 
<=94 cm (men); 
<=80 cm (women) 
281 50 (13.7) 1 132(36.1)  
Family history of 
DM 
Yes 325 77 (23.7) 2.44 (1.50, 3.97) 124 38.1) 1.33 (0.91, 1.91) 
No 245 31 (12.6) 1 92 (37.5)  
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Table 2.3: Univariate analyses− unadjusted odds ratios for DM and prediabetes 
(Continued) 
 
Variable 
All 
DM Prediabetes 
 
N n (%) OR (95% CI) n (%) OR (95% CI) 
Ever smoked 
cigarettes  
Yes 152 32 (21.0) 1.61 (0.07, 2.68) 68 (44.7) 1.73 (1.14, 2.63) 
No 453 81 (17.8) 1 160 (35.3) 1 
Total cholesterol 
(mg/dl) 
<200 377 76 (20.2) 1 130 (34.5) 1 
≥200 228 37 (16.2) 0.89 (0.56, 1.43) 98 (42.9) 1.38 (0.96, 1.99) 
LDL-cholesterol 
(mg/dl) 
<130 377 84 (22.3) 1 118 (31.3) 1 
≥130 226 29 (12.8) 0.68 (0.41, 1.11) 108 (47.8) 1.79 (1.25, 2.59) 
HDL-cholesterol 
(mg/dl) 
Normal 151 18 (11.9) 1 47 (31.1) 1 
Low (<40 in male 
<50 in female) 
454 95 (20.9) 2.55 (1.44, 4.49) 181 (39.8) 1.86 (1.23, 2.81) 
TGs levels (mg/dl) 
Normal 434 65 (14.9) 1 160 (36.9) 1 
High (≥150) 171 48 (28.1) 2.80 (1.74, 4.52) 68 (39.8) 1.61 (1.07, 2.43) 
Hypertension (BP 
≥140/90) 
No 493 77 (15.6) 1 184 (37.4) 1 
Yes 112 36 (33.0) 3.60 (2.08, 6.23) 43 (39.4) 1,79 (1.08, 2.98) 
PA (vigorous) at 
least once a week 
No 428 90 (21.0) 2.06 (1.22, 3.47) 165 (38.5) 1.38 (0.93, 2.03) 
Yes 177 23 (12.9) 1 63 (35.6) 1 
PA (moderate) at 
least once a week 
     
No 477 92 (19.3) 1,23 (0.71, 2.15) 179 (37.5) 1.03 (0.66, 1.58) 
Yes 128 21 (16.4) 1 49 (38.3) 1 
Walk for at least 
30 minutes once a 
week 
     
No 139 26 (18.7) 0.84 (0.50, 1.42) 44 (31.6) 0.68 (0.44, 1.04) 
Yes 466 87 (18.6) 1 184 (39.5) 1 
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Table 2.4: Multivariable multinomial logistic regression analysis− adjusted odds 
ratios (AOR) for DM and prediabetes 
 
Variable 
DM Prediabetes 
Adjusted ORs (95%CI) 
P 
value 
Adjusted ORs (95% 
CI) 
Age  
18-34 years 1.0  1.0 
35-54 years 5.74 (1.91, 17.29) 0.002 2.44 (1.34, 4.47) 
≥55 18.83 (4.97, 71.27) <0.001 3.10 (1.10, 8.74) 
Education level  
No formal education 1.0  1.0 
Up to secondary level 0.27 (0.09, 0.78) 0.015 0.37 (0.14, 0.90) 
>Secondary level 0.15 (0.05, 0.45) <0.001 0.27 (0.10, 0.74) 
WHR 
≥0.90 cm (men); ≥0.85.0 cm 
(women) 
2.24 (1.27, 3.91) 0.005 1.01 (0.65, 1.53) 
<0.90 cm (men); <0.85 cm 
(women) 
1.0  1.0 
BMI 
<25.0 1.0  1.0 
25.0-29.9 1.05 (0.43, 2.55) 0.922 2.51 (1.24, 5.12) 
≥30.0 3.54 (1.55, 8.07) 0.003 4.52 (2.25, 9.08) 
Cigarette smoking  
No 1.0  1.0 
Yes 1.04 (0.56, 1.92) 0.990 1.92 (1.18, 3.11) 
TGs levels (mg/dl) 
Normal 1.0   
High (≥150) 2.09 (1.22, 3.61) 0.008 1.28 (0.81, 2.03) 
Vigorous PA once a week 
No 1.96 (1.06, 3.62) 0.031 1.31 (0.85, 2.00) 
Yes 1.0   
Family history of DM 
Yes 2.95 (1.66, 5.23) <0.001 1.26 (0.84, 1.88) 
No 1.0  1.0 
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2.3.6 Number of People Diagnosed with Prediabetes and DM 
Figures 8 and 9 show the percentage of participants who were diagnosed with 
prediabetes and DM by a doctor’s diagnosis or by HbA1c or FPG. 
 
Figure 8: Percentage of participants diagnosed with prediabetes using HbA1c or FPG 
  
 
Figure 9: Percentage of participants diagnosed with DM by a doctor’s diagnosis or 
HbA1c or FBG 
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2.3.7 Association between Prediabetes, DM and Age 
In the univariable analyses, study participants were more likely to belong to 
older age categories (≥55 versus 18-34 years) with DM (odds ratio [OR] =25.65; 95% 
CI 7.57 to 86.92) as well as with prediabetes ([OR] =3.44; 95% CI 1.44 to 8.25) as 
compared to their normoglycemic counterparts. Moreover, this correlation remained 
significant in the multivariable analyses for both DM (adjusted odds ratio [a OR] 
=18.8; 95% CI 4.9 to 71.2, P<0.001), and prediabetes ([a OR] =3.10; 95% CI 1.1 to 
8.7, P=0.032), respectively. 
2.3.8 Association between Prediabetes, DM and Education Level  
Participants with DM were less likely to report having a formal education 
(OR=0.18; 95% CI 0.00 to 0.4). The same was applicable for prediabetes (OR=0.3; 
95% CI 0.1 to 0.7), when compared to participants with normoglycemia in the 
univariable analyses. This remained significant in the adjusted analyses for DM 
(aOR=0.1; 95% CI 0.0 to 0.4) and prediabetes (aOR=0.2; 95% CI 0.1 to 0.7). 
2.3.9 Association between Prediabetes, DM and Waist Hip Ratio  
Participants were more likely to have a WHR of more than 0.90 cm in men and 
≥0.85.0 cm in women if they had DM (OR=3.5; 95% CI 2.1 to 5.6) or prediabetes 
(OR=1.5; 95% CI 1.0 to 2.2) in univariable analyses, as compared to those with 
normoglycemia. In the multivariable analysis (Table 2.4), the correlation of WHR with 
prediabetes was not significant (p<0.0991). However, a high WHR remained a 
significant correlate of DM.  
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2.3.10 Association between Prediabetes, DM and Obesity 
Participants with DM were more likely to be obese (OR=3.9; 95% CI 1.9 to 
7.9) and, similarly, participants with prediabetes were more likely to have obesity 
issues (OR=4.4; 95% CI 2.4 to 8.3), than those with a normal FBG level in the 
univariable analysis. These findings remained significant even after adjusting for other 
potential confounding data. This was true for both DM (aOR=3.5; 95% CI 1.5 to 8.0) 
and prediabetes (aOR=4.5; 95% CI 2.2 to 9.0).  
2.3.11 Association between Prediabetes, DM and Smoking  
Participants with DM and prediabetes were 1.61 more likely to smoke 
cigarettes. OR=1.61; 95% CI 0.07-2.6 for diabetes, and OR 1.73; 95% CI 1.14-2.63 
for prediabetes when compared to participants with normoglycemia, in univariable 
analyses, This was also significant in the adjusted analyses for prediabetes (aOR=1.9; 
95% CI 1.1 to 3.1; P=0.008) but not for DM (aOR=1.0; 95% CI 0.5 to 1.9; P=0.990). 
2.3.12 Association between Prediabetes, DM and TGs Levels 
Elevated TGs levels (≥150mg/dl) showed a significant association with DM 
(OR=2.8; 95% CI 1.7 to 4.5; P<0.001) and prediabetes (OR=1.6; 95% CI 1.0 to 2.4; 
P=0.022) in univariable analyses. This remained significant for DM in the adjusted 
analyses (aOR=2.09, 95% CI 1.2 to 3.6; P=0.008), but not for prediabetes (aOR=1.28, 
95% CI 0.8 to 2.0; P=0.286). 
2.3.13 Association between Prediabetes, DM and Physical Activity 
Not practicing vigorous PA at least once a week had a significant correlation 
to the presence of DM (OR=2.06; 95% CI 1.2 to 3.4; P=0.007), but not for prediabetes 
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(OR=1.3; 95% CI 0.9 to 2.0; P=0.103) in the univariable analyses when compared to 
those with normoglycemia.. This effect remained significant for DM in the adjusted 
analyses (aOR=1.96, 95% CI 1.0 to 3.6; P=0.031). 
2.3.14 Association between Prediabetes, DM and a Family History of DM 
Participants with DM were 2.4 times more likely to report that they had a 
family history of DM (OR=2.44; 95% CI 1.5 to 3.9, P<0.001) as compared to their 
non-DM counterparts, in the univariable analyses. Again, this remained significant in 
the adjusted analyses for DM (aOR=2.95; 95% CI 1.6 to 5.2; P<0.001). However, no 
association was found between prediabetes and a family history of DM. 
2.4 Discussion 
2.4.1 Prevalence of Prediabetes 
In this cross-sectional study in the UAE, we estimated the prevalence of DM 
and prediabetes and quantified the effect of correlating conditions associated with 
individual characteristics. Our findings suggest that DM and prediabetes have become 
epidemic in the UAE’s adult population. We also found that the prevalence of DM and 
prediabetes varied substantially with the individual’s age, educational level, WHR, 
body weight, TGs levels and PA.  
The study described here measured the prevalence of prediabetes in Al Ain 
using the ADA 2016 recommended prediabetes diagnostic criterion of an HbA1c level 
of 5.7% to 6.4%, and an FBS level of 100 mg/dl to 125 mg/dl1. It demonstrated that 
the prevalence of prediabetes in Al Ain was significant and amongst the highest 
reported globally. The reported prevalence of prediabetes was 37.7% in the study 
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group, which was similar to the figure reported in 2012 for the US adult population 
(38%)30. However, it was much higher than the prevalence reported in a population-
wide cardiovascular screening program (Weqaya) in Abu Dhabi in 2012, where the 
incidence of prediabetes was 27%41. This is probably because of differences in the 
sample size and characteristics. For example, in our study, participants were married 
and older than the population in the Weqaya study. In addition, participants in the 
Weqaya study included different demographic characteristics such as single people 
and people without children.  
The high prevalence of prediabetes in our study should alert policy and 
decision makers to the seriousness of the problem. Unless urgent prevention efforts 
are successfully implemented the prevalence of prediabetes will increase even further, 
and each new case of DM in the UAE will exacerbate future economic and health 
burdens on the country. 
Despite the fact that the incidence prediabetes differs depending on the 
diagnostic criteria, our study’s findings are consistent with the increase in prediabetes 
across the GCC38,39, Asian33,37,152, European32 and North American27,31 countries. 
Roughly similar figures have recently been reported in the US (37%)153, in the UK 
(35.3%)32, Oman (35%)39 and Canada (33.1%)31. However, a lower rate was found in 
Saudi Arabia (11.9%)38 and Bangladesh (11.5%)37. It can be predicted from the 
substantially higher prevalence of prediabetes in the UAE that there will be a further 
increase in DM over the next few years. It also illustrates that prediabetes in the UAE 
offers an urgent context for preventative intervention, especially as worldwide 
evidence indicates that lifestyle modification can not only prevent the onset of 
prediabetes, but also help patients to revert to a normoglycemia status43,154. In addition, 
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effective intervention at the prediabetic stage can lead to a slowing down of the high 
economic and health burden ($60 million per year in the UAE), or even help to prevent 
it42. 
The prevalence of prediabetes was higher among men (40.2%) as compared to 
women (35.7%), even though there were more obese women (52.8%) than men 
(46.8%). Similar findings were reported in the Weqaya study, where 27.8% of men, 
compared to 26.5% of women had prediabetes despite the fact that 38% of women and 
32% men were obese41. Our study also showed that obese people were 4.4 times more 
likely to have prediabetes than those of a normal weight. This relationship indicates 
that despite obesity being related to prediabetes in the UAE, the extent of the effect of 
obesity on prediabetes is not the same for men and women. There is a difference in 
gender-related factors that can affect prediabetes. In a longitudinal population-based 
study in China, it was found that PA in males and WC in females were important 
predictors and causes of prediabetes155. Identifying the most common reasons for 
prediabetes in both men and women is vital in order to inform preventative measures 
and any attempts to return patients back to normal glucose regulation. 
2.4.2 Association between Prediabetes and Age 
Our findings showed that age (non-modifiable), obesity, WHR, TGs levels, PA 
and educational level (all modifiable) were significantly associated with prediabetes. 
The current analysis showed a high proportion (40%) of people aged 34-54 years had 
prediabetes as compared to participants from the younger age categories of 18-34 
(26%). This age-specific finding supports the need for early detection and periodic 
screening in people aged 34-54 years. This priority group also needs to be the target 
of more lifestyle education programs that highlight the importance of increased regular 
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PA, a healthy diet, self-monitoring of their BMI and periodic FBG checks. These can 
be performed in the workplace, or in outpatient clinics in a primary health care setting.  
The ADA suggests there should be prediabetic screening of asymptomatic 
adults of any age who are overweight or obese (BMI ≥25 kg/m2) and have one or more 
additional correlate for DM, like being from a high-risk race, physical inactivity, 
having first degree relatives who have DM, high BP or hyperlipidemia154. The above 
age-specific finding in this study also suggests that published information from the 
WHO or ADA regarding prediabetes screening should can be taken as a general 
guideline, but that each country needs to have its own, more population specific, 
guidelines. 
2.4.3 Association between Prediabetes and Obesity 
As expected, obesity was one of the most important correlates that was 
significantly associated with prediabetes. The distribution of the population per BMI 
category showed that 35.7% were overweight (BMI between 25.0 and 29.9 kg/m2), 
and 50.1% were obese (MBI ≥30 kg/m2). In the univariable analysis, participants who 
were obese were 4.5 times more likely to have prediabetes than those of a normal 
weight. This relationship has also been demonstrated in other studies, including in 
Saudi Arabia and Bangladesh37,38,156. 
The results of this study indicate that there has been an extremely rapid rise in 
the proportion of adults who meet the criteria for obesity. The most recent reports from 
the UAE show a sharp rise (double) in the prevalence of obesity in adults (from 16% 
to 35%), with grade III obesity (BMI ≥40) rising the most dramatically from 2% in 
2000 to over 11% in 2010157. This is nearly four times higher than the increase 
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observed in the proportion of people with morbid obesity in the UK (from 1.8% to 
2.9% between 2005-2015)95. The figure obtained in our study for the prevalnce of 
obesity (50.1% ) is alarming as it is higher than the one reported in the Weqaya study 
(35%) and in other UAE cross-sectional surveys, which revealed an overall obesity 
rate in the UAE of 34%41 in 2000. Our results are consistent with previous studies in 
other GCC countries where there has been an increase in obesity in recent years. This 
suggests that the lifestyle in the GCC countries is conducive to encouraging obesity. 
However, this increase was lower than the rise observed in Saudi Arabia (39%) and 
Kuwait (42%)103 in our study. It compares badly to the prevalence of obesity in 
England (27%)95 and Bangladesh (4.6%)97. 
The UAE has been ranked as the world’s fifth most obese nation158. A number 
of factors at an individual and environmental level, mainly dietary and physical 
inactivity, have contributed to rising numbers of overweight people and obesity in the 
UAE121. Adults in the UAE consume over 3,000 calories per day on average, more 
than 20% over the recommended daily allowance158. The daily fruit and vegetable 
consumption in the UAE is not optimal either130. Between 1998 and 2003, 
approximately 80% of males and over 75% of females in the Emirates reported eating 
less than the recommended five daily servings of fruit and vegetables158. Skipping 
breakfast is also highly prevalent in the UAE119 (28% of Emirati boys and 37% of 
Emirati girls) and consumption of fast food has increased (76% consumed fast food at 
least once per week)145. The number of fast food restaurants in the food courts of 
shopping malls and petrol stations has increased in the UAE. Furthermore, the 
consumption of sugar-sweetened drinks has also increased130 (making up 8%-14% of 
the total calorie intake and 70% of the daily liquid intake158). This is still below the 
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US, UK, and Mexico. In Saudi Arabia, two-thirds of males and adolescent females 
consume sugar-sweetened drinks more than three days per week119. Snacking (1.5 
snacks per day) represents a very large proportion of the calories (20%)158 consumed 
by UAE nationals. In comparison the US population consumes 3 snacks a day on 
average. However, Emiratis eat more calorie dense foods and have longer snack 
periods when compared to Americans157. 
There is a significant lack of PA in the UAE population, especially females and 
those living in urban areas. Only 41%121 of adult Emirati women take moderate, or 
high, levels of PA compared to 82%157 and 65%119 of American and Saudi women 
respectively. A lack of female role models among their peers and families, not having 
culturally acceptable exercise facilities for women, and the hot and dusty weather114 
all create obstacles for women who want to get involved in sports in the UAE. Other 
hindrances to exercise for Emirati women include a lack of information on the benefits 
of exercise, personal motivation and not having the spare time for exercise123. As a 
result, females spend more time indoors doing sedentary activities, including watching 
TV and snacking on high calorie content food119. Furthermore, Emiratis forgo 
domestic chores as these are often carried out by a domestic housekeeper, cook and 
nanny, which results in an even more sedentary lifestyle159. 
The environment in the UAE is obesogenic and cities are unfortunately not 
designed for walking. Therefore, Emiratis rely heavily on automobiles145. Indeed, the 
more urbanized areas may be even more obesogenic. In addition, the high temperatures 
of up to 450C in the Summer and the concomitant dusty conditions discourage people 
in the UAE from exercising114. Policy makers must reshape the environment in the 
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UAE in a way that encourages healthy decision making as this is a key feature in the 
prevention of obesity. 
Furthermore, offering inventive social support programs to help people to 
make better lifestyle choices, to eat healthier diets and do more PA is required. These 
initiatives include improving access to a larger variety of healthier food options that 
are more easily available, more accessible and cheaper in price. Food courts in malls 
and petrol stations need to have healthy restaurants and takeaway outlets and 
incentives must be available to help investors who are willing to open them. For 
example, lower rents and utility costs. One way of limiting access to less healthy 
options is by imposing a sugar tax. This would create an incentive for firms to supply 
healthier alternatives and will also raise funds that can be used to both subsidize the 
price of healthy food (fruit and vegetables) and fund public educational campaigns. 
Health officials should work with city planners to create a more positive built 
environment and design communities that promote active transport and improve access 
to exercise and outdoor activities. This can be achieved through building community 
parks, designing shopping malls with a walking track, and making roads safer for 
exercise. Furthermore, they should ensure that communities, especially female 
members, have easily accessible and reasonably priced exercise facilities that are 
within their cultural context. Moreover, decision makers need to encourage healthy 
behavior, particularly by women. This can be done by promoting a high level of PA 
and encouraging healthy eating from a young age. This is important because children 
are the most likely to adopt the lifestyle behaviors of family members, especially their 
mothers. 
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Health practitioners have a major part to play in combating obesity in the 
community. Their role is to continue screening for obesity by measuring and 
monitoring the weight of their patients (of all ages) during routine and follow-up visits 
to clinics. 
They have a role in preventing unnecessary weight gain and encouraging 
healthy behaviors (PA and healthy eating), in addition to referring patients to dietitians, 
nutritionists, or other specialists, as required. 
The Nutrition Examination Survey (NHANES) showed that the prevalence of 
prediabetes has increased even among adults of a healthy weight. This finding is 
concerning as there are no clear reasons for it. Abdominal obesity and sedentary 
lifestyle were two factors160, but it was concluded that abdominal obesity was not an 
independent correlate. This was contrary to our finding where a WHR of ˃0.90 cm for 
men and ≥0.85.0 cm in women was associated significantly with an increase of 1.5 
times in the possibility of getting prediabetes. Similar findings have been reported in 
Saudi Arabia38 and China161. 
2.4.4 Association between Prediabetes and Educational Level 
Educational level was among the correlates for prediabetes in our study. A high 
educational level was found to be positively correlated with prediabetes. Participants 
who reported an education level of more than secondary school were 0.3 times more 
at risk of developing prediabetes, compared to participants without a formal education. 
This finding might be explained by the fact that educated people are involved in more 
sedentary office work and often have an urban lifestyle, in contrast to less educated 
people who are more involved with manual labor and live in more rural areas. The 
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associations between educational level and prediabetes vary internationally. Our 
finding are in marked contrast to other population-based studies where prediabetes was 
inversely associated with educational level in Indonesia46 and Australia162, while in 
Saudi Arabia38 and Bangladesh37 the findings were consistent with ours. Other studies 
conducted in Hong Kong with Chinese people and in Iran showed there was no 
relationship between prediabetes and the education level of either sex, while one study 
in Iran showed that a higher educational level was a prediabetic correlate only in 
women162. 
2.4.5 Prevalence of DM 
The overall prevalence of DM in our study was 18.7%, which was similar to 
the figure reported in a population-wide cardiovascular screening program (Weqaya)40 
in Abu Dhabi, but lower than the one reported by the International Diabetes Federation 
(IDF) in the UAE, (19.3%). Although earlier studies from GCC countries have 
indicated very similar rates of DM compared to the UAE, our study showed a higher 
rate than those reported in Saudi Arabia (17.6%) and Kuwait (14.3%)163. The 
prevalence of DM in the UAE is rising (13.5% in 2000 compared to 18.7% in our 
study) at a faster rate than in the MENA region and the rest of the world, and the 
number of people with DM is expected to double to 2.2 million by 2040. Many 
explanations exist for this high rate of DM in the UAE and other Gulf countries. The 
most common reasons relate to high rates of obesity, which appear to have got worse 
over the last few decades. Drastic measures need to be implemented at policy level in 
the UAE in order to both combat the DM epidemic and protect the health of the next 
generation. 
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2.4.6 Association between DM and Age 
Our findings confirmed that there are many correlations for DM, including age, 
obesity, WHR, TGs levels, PA and education level. Older participants (≥55 years) 
were 25.65 times more likely to have DM, which is similar to the relationships 
observed around the world, including Bangladesh98. This finding is important as it will 
help decision makers and clinicians to design a screening program for the UAE 
population. People in this age group (≥55 years) have to be the focus before other age 
groups. 
2.4.7 Association between DM and Education Level 
Our findings showed that participants who reported their educational level was 
higher than secondary school had 82% less risk of DM, compared with participants 
without a formal education. This association varies internationally. The positive 
associations we found between these two factors and DM have also been previously 
observed in Bangladesh154 and Brazil. In China, the prevalence of DM was generally 
unaffected by educational level161 Studies from both developing and developed 
countries have found there are inverse associations between DM and educational level, 
maybe because better-educated people are more health-conscious154. 
2.4.8 Association between DM and Waist Hip Ratio  
In our study, we found that having a high WHR was significantly associated 
with an increased risk of getting DM, compared to those with a normal weight. Other 
studies in Saudi Arabia160, Kuwait103 and Bangladesh154 have supported this result. 
The prevalence of obesity has recently increased in the UAE, which is due to rapid 
urbanization that encourages a sedentary lifestyle and less traditional. And healthy, 
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diets. This finding provides decision makers with a mandate to intensify their efforts 
by concentrating on early intervention strategies to target obesity and central obesity 
in adults by increasing their control of food choices, PA and enhancing public 
awareness of obesity and its adverse consequences. These needs are particularly 
significant to the UAE as health illiteracy is very common157. 
Our findings could have important public health implications. The UAE's rapid 
socio-economic growth over the past 46 years has reflected positively on many of the 
UAE's health indicators like mortality rates and life expectancy. If this 
accomplishment is to last, the government has to increase its efforts and focus on 
proven, cost-effective primary prevention services that concentrate on behavior and 
lifestyle modification because of the huge growth in chronic diseases, including 
prediabetes, DM and obesity. In spite of the fact that preventive health services have 
been prioritized in the last few years, policy makers have concentrated on the provision 
of curative and tertiary healthcare services with little emphasis being placed on 
prevention. Furthermore, the existing primary healthcare services that are available in 
the UAE concentrate on providing immunizations and prenatal services instead of 
combating the increased rate of NCD, including prediabetes, DM and obesity. 
2.5 Strengths of Our Study  
Training workshops for nurses were conducted by qualified trainers. The 
training of the nurses in the use of standardized methods of anthropometric and BP 
measurement prior to data collection, assured the quality of the data collection.  
Furthermore, physical activity was assessed by using the IPAQ, which was used in 
conjunction with the WHO STEPS Questionnaire. Both HbA1c and FPG levels were 
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used to identify participants with prediabetes and DM. US National Cholesterol 
Education Program guidelines were used for the definition of dyslipidemia. 
2.6 Limitations of Our Study 
The primary limitation of this study is that it does not allow for causal 
conclusions regarding the relationship between the variables studied and prediabetes 
and DM as it is a cross-sectional study. Also, the measurement of the variables i.e. diet 
and physical activity was self-reported and depended on the participants’ memory and 
accuracy. This might have led to inaccurate data, especially in relation to their family 
history (father and mother), who might even be deceased. 
In addition, the American Diabetes Association recommends a repeat 
measurement after a single hemoglobin A1c, FPG, or 2-hour PG diabetes-positive test 
result, which we could not do because most participants made only one visit. 
Therefore, some participants without DM may have been misclassified as having DM 
and we cannot be certain how frequently this may have happened. 
A potential threat to internal validity was the lack of consistency in the 
biometric testing procedures. For example, the weight and waist measurements were 
taken with clothing on, which could have led to incorrect and inconsistent results. 
Furthermore, design effect was not taken into consideration when choosing our target 
population and our study population included only married adults with school children. 
As such our results should be interpreted with caution as they may be under-
representative of the general population of the UAE. 
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Chapter 3: Characteristics of Prediabetes and Correlates of 
Conversion from Prediabetes to DM in Dubai, the UAE 
3.1 Introduction 
Studies have established the use of simple clinical (weight, WC) and laboratory 
measurements (e.g. glucose, uric acid, lipids) to derive DM prediction models that are 
suitable for general practice3. Many studies have considered the risk factors for the 
conversion of prediabetes to DM3,164,165,166. It is generally assumed that the risk factors 
for prediabetes are similar to those for DM. Nevertheless, it is unclear if the strength 
of association of these risk factors is the same for both prediabetes and DM. The 
incidence of DM among those with prediabetes is higher in women when compared to 
men due to a low level of PA and higher obesity3. Prediabetes is significantly 
associated with being overweight or obese, hypertension, hypercholesterolemia and 
arthritis66. 
In the USA, the Strong Heart Study, a population-based longitudinal study of 
CVD and its risk factors, showed that the risk factors for DM in individuals with 
prediabetes was higher in women and in people with higher BMI, WC, and HbA1c 
who took less PA165. Furthermore, a retrospective longitudinal study in Japan of 2,105 
adults with prediabetes, with a mean observation period of 4.7 years ,showed that the 
independent risk factors for prediabetes becoming DM were a family history of DM, 
being male, a higher than normal BP and glycaemia levels. Additionally, this study 
confirmed that a BMI reduction as small as 1 kg/m2 was related to a 16% decrease in 
the incidence of DM in people with prediabetes26. Obesity was a common risk factor 
for the transformation of prediabetes to DM in a population-based study in Denmark 
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and in other studies (above). There were also other factors, like hypertension and 
hypertriacylglycerolaemia167. 
In the UAE, there have been several studies into the risk factors for DM in the 
UAE population and fewer studies on prediabetes. However, to the best of our 
knowledge, no study has been conducted on the predictors for the conversion of 
prediabetes to DM in the UAE. The results of our study will have a major impact on 
public health in the UAE and can be used as a guide for policy and decision makers. It 
will also help to shape future healthcare in the UAE.  
3.1.1 Secondary Aims and Objectives 
3.1.1.1 Aims 
Prediabetes is associated with a significant risk of developing DM and CVD. 
Early screening and diagnosis of prediabetes, along with preventive measures, are 
essential in preventing DM or delaying its progression. Our study aims to improve 
current understanding of prediabetes in order to ensure early detection of DM. This 
would allow us to plan for better control and prevention of DM in the UAE. 
3.1.1.2 Specific Objectives 
- Objective 1: To identify the characteristics of Emirati adults with prediabetes.  
- Objective 2: To identify the correlates which lead to the progression of 
prediabetes to DM in Emirati adults. 
The Research Hypothesis: 
People with prediabetes who reported positive symptoms related to sleep apnea 
on the Berlin Questionnaire Scale are more likely to develop DM as compared to their 
counterparts without the symptoms of obstructive sleep apnea.  
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3.2 Methods 
3.2.1 Study Design  
We used a cross-sectional design to achieve our study objectives. 
3.2.2 Study Site 
This study was conducted in five healthcare centers in Dubai. Dubai is the most 
populous city in the UAE. It is located on the southeast coast of the Arabian Gulf and 
covers an area of 4,110 km2 with a population of 2.847million, according to the 2017 
census.  
3.2.3 Study Population 
The previous data from Al Ain was sampled from other data. For this 
dissertation a study planning workshop was conducted in order to recruit 700 UAE 
nationals, aged over 18, with prediabetes from five primary healthcare centers in 
Dubai. Out of 700 subjects contacted, 487 participants met the inclusion criteria of the 
study protocols, agreed to take part and completed the questionnaires. Before reducing 
the sample to 700, 300 subjects had already failed to meet the inclusion criteria.  
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Figure 10: Study population in Dubai, the UAE (n=487)    
 
3.2.4 Sample Size and Selection of Study Participants Correlate 
Our main aim in this study was to evaluate the role of sleep apnea in the 
conversion of prediabetes to DM. We could not perform sleep studies in order to 
identify sleep apnea. However, we used the Berlin questionnaire to identify people at 
risk of obstructive sleep apnea. 
We wanted to demonstrate a difference of a third of the (within group) standard 
deviation of blood sugar levels in the negative sleep apnea group, as compared to the 
group of prediabetics with sleep apnea with a Type I error of 5% and a Type II error 
of 10%. Using the standard formula for two groups with continuous outcomes, we 
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required 146 participants per study strand. After adjusting for clustering effects in the 
health care centers by using an average design effect of 1.76 (based on the largest 
design effect that had been observed in previous studies), and accounting for the loss 
to any follow-ups and retractions of informed consent, we recalculated the need for 
400 study participants.  
3.2.4.1 Inclusion Criteria 
- Emirati national. 
- Aged 18-64 years. 
- Living in the Emirate of Dubai.  
- Diagnosed with prediabetes (HbA1c 5.7-6.4) or (FBG 100-125   
            mg/dl). 
- Not using any medicine for DM.  
- Willing and agreed to participate. 
3.2.4.2 Exclusion Criteria 
- Participants aged <18 and >65. 
- History of DM (self-report of a previous diagnosis by a physician or 
other health professional or determined from a medical report). 
- Major psychiatric diseases (determined from medical report). 
- Current, planned, or previous pregnancy within the past 6 months. 
- Refusal to participate or withdrawal from the study. 
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3.2.5 Study Measurement 
3.2.5.1 The Primary Variable 
The primary variable was the conversion from prediabetes to DM. DM was 
diagnosed by self-reporting during telephone interviews, and/ or by having an FBG of 
>=126 mg/dl and an HbA1c >=6.5. 
3.2.5.2 The Other Variable 
The other variable was sleep apnea. Symptoms for sleep apnea were detected 
by using the Berlin questionnaire on sleep apnea. 
3.2.5.3 Other Variables 
Socio-demographic characteristics 
- Age, tobacco use, educational level, smoking, history of chronic diseases and 
family history of chronic conditions. 
Anthropometric measurements 
- Height, Weight and BMI. 
Blood Tests 
- FPG, HbA1c, total cholesterol, TG, HDL and LDL cholesterol. 
- The level of PA. 
3.2.6 Data Collection Procedure 
Dubai Health Authority (DHA) launched the Dubai Standards of Health Care 
on March 16th, 2015 to ensure early detection and unified management of DM and 
prediabetes in the Emirate of Dubai.   Prediabetes screening was conducted across 18 
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primary health care centers. The subjects were originally 5,131 UAE nationals in 
Dubai in 2015. They data came from 18 healthcare centers and the subjects were 
identified via the electronic system SAM (electronic system available in primary 
healthcare centers in DHA) as part of a screening program. The screening included 
taking blood samples for a lipid profile, fasting blood sugar and HbA1C. The blood 
results were obtained from the SAM system at the DHA.  
In 2017, we used a sampling frame with the data above for our current study. 
This time five primary healthcare centers in Dubai were chosen at random from the 18 
(Simple Random Sampling). A list of the total number of patients in each of the five 
healthcare centers was generated. Then a study sample proportionate to the size of each 
of the five health centers was prepared.  
Next, we conducted a workshop. The workshop included project staff, one 
primary health care physician and a registered nurse from each of the five centers. The 
study team explained the aims and objectives of the study to the workshop participants. 
With the help of prediabetic screening staff and workshop participants, 1000 UAE 
nationals with prediabetes were identified based on fasting plasma glucose and HbA1c 
levels, according to the ADA guidelines. The identification of possible study 
participations was undertaken by a nurse at each of the five centers under the 
supervision of a doctor (one doctor per five nurses) using the SAM system. With a 
grant in place from the NRF for Diabetes Prevention, 700 DHA screening program 
subjects were contacted to participate in a more intensive diabetes prevention program.  
A team of final year female medical students at UAE university (n=12) was 
identified to serve as research assistants. A training workshop was also conducted for 
the medical students by qualified trainers, to explain the study protocol and give 
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training on standardizing methods for gathering data by phone call questionnaires. 
Participants diagnosed with prediabetes (ADA guidelines of FBG 100-125 mg/dl and 
A1C 5.7% to 6.4%) in our 2015 study were contacted to take part in the phone-based 
study. 
Each subject received three phone calls after which they were excluded if no 
response was obtained. Verbal consent was granted by each participant at the 
beginning of the call. Participants who did not give their consent were excluded from 
the study. We used a structured questionnaire that identified socio-demographic, 
lifestyle and clinical data and used the Berlin questionnaire to assess the extent, or not, 
of symptoms of sleep apnea. The data was collected from 700 UAE nationals over the 
phone. Out of the 700 Emiratis who completed screening test and were diagnosed with 
prediabetes, 487 agreed (respond rate 69%) to complete our study questionnaire and 
tanswer he Berlin questionnaire to scale obstructive sleep apnea. Socio-demographic 
and behavioral information on tobacco use, daily consumption of fruit, PA level, 
history of chronic diseases, and family history of chronic conditions was also obtained. 
Data regarding anthropometric measurements, such as height and weight was self-
reported. 
Data regarding exercise behavior was determined by asking participants about 
the frequency and duration of their daily exercise. The PA activity was classified into 
three levels: vigorous, moderate and light. ‘Vigorous-intensity activities’ require hard 
physical effort and cause a large increase in our breathing or heart rate, ‘moderate-
intensity activities’ require moderate physical effort and cause a small increase in our 
breathing or heart rate, and ‘light-intensity activities’ require the least amount of effort. 
Participants were classified as being sufficiently active if they exceeded the minimum 
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recommended duration of PA per week, as suggested by the WHO, i.e. 150 minutes of 
moderate intensity PA, or 75 minutes of vigorous intensity PA or an equivalent 
combination of moderate and vigorous intensity PA per week, with each activity 
performed for at least 10 minutes. Fruit and vegetable consumption was also measured 
by finding out if they ate these foodstuffs “every day” or “not every day”. 
Individuals were considered to have DM or high BP if a health care provider 
had ever told them they had hypertension or DM, or were on medication for 
hypertension or DM, excluding gestational diabetes. Hypertension was defined as a 
mean systolic BP of  ≥140, a mean diastolic BP of  ≥90 or if individuals had been 
diagnosed by a physician and were on anti-hypertensive medication (self-reported). 
Participants with DM were asked about the type of treatment they were on (diet, tablets 
or insulin injections) and if they had a device to check blood sugar levels at home. 
Respondents were asked whether any of their living or deceased, first or second, blood 
relatives (including grandparents, aunt, uncle, first cousin, parents, brothers, and 
sisters) had ever been told by a physician that they had DM. We ascertained DM by 
self-reporting or a physician’s diagnosis of DM and the use of diabetic medication or 
a blood glycated hemoglobin level ≥6.5%. We excluded any individuals with a 
previous history of DM from the analysis.  
We also asked if they had a history of smoking cigarettes or shisha. Smoking  
was classified into current, non-smoker or ex-smoker shisha or cigarettes. Shisha 
smoking – a water pipe – is a way of smoking tobacco, which is sometimes mixed with 
fruit, through a hose and bowl. The hose ends in a mouthpiece from which the smoker 
inhales the smoke. 
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The Berlin questionnaire evaluated whether participants were at risk of 
obstructive sleep apnea. It is the preferred instrument rather than a STOP-BANG 
questionnaire, STOP questionnaire or Epworth sleepiness scale. The questionnaire had 
three categories ssociated with the risk of having sleep apnea. Participants can be 
classified into high risk or low risk, depending on their responses to each question and 
their overall scores in the symptom categories. The questionnaire consisted of nine 
questions that related to snoring and the last question asked whether participants had 
high BP, did not have it, or did not know if they did. The Berlin Questionnaire was 
used to assess if sleep apnea was one of the correlates for developing prediabetes. A 
copy is attached in Appendix 3 along with instructions on the scoring system used in 
this study to identify participants with a high Berlin score. 
Biometric screening exam data was extracted from the electronic medical 
records at the Dubai Health Authority. This retrieved data was collected as part of the 
prediabetic screening program at the Dubai Health Authority in 2005 and included 
FBG, HbA1c, total cholesterol, TG, HDL and LDL cholesterol. Two different cut-offs 
had been used to define prediabetes: fasting blood glucose of ≥100 mg/dl (≥5.6 and 
<126 mg/dl) and fasting blood glucose of ≥110 mg/dl (≥6.1 and <126 mg/dl) or an 
HbA1c level of 5.7-6.4%. Participants were classified as having DM, or being free of 
DM, based on their HbA1c level of ≥6.5% and fasting blood glucose level of ≥126 
mg/dl, and/ or those diagnosed by a physician and/ or on antidiabetic medication. The 
National Cholesterol Education Programme guidelines that we used define 
dyslipidemia as follows: HyperTGmia—serum TG levels ≥150 mg/dl and/ or 
Hypercholesterolemia-serum cholesterol level of <200 mg/dl. The optimal HDL 
cholesterol level was <100 mg/dl and LDL cholesterol level was <40 mg/dl40. 
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3.2.7 Ethical Considerations 
3.2.7.1 Ethical Approval of Study 
The study protocol was approved by the Human Research Ethics Committee at 
the Dubai Health Authority, Dubai, the UAE (MRC-05/2014_06, Appendix 2). 
3.2.7.2 Informed Consent 
Verbal consent was obtained over the phone from all of the subjects before 
taking part. 
3.2.7.3 Confidentiality 
The data and questionnaires are stored in the Institute of Public Health at UAE 
University, where their protection is guaranteed through a password protected file. 
3.2.8 Timeline 
The baseline data on prediabetes status, based on HbA1c, FBG and plasma 
lipid levels, was collected within a six month timegrame, from April 2015 to August 
2015. Follow-up data, by telephone, was collected within a six month timeframe, from 
January 2017 to June 2017. 
3.2.9 Data Analysis 
We entered data into Microsoft Access before it was imported into STATA 
version 14.0 (StataCorp LP, College Station, TX) for analysis. We summarized 
categorical variables proportions, and continuous variables using the mean, or median, 
depending on whichever was most applicable, with 95% confidence intervals. The 
Chi-square test compared proportion across every group and the ANOVA test 
compared means across the groups. A descriptive analysis describes the characteristics 
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of the case data from Dubai. Some of the cases of prediabetes have become DM since 
the date of the screening and we have completed univariate and multivariate analysis 
to identify the correlates of prediabetes developing into DM.   
Our outcome was to identify how many people with prediabetes have 
developed DM without following up each patient to see when this transformation 
actually took place (in term of how many weeks each prediabetic patient took to 
develop DM) (dominator data was missing). Therefore, we used logistic regression 
analysis. Furthermore, OR was used in our study to establish the strength of association 
between the conversion from prediabetes to DM and its correlates. 
As our objective was to identify all the variables associated with prediabetes 
becoming DM, all the variables were included in the analysis. However to account for 
unstudied variables (residual confounding) we used multivariable analysis. 
Furthermore, we have checked our data for interactions but could not find any between 
the variables in our study. 
The issue of missing data was only present for the data collected in Dubai. We 
treated our missing data by referring to a biostatistician who used statistical methods 
to verify the data. Analysis on the Dubai data was done twice. One analysis was 
without the missing data and second one was conducted with assumptions made for 
the missing data. No difference was noted in the results. 
3.3 Results 
The demographic and clinical characteristics of the study population are 
presented as a percentage for the categorical variables and as a mean±standard 
deviation for the continuous variables, in Table 3.1. 
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Table 3.1: Demographic and clinical characteristics of the study population 
(n=487) in Dubai, the UAE 
Variables All Male (n=135) Female (n=352) 
Age (years) 39.6±10.3 37.8±10.0 40.3±10.4 
Height (cm) 162.7±8.9 172.2±6.8 159.2±6.8 
Weight (kg) 80.4±19.9 87.2±17.6 77.9±20.3 
BMI (kg/m2) 30.5±10.1 29.4±5.7 31±11.2 
Total cholesterol (mg/dl) 196.8±38.3 198.2±40.1 196.2±37.5 
HbA1c (%) 5.9±0.4 5.9±0.4 5.9±0.4 
LDL (mg/dl) 122.6±33.7 126.1±35.9 121±32.5 
HDL (mg/dl) 54.2±15.3 47.7±13.2 57.2±15.3 
TG (mg/dl) 116.5±63.1 136.1±76.8 107.7±53.6 
FBG (mg/dl) 102.4±13.2 102.3±12.7 102.5±13.5 
Marital Status 
Single 82 (17.1) 23 (17.6) 59 (17.0) 
Married 361 (75.4) 105 (80.2) 256 (73.6) 
Widowed or Divorced 36 (7.5) 3 (2.3) 33 (9.5) 
Occupation 
Housewife 169 (35.7) 2 (1.6) 167 (48.5) 
Healthcare 13 (2.7) 2 (1.6) 11 (3.2) 
Army/ Police 24 (5.1) 19 (14.7) 5 (1.5) 
Office job 109 (23) 41 (31.8) 68 (19.8) 
Business 14 (3) 13 (10.1) 1 (0.3) 
Other jobs 144 (30.4) 52 (40.3) 92 (26.7) 
Education 
No school 16 (3.4) 2 (1.6) 14 (4.1) 
Primary or High school 200 (42.8) 51 (40.2) 149 (43.8) 
College or University 251 (53.7) 74 (58.3) 177 (52.1) 
PA for at least 30 minutes once a week 
Yes 216 (45.4) 74 (56.5) 142 (41.2) 
Consumption of fruits and vegetables 
Everyday 285 (59.3) 71 (53.4) 214 (61.5) 
Hypertension (BP ≥140/90) 
Yes 106 (22.1) 32 (24.1) 74 (21.4) 
Walk for at least 30 minutes once a week 
Yes 312 (69.3) 89 (71.2) 223 (68.6) 
PA (moderate) at least once a week 
Yes 82 (19.7) 35 (31.3) 47 (15.5) 
PA (vigorous) at least once a week 
Yes 41 (10) 24 (21.8) 17 (5.7) 
Current smoking state 
Yes 46 (9.6) 36 (27.3) 10 (2.9) 
Sleep apnea 
Low risk 426 (87.5) 116 (85.9) 310 (88.1) 
High risk 61 (12.5) 19 (14.1) 42 (11.9) 
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3.3.1 Baseline Demographic and Clinical Characteristics of the Study 
Population 
The mean age of the study population was 39.6±10.3 years, ranging from 17 to 
60 years. The average age of the male participants was significantly different from the 
females (37.8 vs. 40.3, P=0.017). The percentage of single participants was 17.1%, 
while 75.4% of the study population were married and 7.5% reported being divorced 
or widowed. Marital status was found to be significantly different between the males 
and females (P=0.025), as more women were widowed or divorced compared to men 
(9.5% vs. 2.3%, respectively). Occupation was significantly different between males 
and females too (P<0.001). Being a housewife, or househusband, was more common 
among females than males (48.5% vs. 1.6%, respectively). Moreover, more males did 
office jobs when compared to females (31.8% vs. 19.8%, respectively). The 
participants’ level of education varied from no formal education, up to secondary level 
and above secondary level (3.4%, 42.8%, and 53.7%, respectively). The mean values 
of height (cm), weight (kg), HDL-cholesterol (mg/dl), and TG (mg/dl) were also 
significantly different between males and females (P<0.001). 
3.3.2 Follow-Up on PA Levels 
Figure 11 shows the percentage of participants who reported walking for at 
least 30 minutes once a week, or were physically active (moderate) at least once a 
week, or were physically active (vigorous) at least once a week by gender. 
The percentage of participants physically active for at least 30 minutes once a 
week was 45.4%, whereas the percentage of participants who walked for at least 30 
minutes once a week was 69.3%. When the participants were asked about practicing 
moderate PA at least once a week, 19.7% of them answered “yes”, whereas only 10% 
94 
 
 
 
 
reported practicing vigorous PA at least once a week. More men stated that they 
practiced moderate and vigorous PA as compared to women (31.3% vs. 15.5% and 
21.8% vs. 5.7%, respectively) (P<0.001). 
 
 
Figure 11: Percentage of participants, by gender, who are PA (n=487) in Dubai, the 
UAE 
3.3.3 Follow-up on Fruit and Vegetable Consumption  
Figure 12 shows the percentage of subjects who consume fruit and vegetables 
on a daily basis compared to those who do not. We have compared by gender. 
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The percentage who consumed fruit and vegetables on a daily basis was 59.3%. 
Those who currently smoked cigarettes or shisha was 9.6%. Most of the smokers were 
men (27.3%) rather than women (2.9%) (P<0.001). 
 
 
Figure 12: Percentage of participants, by gender, who consume fruit and vegetables 
on a daily basis (n=487) in Dubai, the UAE 
3.3.4 Follow-Up on Sleep Apnea 
Figure 13 shows the percentage of participants who appeared to be at high risk 
of suffering from sleep apnea according to their Berlin Questionnaire answers. Once 
again, it has been compared across genders. About 12% of females were at high risk 
of developing sleep apnea as compared to 14.1% of the male subjects. Overall, about 
12.5% of our study participants had a high risk of developing sleep apnea when we 
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administered the Berlin Questionnaire, which identifies respondents as prone to sleep 
apnea if they record a high Berlin score. 
 
Figure 13: Percentage of participants, by gender, who were found to be at high risk 
of sleep apnea after using the Berlin Questionnaire (n=487) in Dubai, UAE 
3.3.5 Rate of Conversion of Prediabetes to DM  
The rate of prediabetic Emirati adult patients developing DM in Dubai was 
23.4%, or 114 of our study subjects.  
3.3.6 Association between Independent Variables and Conversion from 
Prediabetes to DM 
Regression analysis was used to determine the association between 
independent variables, such as age, family history, anthropometric measures and 
biochemical measures, and developing DM from prediabetes. Table 3.2 and Table 3.3 
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show the univariable and multivariable regression analyses results for the potential for 
prediabetes to become DM by possible correlates. 
Table 3.2: Univariate analyses− unadjusted odds ratios for conversion to DM 
Characteristic  
All Converted to DM 
n n (%) OR (95% CI) 
Overall Prevalence  487 114 (23.4)  
Age  
17-30 years 100 10 (8.8) 1 
31-44 years 165 36 (31.6) 2.51 (1.19, 5.32) 
45-60 years 184 68 (59.6) 5.28 (2.57, 10.82) 
Gender 
Male 122 32 (28.1) 1.06 (0.66, 1.71) 
Female 327 82 (71.9) 1 
Marital Status 
Single 75 10 (8.8) 1 
Married 337 91 (79.8) 2.40 (1.19,4.88) 
Widowed or Divorced 35 13 (11.4) 3.84 (1.48, 9.99) 
Education 
No School 15 8 (7.1) 1 
Primary or High School 187 54 (47.8) 0.36 (0.12, 1.03) 
College or University 236 51 (45.1) 0.24 (0.08, 0.70) 
PA for at least 30 minutes once a week 
No 245 66 (58.9) 1 
Yes 199 46 (41.1) 0.82 (0.53, 1.26) 
Consumption of Fruit and Vegetables 
Not Everyday 185 44 (38.6) 1 
Everyday 264 70 (61.4) 1.16 (0.75, 1.79) 
Hypertension (BP ≥140/90) 
No 349 72 (63.7) 1 
Yes 99 41 (36.3) 2.72 (1.69, 4.38) 
Walk for at least 30 minutes once a week 
No 134 36 (32.7) 1 
Yes 287 74 (67.3) 0.95 (0.59, 1.51) 
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Table 3.2: Univariate analyses− unadjusted odds ratios for conversion to DM 
(Continued) 
Characteristic  
All Converted to DM 
n n (%) OR (95% CI) 
PA (moderate) at least once a week 
No 310 82 (84.5) 1 
Yes 79 15 (15.5) 0.65 (0.35, 1.21) 
PA (vigorous) at least once a week 
No 342 92 (96.8) 1 
Yes 39 3 (3.2) 0.23 (0.07, 0.75) 
Current Smoking State 
No 406 100 (87.7) 1 
Yes 41 14 (12.3) 1.59 (0.80, 3.14) 
Sleep Apnea 
Low risk 393 96 (84.2) 1 
High risk 56 18 (15.8) 1.47 (0.80, 2.69) 
BMI Categories  
<25 72 14 (16.9) 1 
25.0-29.9 109 22 (26.5) 1.05 (0.50, 2.21) 
≥30.0 147 47 56.6) 1.95 (0.99, 3.84) 
Total Cholesterol Levels (mg/dl) 
<200 184 55 (63.2) 1 
≥200 165 32 (36.8) 0.56 (0.34, 0.93) 
LDL-Cholesterol Levels(mg/dl) 
<130 203 62 (71.3) 1 
≥130 146 25 (28.7) 0.47 (0.28, 0.79) 
HDL-Cholesterol Levels (mg/dl) 
Normal 274 59 (67.8) 1 
Low (<40 in male <50 in 
female) 
75 28 (32.2) 2.17 (1.25, 3.76) 
TGs Levels (mg/dl) 
Normal 268 62 (71.3) 1 
High (≥150) 81 25 (28.7) 1.48 (0.86, 2.57) 
By using multivariable analysis we were able to select variables that were 
shown be significant in the univariable analysis. These were: age, marital status, level 
of education, hypertension, practicing vigorous PA at least once a week, total 
cholesterol levels, LDL-cholesterol levels, and HDL-cholesterol levels. 
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Table 3.3: Multivariable logistic regression analysis− adjusted odds ratios (AORs) 
for conversion to DM 
 
Characteristic 
Converted to DM 
Adjusted ORs 
 (95% CI) 
Age 
18-30 Years 1 
31-44 Years 0.95 (0.34, 2.62) 
45-60 Years 2.33 (0.84, 6.44) 
Marital Status 
Single 1 
Married 1.28 (0.513, 3.19) 
Widowed or Divorced 1.46 (0.37, 5.85) 
Education 
No School 1 
Primary or High School 0.44 (0.11, 1.80) 
College or University 0.43 (0.11, 1.78) 
Hypertension (BP ≥140/90) 
No 1 
Yes 1.70 (0.85, 3.39) 
PA (vigorous) at least once a week 
No 1 
Yes 0.28 (0.08, 0.99) 
Total Cholesterol Levels (mg/dl) 
<200 1 
≥200 1.18 (0.45, 3.06) 
LDL-Cholesterol Levels(mg/dl) 
<130 1 
≥130 0.41 (0.15, 1.11) 
HDL-Cholesterol Levels (mg/dl) 
Normal 1 
Low (<40 in male <50 in female) 3.45 (1.74, 6.85) 
 
 
3.3.7 Association between DM and Age 
Univariable Analyses 
In the univariable analyses, older participants (45-60 years) were 5.2 times 
more likely to develop DM ([OR] =5.2; 95% CI 2.57 to 10.82) as younger participants 
(18-30 years).  
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Multivariable Analyses 
The relationship between DM and age was not significant in these 
multivariable analyses. 
3.3.8 Association between DM and Marital Status 
Univariable Analyses 
Widowed or divorced participants were 3.8 times more likely to develop DM 
([OR] =3.8; 95% CI 1.4 to 9.9) as single participants (P=0.006), and married 
participants were 2.4 times more at risk of becoming diabetic ([OR]=2.4; 95% CI 1.1 
to 4.8) when compared to single participants (P=0.015).  
Multivariable Analyses 
The correlation between DM and marital status was not significant in these 
multivariable analyses. 
3.3.9 Association between DM and Educational Level  
Univariable Analyses 
Participants who reported an education at college or university level (n=236) 
had a 0.24 times higher risk of becoming diabetic (OR=0.24; 95% CI 0.08 to 0.70) 
when compared to participants without a formal education (n=15) in these univariable 
analyses (P=0.009). 
Multivariable Analyses 
The association of DM and educational level was not significant in the adjusted 
analyses. 
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3.3.10 Association between DM and Physical Activity  
Univariable Analyses 
Practicing vigorous PA at least once a week was significantly associated with 
a 0.23 risk of DM (P<0.015) in the univariable analyses, when compared to those who 
did not do vigorous PA at least once a week (OR=0.23; 95% CI 0.07 to 0.75). 
Multivariable Analyses 
The association between DM and PA remained significant in the adjusted 
analyses (aOR=0.28; 95% CI 0.08 to 0.99; P=0.047). 
3.3.11 Association between DM and Hypertension 
Univariable Analyses 
Participants who reported having hypertension (n=99) had a 2.7 times higher 
risk of DM (OR=2.72; 95% CI 1.69 to 4.38) as compared to participants with normal 
BP(n=349) in these univariable analyses. 
Multivariable Analyses 
The relation between DM and hypertension was no longer found to be 
significant after adjustment was made for confounding factors. 
3.3.12 Association between DM and Cholesterol and HDL-Cholesterol Levels 
Univariable Analyses 
Elevated total cholesterol levels (≥200 mg/dl) showed a significant relationship 
to the conversion of prediabetes to DM (OR=0.56; 95% CI 0.34 to 0.93; P<0.001) in 
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univariable analyses. Participants who had low HDL-cholesterol levels (<40 mg/dl 
male <50 mg/dl female) (n=75) had a 2.1 times higher risk of developing DM 
(OR=2.17; 95% CI 1.25 to 3.76, P=0.006) when compared to participants with normal 
HDL-cholesterol levels (n=274) in the univariable analyses. 
Multivariable Analyses 
There was no significant association between DM and cholesterol after 
adjusting for confounding factors. However, the association between DM and HDL-
cholesterol levels remained significant in the adjusted analyses (aOR=3.45; 95% CI 
1.74 to 6.85; P<0.001). 
3.3.13 Association between DM and Other Associates  
The univariable analyses did not show any significant association between 
developing DM and any of the following variables: these were gender; being 
physically active for at least 30 minutes once a week; walking for at least 30 minutes 
once a week; practicing moderate PA at least once a week; daily consumption of fruit 
and vegetables; smoking; being at high risk of sleep apnea; BMI categories and TGs 
levels. 
3.4 Discussion 
In the retrospective follow-up study, we measured the correlates that lead to 
prediabetes becoming DM and quantified the effect of these correlates on individual 
characteristics. Although there is a widespread consensus that prediabetes is a risk 
factor in developing DM20,32,45 and the correlates for DM in people with prediabetes 
differ from those with normal glucose tolerance165 there are, to our knowledge, no 
studies available that deal with this development (from prediabetes to DM) in the UAE. 
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The majority of studies on the risk factors and correlates for NCD that have 
been conducted in the UAE were done so in an educational setting (schools and 
universities). Very few have been done outside of such settings and our study sought 
to redress this imbalace. This study, which involved 487 prediabetic participants  
showed that 37% of men and 21% of women practice moderate to vigorous PA. The 
percentage of PA for women was much lower than the figures reported in previous 
studies by Shu Wen (41%)121  but is consistent with the other studies120 showing that 
men were more active than women in the UAE. In several previous studies, it was 
reported that the consumption of fruit and vegetables is low in the UAE136. In our study 
59% of the participants consumed fruit and vegetables on a daily basis. 
Our findings show that age, marital status, education level, PA, hypertension, 
elevated total cholesterol level and low HDL cholesterol level were associated with 
the conversion of prediabetes into DM for our study population. There are several 
studies extant in the UAE dealing with the risk factors for developing DM in the UAE 
but fewer studies on prediabetes. However, to the best of our knowledge, there is no 
other study, in a UAE context, that examines the correlates for prediabetes developing 
into DM in the national population. 
3.4.1 Rate of Conversion of Prediabetes to DM 
Prediabetes is a high-risk disorder that can develop into DM11. Type one 
diabetes is not associated with prediabetes as it has a different pathogenesis27. Between 
5% and 10% of people with prediabetes develop DM each year164. In most of the 
populations studied, 60% of people who develop DM have either IGT or IFG for five 
years or so before the onset of the disease27. The rate of conversion from IFG and IGT 
to DM is similar, with IGT having greater sensitivity but less specificity when 
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compared to IFG in terms of predicting conversion to DM. The positive predictive 
value for IGT and IFG to develop into DM is the same45. 
The development of prediabetes into DM happens in stages3. The first phase is 
the compensatory stage where insulin resistance is present, in addition to an increase 
in insulin secretion and beta cell mass. Stable adaptation is the second stage where beta 
cells no longer fully compensate for increased insulin resistance. At this stage, the 
insulin level decreases but the fasting and postprandial glucose levels are still normal. 
The first and second stages occur before the prediabetic stage has been reached. During 
the third stage of developing DM, the period from prediabetes to DM, beta cells lose 
their compensatory mechanism for insulin resistance. Thus, glucose levels increase 
quickly3. 
In our study, the rate of conversion of prediabetes patients to DM in Emirati 
adults in Dubai was observed in 114 (23.4%) of our participants. The first FPG was 
taken in 2015 as part of a DHA screening process in primary healthcare centers in 
Dubai. Then in 2017, a 1,000 sample frame (prediabetic patients) was taken from the 
date above and another FPG was measured with the same patients. The rate of 
conversion from prediabetes to DM in a two-year period was 23.4%. This is equivalent 
to a yearly conversion rate of around 12%. This rate was higher than was reported in 
another study, where the rate was between 5% and 10% of people with prediabetes 
developing DM each year164. 
Adults in the USA with normal glucose levels have a 0.7% average yearly risk 
of developing DM165. The ADA expert panel has predicted that up to 70% of 
individuals with prediabetes will eventually develop DM165. This conversion varies, 
according to the definition of prediabetes and population characteristics. In a Chinese 
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diabetes prevention trial, the 20-year cumulative incidence of DM was >90% when 
using IGT defined with repeated OGTTs66. In India, a 10-year follow-up to the 
Chennai Urban Rural Epidemiology Study showed that 58.9% of people with 
prediabetes developed DM. Those patients had a considerably greater level of FBG, 
two-hour postprandial, and HBA1c, and were more likely to have a family history of 
DM. They were also less likely to consume alcohol168. On the other hand, several trials 
have proven that people with prediabetes can become normoglyceamic after lifestyle 
and drug-based interventions81. In England, for example, 55%-80% of people with IFG 
had a normal FBG after 10 years. However, other trials reported a lower conversion 
rate11.  
In summary, people with prediabetes face three different scenarios: around a 
third of cases will develop DM, another third will remain prediabetic and the remaining 
third can revert to normoglycemia status6. Studies show that the risk of developing 
DM can be reduced by 58% if people exercise moderately for 30 minutes a day, five 
days a week and lose 7% of their total body weight1. 
3.4.2 Percentage of Smokers in our Study Population 
The percentage of smokers (cigarettes or shisha) in our sample was 9.6%. Most 
smokers were men (27.3%) as compared to women (2.9%). This figure is similar to 
the one reported in a review of an approach to chronic diseases in Abu Dhabi by Hajat 
et al. (9%), but is lower than the figure reported in the Weqaya screening program 
(11%). It is significantly lower than the 2007 rates in the USA (20%) and the UK 
(22%)41. The reasons for these findings are beyond the scope of this study. 
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3.4.3 Percentage of People with Sleep Apnea in our Study  
The current study used the Berlin questionnaire on sleep apnea a determinant 
of sleep apnea syndrome in prediabetic patients. About 12.5% of sparticipants were 
found to be at high risk of obstructive sleep apnea. This figure is much lower than the 
one previously reported in the UAE (20.9%)169, Saudi Arabia (33.3%), Jordan 
(16.8%)170 and Spain (26.7%)171.  
3.4.4 Physical Activity as a Correlate of Conversion from Prediabetes to DM 
Physical inactivity was one of the correlates in our study. Practicing vigorous 
PA at least once a week was significantly associated with a 77% reduction in the 
conversion of prediabetes to DM, when compared with those who do not do vigorous 
PA at least once a week. This finding is consistent with findings in several other 
studies168, including the Strong Heart Study165 where physical inactivity was reported 
as being an independent correlate for the conversion of prediabetes to DM. 
3.4.5 Lipid Profile as a Correlate of Conversion from Prediabetes to DM 
Elevated total cholesterol levels and a low level of HDL were another correlate 
for conversion of prediabetes to DM in our study. Participants who reported having 
elevated total cholesterol levels (≥200 mg/dl) and low HDL-cholesterol levels (<40 
mg/dl male <50 mg/dl female) had 44% more chance, and were 2.17 times more at 
risk, of developing DM, when compared to participants with normal total cholesterol 
and HDL-cholesterol levels in our univariable analyses. This finding has been 
confirmed in other studies165,168,173. While an elevated total cholesterol level was found 
to be no longer significant after adjusting for confounding factors such as age, low 
HDL-cholesterol levels remained significant in the adjusted analyses (aOR=3.45). In 
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spite of this, the HDL-level was not related significantly to the incidence of DM in the 
Strong Heart Study165. 
3.4.6 Age as a Correlate of Conversion from Prediabetes to DM 
Our analysis showed that age is a significant correlate for DM in those with 
prediabetes (univariable analyses). Older participants (45-60 years) were 5.28 times 
more likely to develop DM than younger participants (18-30 years). This finding is 
consistent with the results found in several other studies168,172, including the Strong 
Heart Study165 and a retrospective cohort study, which studied 5,452 prediabetic 
subjects in the United States. This study confirmed that the prevalence of DM increases 
markedly with age in people with prediabetes. Furthermore, the younger the person is 
at the time of the diagnosis of prediabetes, the more likely they are to develop DM. 
This could be due to the fact that the development of hyperglycemia at a younger age 
means there is a greater degree of insulin resistance and a decline in beta cell function, 
leading to a fast rise in glucose levels. It is also possible this is due to an increase in 
the rate of  identifying DM at this younger age as clinicians do more frequent screening 
for high glucose levels173. However, in our study, the effect of age on the conversion 
to DM was not significant in the multivariable analyses, but it was in the Strong Heart 
Study after adjusting for covariates165. 
Our research has explored the correlates for DM developing in prediabetic 
patients. These included age, marital status, education level, PA, hypertension, 
elevated total cholesterol and low HDL cholesterol level. The significance of the 
associations differed among the correlates. Some of the correlates showed a stronger 
significance (age, marital status, the presence of hypertension, low HDL-cholesterol 
levels) compared to others (PA level, educational status, elevated total cholesterol 
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levels). Furthermore, some of the correlates that showed significant association in the 
univariable analyses did not remain significant after adjusting for other potential 
confounding factors such as hypertension, elevated total cholesterol levels, etc. in the 
multivariable analyses. These were age, marital status, education level, HT. Low HDL-
cholesterol levels and physical activity levels were the only correlates that showed 
significance in the univariable analysis and remained the same in the adjusted 
multivariable analyses. Furthermore, many variables in our study, such as smoking, 
gender, BMI and sleep apnea, were commonly reported as being independent risks for 
the conversion of prediabetes into DM in previous studies164,165,172,173,177,178 but did not 
show as significant in our study. We reflected that the biological difference between 
the baseline and outcome cohort was not great enough for minor variables to be 
recognized as independent and significant correlates. Of course, differences in the 
entry and outcome standards of our study and previous studies might also account for 
differences in the significance outlines. 
3.5 Strengths of Our Study 
To our knowledge, this is the first study in Dubai, the UAE, to explore the rate 
of conversion of prediabetes to DM and its correlates and associations. Furthermore, 
the recruitment of subjects followed strict inclusion criteria to ensure control of 
selection bias. Measurement bias was overcome by collecting with well-trained staff 
from five healthcare centers in Dubai. Furthermore, an adequate sample size was used 
and our study adjusted for many correlates. 
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3.6 Limitations of our Study 
There are some potential limitations of our study that need to be considered. 
For example, the primary limitation is the inability to find out the exact date of 
conversion from prediabetes to DM as we did not follow-up individual participants 
and could not calculate person-time to use as denominator. Furthermore, every 
variable included in our analysis was self-reported, and thus dependent upon the 
participants’ memory. This might have led to inaccurate data, especially in relation to 
family history. However, the self-report format does have the advantages of 
convenience, simplicity and low costs, and may be more uniform in its presentation 
than face-to-face screening. In addition, the Berlin Questionnaire was used to assess 
sleep apnea. This questionnaire has a very low specificity. Furthermore, we could not 
independently approve or refute reports of snoring or daytime sleepiness by the 
respondents.  
Furthermore, the ADA recommends a repeat measurement after a single HA1c, 
FPG, or 2-hour PG diabetes-positive test result, which we could not do because most 
participants had only one blood test. Therefore, some participants without DM may 
have been misclassified as having DM in our study and it is unclear how frequently 
this has occurred. 
Design effect is important in any cross-sectional study. With probability 
proportional to size, where samples from different sized subgroups are used and 
sampling is taken with the same probability, the chances of selecting a member from 
a large group are less than selecting a member from a smaller group. This takes varying 
sample sizes into account, but was not taken into account when choosing our target 
population. Therefore our data may be under-representative of the general population 
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of the UAE. We feel that not considering probability proportional to size in our design 
is one of our study’s limitation. Moreover, the participants were not all UAE nationals, 
so the findings cannot be generalized to groups with different ethnic backgrounds even 
if living in the UAE.  
  
 
  
111 
 
 
 
 
Chapter 4: Conclusion 
4.1 Overall Summary 
This descriptive study is intended to measure the prevalence, characteristics 
and correlates of prediabetes in the adult population of the UAE. It is vital to identify 
prediabetes in any population as it increases awareness levels in the community and 
also helps in the design of appropriate educational programs to modify the correlates 
for prediabetes and can lead to the prevention or delay in progression of prediabetes to 
DM. Therefore, the information collected in this study will help both decision makers 
and policy makers in many ways. Additionally, the analysis in this study provided 
useful information about the prevalence of prediabetes, DM and obesity in the UAE. 
It also explored the correlates of prediabetes and DM, and factors that can lead to the 
conversion of prediabetes into DM. 
The prevalence of prediabetes in this study (37.7%) was much higher than 
reported in a population-wide cardiovascular screening program (Weqaya) in Abu 
Dhabi in 2012, where prediabetes was only 27%40. This increase is consistent with the 
increasing incidence of prediabetes in GCC38,39, Asian33,37,152, European32 and North 
American23,31 countries. Furthermore, the prevalence of prediabetes increases with 
age, with the highest incidence in people aged 34-54 years. Increased body mass index 
was another correlate for developing prediabetes, particularly if in the obese BMI 
range. Prediabetes was also significantly associated with educational level. 
The overall prevalence of DM in our study was 18.7%, which was similar to 
the one reported in a population-wide cardiovascular screening program (Weqaya)40 
in Abu Dhabi. We found that older age (≥55 years), obesity, lack of PA, education 
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level, high WHR, having a family history of DM and TGs level were statistically 
significant correlates for DM in our study.  
The prevalence of obesity in the UAE was shown to be rising and was 
significantly associated with prediabetes and DM. Furthermore, being overweight 
(BMI between 25.0 and 29.9 kg/m2) and obesity (MBI ≥30 kg/m2) were detected in 
35.7% and 50.1% of the study population, respectively. This figure is alarming as it is 
higher than the one reported in the Weqaya study in 2012 (35%) and a population-
based cross-sectional study in 2000, also in the UAE (34%)40. 
Our findings show a lack of vigorous PA to be a significant correlate of DM 
and prediabetes, and practicing vigorous PA at least once a week reduced the 
conversion rate of prediabetes to DM by 77%. Furthermore, many variables in our 
study, such as age, hypertension, smoking, gender, BMI and sleep apnea, have been 
commonly reported in previous studies as independent risks for the conversion of 
prediabetes to DM. However, they did not show any significance in our study. It is 
likely this is due to the sample size of our study, which could somewhat clarify the 
inconsistent results. Furthermore, having a healthy diet and good weight management 
via PA and controlling lipid profiles will help to reduce the prevalence of prediabetes 
and the conversion of prediabetes to DM. 
The UAE’s health care system is facing difficult challenges as prediabetes, DM 
and obesity are all becoming more prevalent and putting a strain on the UAE’s human 
and financial resources. Unless policies, laws and the healthcare system are modified, 
the advances in healthcare that have been accomplished over the past forty years will 
be eroded. 
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In addition, there needs to be future intervention studies in order to explore the 
correlates for prediabetes and the conversion of prediabetes into DM in a larger, more 
diverse non-local population in the UAE. The relationship between sleep apnea and 
prediabetes also requires additional examination. Future studies must be conducted, 
and repeated, in different Emirates to determine if the findings continue to be 
consistent with the results of our study. 
4.2 Recommendations 
The UAE’s epidemic of obesity requires urgent and aggressive intervention. 
This is necessary to prevent chronic diseases from damaging the accomplishments of 
the UAE government over the last 40 years in improving the overall health of UAE 
nationals. In order to achieve this, polices and laws must be formulated and efforts 
united. Lifestyle management plays a major role in combating obesity, prediabetes and 
DM at an individual level. Both policy makers and decision makers have an important 
role in this battle. 
As the prevalence of prediabetes is high in the Emirati population, educating 
people about prediabetes, its correlates and the measures required to return to a normal 
state, is vital. It is also crucial to recognize prediabetes as a disease that leads to several 
complications, including DM. Moreover, early detection of prediabetes and 
implementing preventative measures to stop its progression to DM is essential. Other 
important recommendations include:  
 Collective efforts are needed to reduce the prevalence of prediabetes and DM 
to empower the public to take care of their own health. This can be done 
through education. This education should concentrate on the dangers of an 
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unhealthy lifestyle and behaviors (PA and an unhealthy diet) and can be 
delivered via the media and social media channels. Furthermore, educational 
programs (which target the correlates for chronic diseases like DM and 
hypertension) are required to target people in schools and the community. 
Increasing levels of health education amongst the public will encourage people 
to make healthier selections. 
 It is essential to strengthen the role of primary healthcare centers. This can be 
achieved by applying preventative strategies in primary healthcare that can  
detect who is at high risk of prediabetes and obesity. This will ensure the early 
detection of prediabetes and interventions that can lead to a delay in the 
progression of prediabetes to DM. An individualized wellness program could 
be established, which must include diet counselling and exercise plans to 
address the correlates for chronic diseases, like obesity, as well as a lack of PA 
and unhealthy eating habits. These programs will increase people’s awareness 
of the risks.  
 Public health policies at a national level need to be implemented in the UAE. 
These polices have to focus on improving public health by creating a healthy 
community that replaces the “obesogenic” environment and encourages 
healthy lifestyle behaviors. This should concentrate on limiting the spread of 
fast food outlets, making healthy food both easily affordable and accessible, 
and imposing taxes on tobacco, foods high in fat and sweet drinks. It is also 
important to create an encouraging environment for exercise and PA for both 
genders and all ages. 
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Appendix 4: Global Health-Developed Developing Countries Partnership for 
Non-Communicable Disease Prevention 
   
Researcher Name Coordinator Name 
Date of interview Time of Interview 
 
Student Name Student No. 
Class  
Name of School  
Respondent’s Name: 
1
- 
Respondent’s Gender:   
1.  Male 
2. Female 
 
2
- 
Nationality UAE Others……………….. 
3
- 
Age in years …………………      DOB …../…../………..  
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Section A 
General Information 
     
5- What is the highest class/level of education that 
completed? 
Illiterates 1  
  Primary 2  
  Middle 3  
  Secondary  4  
  Diploma, Graduate, 
Masters/MBA,PHD 
5  
   
6- What is your marital status?                                           Married 1  
  Divorced 2  
  Widowed 3  
  Do not know 77  
  Refused 99  
    
7- Are you blood related to your spouse? Yes 1  
  No 2  
     
8- IF YES-What’s the relationship with your spouse? First cousin1 1  
  Second cousin2 2  
  Other: ________________  
     
9- How many children do you have? Boys________ Girls  _______  
    
10- In which type of family system do you live?                      Joint family system1 1  
 1. Husband, wife, parents, in-laws and other Nuclear2 2  
 2. Only husband, wife and children   
    
11- What is your Mother Language? ____________________   
     
12- Are you currently employed or engaged in any 
business? 
Yes   
 If Yes No   
13- What Nature of your work/employment? 
…………………………. 
____  
14- 
15- 
How Many Years in the current work? 
………………………………. 
Monthly salary/income?   ………………………..Dh 
 
If Not 
   
16- Reason for not being employed?                               Student   1  
 (Multiple responses possible)                                   Housewife  2  
  Retired  3  
  Jobless   4  
  Other 5  
  Specify _____________  
17- Do you own the house you live in?  Yes   
18- How many people live in the house? …………………. No   
 
2
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SECTION B  
In this section I would like to ask you about your health 
 
B1 What would you say about your health in general? Excellent 1  
  Very Good 2  
  Good 3  
  Fair 4  
  Poor 5  
     
B2 How much you are satisfied with your life? Very happy 1  
  Happy 2  
  Fair 3  
  Not happy 4  
  Very unhappy 5  
     
B3 Before this interview, Had your BPever been 
checked?  
Yes 1  
  No 2  
    
     
B4 Has a health care provider ever told you that you 
have high BPalso called hypertension?                                        
  
Yes 1  
  No 2  
 If not-Move to Question B10 
 
   
     
B5 What was your age when you were told that you 
have high BP? 
______ years  
    
     
B6 Because of your high BPhave you were ever being 
told by a health care provider to take prescribed 
medicine?                
Yes 1  
 No 2  
     
B7 Are you currently (since last month) taking any 
medicine for BP? 
Yes 1  
 No 2  
 
 
 
 
 
B8 Please, mention the names and dosages of medicines you are using. If you do not know the 
names of medicines then kindly show me these medicines. 
No. Name of Medicines 
Type  
1. Tablets, 2. Capsules, 3. 
Syp/Susp, 4. Injection, 5. Inhalers, 
6. Others  
 
Dosage  per day 
01     
02     
03     
04     
05     
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B9 Have you taken your BPmedicine today or during 
the last 2 days? 
Yes today 1  
 Yes in last two days 2  
  No 3  
 If not, what was the reason for not taking the 
BPmedicine? 
__________________________
__ 
  
  ____________________________  
    
     
B10 Did any of your first degree relatives (mother, 
father, brother, sister, son, daughter) were told by a 
doctor or other health professional that they had 
high BP? 
Yes 1  
 No 2  
 Don’t know 3  
     
Heart Disease 
B11 Has a doctor or other health professional ever told 
you that you have Heart Disease?                                         
         
Yes 1  
  No 2  
 If Not-Move to Question B16 
 
   
B12 What was that heart disease? Angina 1  
  Heart Attack 2  
  Other (specify)_____________ 3  
    
B13 How old were you when you were told?  _________years  
     
B14 Were you prescribed treatment for it?  Yes 1  
 If Not-Move to Question B16 
 
 No 2  
     
B15 If yes, the type of treatment was? Medical treatment only 1  
  Medical & surgical treatment  2  
  Other (specify) _____________ 3  
     
B16 Did any of your first degree relatives (mother, 
father, brother, sister, son, daughter) were told by a 
doctor or other health professional that they had a 
heart attack before the age of 55 years?? 
Yes 1  
  No 2  
  Don’t Know 3  
     
Cholesterol and TG  
B17 Have you ever had your blood lipids measured (Cholesterol or 
TGs)? 
Yes 1  
 No 2  
     
B18 Have you ever been told by a doctor, or another health 
professional that your blood cholesterol level was high? 
Yes 1  
  No 2  
 If Not-Move to Question B20    
    
B19 Are you currently taking any treatment for your high 
cholesterol? 
Yes 1  
  No 2  
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Kidney Disease    
B20 Has a doctor or other health professional ever told you that 
you have a kidney disease? 
Yes 1  
  No 2  
     
B21 If yes, what kind of kidney disease you had? ______________________  
  ______________________  
     
Diabetes 
B22 Has a health care provider ever told you that you have 
Diabetes? 
 
Yes 1  
  No 2  
     
 If Not-Move to Question B20 
 
   
B23 How was your diabetes diagnosed?  Had symptoms 1  
B24 (More than one responses possible) Screening test (high 
blood sugar) 
2  
  Sugar in Urine 3  
 
 
 Others 
(specify)____________ 
4  
B25 Were you prescribed any treatment or restricted diet for 
your diabetes?   
Yes 1  
  No 2  
     
B26 If yes, Type of current treatment you are taking for 
diabetes? 
Insulin injections 1  
 (More than one responses possible) Tablets 2  
  Restricted Diet 3  
  Others 
(specify)____________ 
4  
B27 Have you taken your diabetes medicine today or during the 
last 2 days? 
Yes, today 1  
  Yes, in the last 2 days 2  
  No, I did not take any 
medication 
3  
  Why?______________
______ 
 
  ___________________
_____ 
 
     
B28 Do you have a blood sugar checking device at your home? Yes 1  
  No 2  
  Don’t Know 3  
     
B29 Did any of your first degree relatives (mother, father, 
brother, sister, son, daughter) were told by a doctor or 
other health professional that they had diabetes? 
Yes 1  
  No 2  
  Don’t Know 3  
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Stroke 
B30 Has a doctor or other health professional ever told 
you that you had a stroke?                                                                          
        
Yes 1  
   No 2  
  Don’t know 3  
     
B31 Do you know the cause of stroke? Yes 1  
    No 2  
     
B32 If Yes, what is the major cause? Specify: _______________________  
     
B33 Did any of your first degree relatives (mother, father, 
brother, sister, son, daughter) were told by a doctor 
or other health professional that they had a stroke? 
Yes 1  
   No 2  
    
     
Injury 
B34 Did you get an injury in the past 12 month that 
needed treatment? 
Yes 1 
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SECTION C 
International Physical Activity Questionnaire (IPAQ) Short-version 
We are interested in finding out about the kinds of physical activities that people do as part of 
their everyday lives. The questions will ask you about the time you spent being physically active in 
the last 7 days. Please answer each question even if you do not consider yourself to be an active 
person. Please think about the activities you do at work, as part of your house and yard work, to 
get from place to place, and in your spare time for recreation, exercise or sport. 
Vigorous 
Think about all the vigorous activities that you did in the last 7 days. Vigorous physical activities 
refer to activities that take hard physical effort and make you breathe much harder than normal. 
Think only about those physical activities that you did for at least 10 minutes at a time. 
C1 During the last 7 days, on how many days did you do vigorous 
physical activities like heavy lifting, digging, aerobics or fast 
bicycling?                                                                    
 
None 1 
 1 Day 2 
2 Day 3 
3 Day 4 
4 Day 5 
5 Day 6 
6 Day 7 
7 Day 8 
Don’t  Know 7
7 
Refuse 9
9 
 If None, Don’t Know, Refuse  Skip to Q. C3 
 
  
C2 How much time did you usually spend doing vigorous physical 
activities on one of those days? 
_____ hours/day  
_____ minutes/day  
   
Moderate 
 
Think about all the moderate activities that you did in the last 7 days. Moderate activities refer to 
activities that take moderate physical effort and make you breathe somewhat harder than 
normal. Think only about those physical activities that you did for at least 10 minutes at a time. 
 
 
C3 During the last 7 days, on how many days did you do 
moderate physical activities like carrying light loads, bicycling 
at a regular pace, or doubles tennis?   
                      
Do not include walking.  
None 1 
 1 Day 2 
2 Day 3 
3 Day 4 
4 Day 5 
5 Day 6 
6 Day 7 
7 Day 8 
                                    
Don’t  Know 
7
7 
 Refuse 9
9 
 If None, Don’t Know, Refuse  Skip to Q. C5 
  
  
C4 How much time did you usually spend doing moderate 
physical activities on one of those days?  
_____ hours/day  
 _____ minutes/day  
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Walking 
 
Think about the time you spent walking in the last 7 days. This includes at work and at home, 
walking to travel from place to place, and any other walking that you might do solely for 
recreation, sport, exercise, or leisure. 
 
C5 During the last 7 days, on how many days did you walk for at 
least 10 minutes at a time?                                                                
None 1 
1 Day 2 
2 Day 3 
3 Day 4 
4 Day 5 
5 Day 6 
6 Day 7 
7 Day 8 
Don’t  Know 77 
 Refuse 99 
 If None, Don’t Know, Refuse  Skip to Q. C7 
 
  
C6 How much time did you usually spend walking on one of those 
days? 
_____ hours/day  
_____ minutes/day  
 
C7 During the last 7 days, how much time did you spent sitting on 
week days during the last 7 days? Include time spent at work, at 
home, while doing course work and during leisure time. This 
may include time spent sitting at a desk, visiting friends, reading, 
or sitting or lying down to watch television.  
 
_____ hours/day  
_____ minutes/day  
Sitting 
 
 
C8 During the last 7 days, on how many days did you spent 
sitting or lying down to watch television, work/play 
computer, play electronic games?  
None 1 
1 Day 2 
2 Day 3 
3 Day 4 
4 Day 5 
5 Day 6 
6 Day 7 
7 Day 8 
Don’t Know 77 
Refuse 99 
 If None, Don’t Know, Refuse  Skip to Q. D1 
 
  
C9 How much time did you usually spend sitting on one of 
those days? 
____________hrs/day  
___________min/day  
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SECTION D 
Section of Lifestyle 
D1 Have you ever smoked cigarettes/cigars/biddies? 
 
Go to D13Never 1  
 2- At what age did you start smoking? 
________ yrs 
3- For how many years have you/did you 
smoked? ________yrs 
4- When did you quit smoking ?__________ 
years   _________months 
5- What was the average number of cigarettes 
per day that you smoked in the 
past?______ cigarettes 
 
Former Smoker 
 
2 
 
 6- At what age did you start smoking? 
________ yrs  
7- How many years have you/did you smoked? 
________yrs 
8- How many cigarettes you smoke per day?  
cigarettes/day ______ 
 
Current Smoker 
 
3 
 
 During the last week, 
How many smoke: 
9-Ciggarettes 10-Cigar 11-Water pipe or shisha 12-
Naswar 
 None     
 Once/week     
 2-3 times/week     
 4-5 times/week     
 Every day      
  
D13 On how many of the past 7 days did someone smoke 
in your indoor workplace while you were there? 
None 1  
Once/week 2 
2-3 times/week 3 
4-5 times/week 4 
Every day 5 
Don’t know 77 
   
D14 On how many of the past 7 days did any one smoke 
in your home while you were there? 
None 1  
Once/week 2  
2-3 times/week 3  
4-5 times/week 4  
Every day 5  
Don’t know 77  
   
D15 How often are cigarettes smoked inside your home 
in a typical week? 
Never 1  
  Once in a week 2  
  2-3 times/week 3  
  4-5 times/week 4  
  Daily 5  
  Don’t  know 77  
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Section E 
Questions related to diet at home 
 
E1 
 
Do you add extra salt on your food? 
 
Yes 
 
1 
 
 Skip to Q   No 2  
     
 
E2 
 
How often do you add salt on your food? 
 
Occasionally (<7/week) 
 
1 
 
  Often (>7/week) 2  
  Always 3  
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3-How often you eat the following food in a day, week, month or year. 
S# 
Food item 
consumed 
Use Frequency  Serving  
Your 
Portion  
1. Yes  
2. No 
yearly  
monthl
y  
weekly daily 
Season 
/fest 
  
3-1 Mutton (curry, 
roasts, etc.) 
            Plate   
3-2 Beef (curry, 
roasts, kabab, 
qeema, 
barbecued etc.) 
            Plate  
3-3 Chicken (curry, 
roasts, tikka, 
barbecued, broast 
etc.) 
            Plate  
3-4 Fish (curry, fry, 
etc.) 
            Plate  
3-5 Milk             Glass  
3-6 Lassi       Glass  
3-7 Yogurt 
(Dahi)/Raita 
            Cup  
3-8 cheese         
3-9 Other milk 
products 
        
3-10 Eggs             Numbers  
3-11 Lentils (Mung, 
Masoor, etc), 
Beans (Lobia, 
Choley)  
            Plate  
3-12 Raw 
vegetables/Salad 
(Tomato, 
cucumber, 
onions, 
reddish/beetroot 
etc) 
            Plate  
3-13 Cooked 
Vegetables (not 
including 
potatoes) 
            Plate  
3-14 Fresh fruits (do 
not include juices) 
            Numbers  
3-15 Pure fruit juices: 
fresh/packaged 
juices (not 
including 
packaged Drinks* 
like Frost, Frooto 
etc.) 
            Glass  
3-16 Sweets       Piece/plate  
3-17 Dry fruits e.g. 
nuts, peanuts, 
pista,  almonds, 
chilgoza etc. 
            Numbers  
3-18 Bread       Numbers  
3-19 Rice       Plate   
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SECTION F   
Physical Examination 
     
 Have you smoked a cigarette or taken coffee or tea in the last 30 
minutes? 
Yes 1  
  No 2 
 
 BP 
  Systolic 
BP 
Diastolic BP Pulse 
 1st reading  _______ _______ _______ 
      
 2nd reading after 05 minutes 
of 1st one 
_______ _______ _______ 
 
 3rd reading after 05 minutes 
of 2nd one 
 
_______ _______  _______ 
 
 Anthropometric Measurements  
  1st reading 2nd reading  
Height  _______________c
m 
_______________cm  
      
Weight  _______________Kg _______________Kg  
      
Waist circumference  ______________cm _______________cm  
     
Hip circumference  ______________cm _______________cm  
      
 
SECTION G 
LABORATORY TESTS RESULTS  
 Test 
Date 
   Report Number   
        
G1 Glucose 
Fasting  
  G2 Serum Cholesterol    
        
G3 LDL    G4 HDL   
        
G5 TGs   G6 Hb1C   
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-noN rof pihsrentraP seirtnuoC gnipoleveD depoleveD :5 xidneppA
 noitneverP esaesiD elbacinummoC
  ةنتاال الاتعاون الدول المتطورة والدول النامية للوقاية من الامراض غير 
 
 
 
حول تعاون الدول المتطورة والدول النامية للوقاية من  دراسـة
 الامراض الغير انتقالية 
 
 الاستبيــــــان
 الخاص بأولياء الأمور 
 
 
 
 
 
 جامعة الإمارات العربية المتحدة
  والعلوم الصحيةكلية الطب 
  دولة الامارات -العين
 
 
 
 
 
 بالتعاون مع
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 أسئلة عامة )أ
    :اسم المشرف وتوقيع    :اسم الباحث وتوقيع 
  
 ........................... الوقت:: .............................................................. تاريخ الماابلة
 
                           :رقم الطالب                                :اسم الطالب
       :الصف والمرحلة الدراسية
                                                                                : اسم المدرسة 
    رقم بطاقة التأمين الصح     اسم المشارك (الأب أو الأم):
 
 أنثى  2-   ذكر  1-    الجنس:-1
   :حدد/أخرى - 2  الإمارات  - 1   الجنسية:-2
  ................: أو  العمر بالسنوات    __ __/__ __/__ __ :تاريخ الميلاد (اليوم | الشهر | السنة)-3
 
 المستوى التعليم  لول  أمر الطالب-5
 الثانوي    -4 عداديا    -7ابتدائي       -2لا يقرأ ولا يكتب      -1
 دكتوراه)         /دراسات عليا (ماجستير /جامعة/معهد  -1
 
 الحالة الاجتماعية الحالية لول  الأمر؟ -6
 رفض الإجابة  -1 لا يعلم   -4  أرمل  -7  مطلق  -2متزوج     -1
 
 زوجتك؟هل هناك قرابة دم بينك وبين زوجك/-7
 لا    -2   نعم     -1
 
 اذا كان الجواب نعم، ما هو نوع الارابة بينك وبين زوجك/زوجتك؟ -8
 أقارب من بعيد     -7ن الدرجة الثانية               م     2-  من الدرجة الاولى     1-
 
 أولاد: ________  بنات:  ____________                       كم عدد أولادك وبناتك ؟-9
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 هل تعيش مع أولادك ف  -11
 اقارب آخرين)-الجد والجدة-الأولاد-الزوجة-عائلة ممتدة (الزوج    1-
 الأولاد فقط)-الزوجة-عائلة مفردة (الزوج    -2
 
 ......................................ما ه  لغتك الأم (لغة الأباء والاجداد):-11
 هل انت تعمل حاليا؟-21
 لا    -2  نعم    -1
 *  اذا كان الجواب  نعم  
 ما نوع العمل/الوظيفة؟ ______________________-31
 ؟______________كم هو عدد السنوات الت  قضيتها ف  هذا العمل-11
 ؟ ________________________ما هو معدل دخلك الشهري-51
 كان جوابك  لا ، * اذا
 ما هو سبب عدم انخراطك بالعمل؟-61
 متقاعد    -7                ربة منزل    -2   لا ازال طالبا    -1
 غير ذلك, حدد___________    -1                     لا أجد عمل    -4
 ت الذي تعيش فيه؟يهل تمتلك الب-71
 لا    -2 نعم    -1
 : ..........................كم شخص يعيش معك ف  المنزل-81
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 الصحة العامة )ب
 نود الان ان نسألك عن صحتك
 هل تستطيع أن تصف ل  الوضع الصح  العام لك على أنه -1
 جيد    -7                جيد جدا   -2   ممتاز    -1
 ضعيف    -1                     متوسط   -4
 كم أنت سعيد ف  حياتك؟-2
 متوسط    -7                سعيد    -2         سعيد جدا    -1
 أبدا لا أشعر بالسعادة    -1       غير سعيد                  -4
 ضغط الدم
 هل فحصت ضغط الدم من قبل؟-3
 لا    -2  نعم   -1
 هل تم اخبارك من قبل طبيب او اي اختصاص  ان لديك ضغط دم مرتفع؟-1
 11رقم  إذا كان الجواب ب لا انتال الى السؤال    لا                       -2  نعم    -1
 
 ............................  الدم لديك مرتفع؟  العمر بالسنواتكم كان عمرك عندما أخبرت بأن ضغط -5
 هل وصف لك دواء او علاج لضغط الدم المرتفع؟-6
 لا   -2  نعم    -1
 هل تتناول حاليا اي دواء لتخفيض ضغط الدم ( خلال الشهر الأخير) ؟-7
 لا    -2  نعم    -1
 أرجو كتابة اسماء الادوية التي تتناولها لعلاج ضغط الدم (الاسم والنوع والجرعة وعدد المرات):-8
 عدد المرات
 في اليوم
 النوع الجرعة
حقن -4شراب -7كبسولات -2حبوب -1(
 غير ذلك)-1بخاخ -1
 الرقم اسم الدواء
 1    
 2    
 7    
 4    
 1    
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 هل تناولت دواء لتخفيض ضغط الدم ف  اليومين الاخيرين؟-9
 اليومين الأخيرين-نعم    -2  اليوم -نعم    -1
 ................................................... ما هو السببلم اتناول الدواء في اليومين الأخيرين ( -لا    -7
 .......).............................................................................................................................
 هل تم اخبار احد اقربائك (اب, ام, اخ, اخت, ابن, ابنة) من قبل طبيب او اختصاص  ان لديه ضغط دم مرتفع؟-11
 لا اعلم     -7لا                -2  نعم    -1
 مرض الالب
 هل تم اخبارك من قبل طبيب او اختصاص  انك تعان  من مرض الالب؟-11
   61إذا كان الجواب ب لا انتال الى السؤال رقم  لا                   -2  نعم    -1 
 هل هذا المرض هو؟-21
 حدد .......................-غير ذلك    -7نوبة قلبية                -2  ذبحة صدرية    -1 
 ................. بالسنواتالعمر :                كم كان عمرك عندما اخبرت بذلك-31
 هل وصف لك علاج لمرض الالب؟-11
 لا    -2  نعم    -1
 هل كان العلاج الذي وصف لك -51
 حدد ..........................-غير ذلك    -7دواء مع جراحة قلب                   -2 دواء فقط   -1
هل تم اخبار أحد اقربائك (اب, ام, اخ, اخت, ابن, ابنة) من قبل طبيب او اختصاص  انه تعرض لنوبة قلبية قبل -61
 ؟55سن ال 
 لا اعلم    -7لا                                    -2  نعم   -1 
 
  مم مستوى الدهنيات (الكوليسترول و التريغسيريد)؟
  هل تم فحص مستوى الدهنيات لديك من قبل (الكوليسترول او التريغسيريد)؟-71
 لا اعلم    -7لا                                    -2  نعم    -1 
 الكوليسترول ف  الدم؟هل تم اخبارك من قبل طبيب او اي اختصاص  ان لديك نسبة عالية من -81
  12السؤال رقم إذا كان الجواب ب لا انتال الى      لا                           -2   نعم    -1 
 هل تتناول حاليا اي دواء لتخفيض نسبة الكوليسترول ف  الدم؟-91
 لا                                    -2   نعم   -1 
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 مرض الكلى
 هل تم اخبارك من قبل طبيب او اي اختصاص  انك تعان  من مرض الكلى؟-12
 ،اذا كان الجواب ب نعملا                 -2  نعم    -1
 ......................................................ما هو هذا المرض؟ حدد -12
 مرض السكري
 هل تم اخبارك من قبل طبيب او اي اختصاص  انك تعان  من مرض السكر؟-22
  92إذا كان الجواب ب لا انتال الى السؤال رقم  لا                      -2   نعم   -1
 كيف تم تشخيص أو اكتشاف مرض السكري لديك؟-32
 البول أرتفاع سكر    -7أرتفاع سكر الدم              -2  وجود أعراض مرض السكري   -1
 غير ذلك ، حدد ......................................................................  -4
 كم عدد السنوات منذ تم تشخيص أو اكتشاف مرض السكري لديك؟     -12
                                                    ف  حال المدة أقل من سنة) 1ضع (.........                           عدد السنوات 
 وصف لك علاج معين أو حمية غذائية لخفض مستوى السكر او لعلاج السكري لديك؟ هل-52
 لا   -2              نعم   -1
 اذا كان الجواب ب نعم، هل تخضع حاليا الى أي من الآت  لخفض مستوى السكر او لعلاج السكري لديك؟ -62
 حمية غذائية    -7حبوب                         -2             حقن الانسولين   -1
 حدد .......................     -غير ذلك    -4
 هل تناولت دواء لتخفيض سكر الدم اليوم أو خلال اليومين الاخيرين؟-72
 اليومين الأخيرين-نعم    -2  اليوم -نعم    -1
 لم اتناول الدواء في اليومين الأخيرين ( ما هو السبب ...................................................-لا   -7
 هل تستخدم جهاز فحص السكر ف  المنزل فحصت من قبل نسبة السكر (الغلوكوز) ف  الدم او البول؟-82
 لا اعلم       -7                               لا      -2                       نعم    -1
هل تم اخبار احد اقربائك (اب, ام, اخ, اخت, ابن, ابنة) من قبل طبيب او اختصاص  انه يعان  من مرض -92
 السكري؟
 لا اعلم   -7                               لا      -2   نعم   -1
 لا   -2                       نعم   -1
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 ekortSالسكتة دماغية  
 دماغية؟هل تم اخبارك من قبل طبيب او اختصاص  انك تعرضت لسكتة -13
 لا اعلم   -7                              لا    -2                       نعم    -1 
 هل تعلم سبب السكتة الدماغية؟-13
 إذا كان الجواب ب نعم ، لا                      -2                       نعم    -1
 .......................................؟ ما هو السبب الرئيس  للسكتة الدماغية-23
 هل تم اخبار احد اقربائك (اب, ام, اخ, اخت, ابن, ابنة) من قبل طبيب او اختصاص  انه تعرض لسكتة دماغية؟-33
 لا                                   -2                       نعم    -1 
 yrujnI الاصابات 
 ؟ مما استدعى تلا  العلاج لهذه الاصابةشهرا الماضية  21هل تعرضت لأي اصابة خلال ال -13
 لا    -2                       نعم   -1
 ......................................................................................................... كيف حدثت الاصابة؟-53
 .......................................................................................................... أين حدثت الاصابة؟-63
 ................................................................................................... ما هو سبب هذه الاصابة؟-73
 اين تلايت العلاج ل هذه الاصابة؟-83
 الرعاية الصحية (المراكز الصحية)       -2 مستشفى حكومي                                   -1
 ............غير ذلك، حدد ....................................   -4                             المستشفيات الخاصة   -7
 صحة الاب والام
 كيف تايم صحة الاب؟ -93
      جيدة    -1
 مريض، حدد ما هو المرض ............................................................................................       -2
 متوفي: حدد سبب الوفاة .................................................................................................   -7
 كيف تايم صحة الام؟ -11
      جيدة    -1
 مريضة، حدد ما هو المرض ............................................................................................        -2
 .......................................................................................... متوفية: حدد سبب الوفاة   -7
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 الأنشطة الجسدية (الرياضية) )ج
 .الماضية أيام 7ال  خلال بدن  نشاط ف  قضيته الذي الوقت عن أسألك سوف
 الانتاال ، العمل ف  بها تاوم الت  الأنشطة اعتبر .نشيط شخص بأنك نفسك تعتبر لا كنت لو سؤال حتى كل إجابة الرجاء
 الرياضية. الألعاب أو الرياضية التمرينات ، للإستجمام فراغك وقت وف  ، آخر إلى من مكان
 الماضية أيام 7ال  خلال بها قمت والت  شاق بدن  جهد إلى تحتاج الت  الأنشطة جميع ف  فكر والآن
تشمل حمل الأثاال،  وقد المعتاد التنفس من كثيرا أكثر بصعوبة تتنفس تجعلك شاق بدن  جهد إلى تحتاج الت  الأنشطة
 بسرعة. الدراجة ركوب الحفر، الأيروبك، 
 , مثل العببأنشطة بدنية تحتاج الى جهد بدن  شاقأيام الماضية, ما هو عدد الأيام الت  قام طفلك خلالها  7خلال الـــ -1
دقائق على الأقل)؟ (الأنشطة الت   11دية الرياضية أو الشارع, ركوب المزلجة أو ركوب الدراجة بسرعة (لمدة ف  الأن
  تحتاج الى جهد بدن  شاق تجعل تنفسك بطرياة أصعب كثيرا من المعتاد)
 يوم     -2     ولا مرة    -1
 أيام 7    -4   يومان    -7
  أيام 1  -1        أيام 4  -1
   أيام 3     -.                  أيام 1   -3
 رفض الاجابة     -99                        لا يعلم             -33
  3رقم أذا أجاب بــ (ولا مرة, لايعلم, رفض الاجابة) انتال الى سؤال 
 
 في يوم من تلك الأيام؟ الانشطة البدنية التي تحتاج الى جهد بدني شاقكم من الوقت تستغرق عادة في عمل -2
 اليومساعة ف       
 دقياة ف  اليوم     
, مثل قفز الحبل, التزلج على الجليد بأنشطة بدنية معتدلةأيام الماضية, ما هو عدد الأيام التي قمت خلالها  7خلال الـــ -3 
دقائق على الأقل)؟ لا تقم بتضمين المشي.  11في مجمع تجاري أو مراكز التزلج, أو ركوب الدراجة بسرعة عادية (لمدة 
 طة التي تحتاج الى جهد بدني معتدل تجعل تنفسك بصورة أصعب بعض الشي من المعتاد)(الأنش
 يوم     -2     ولا مرة    -1
 أيام 7    -4   يومان    -7
  أيام 1  -1         أيام 4  -1
   أيام 3     -.       أيام 1   -3
 رفض الاجابة     -99            لا يعلم                 -33
 .5رقم  أذا أجاب بــ (ولا مرة, لايعلم, رفض الاجابة) انتال الى سؤال      
 ف  يوم من تلك الأيام؟ الانشطة البدنية الت  تحتاج الى جهد بدن  معتدلكم من الوقت تستغرق عادة ف  عمل -1
 __________________ساعة ف  اليوم
 __________________دقياة ف  اليوم
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دقائق على الأقل؟ ويشمل ذلك المش   11, لمدة بالمشــ أيام الماضية, ما هو عدد الأيام الت  قمت خلالها  7خلال الـــ -5
المش  للتنال من مكان الى آخر, أو اي مش  أخر قد تاوم به لمجرد الترفيه, الرياضة, التمرينات  ,ف  العمل, ف  المنزل
 البدنية أو ف  وقت الفراغ؟
 يوم     -2     ولا مرة    -1
 أيام 7    -4   يومان    -7
  أيام 1  -1        أيام 4  -1
   أيام 3     -.                  أيام 1   -3
 رفض الاجابة     -99                        لا يعلم             -33
 7رقم  أذا أجاب بــ (ولا مرة, لايعلم, رفض الاجابة) انتال الى سؤال
 \ف  يوم من تلك الأيام؟ المشـــ كم من الوقت تستغرق عادة ف   -6
 ساعة ف  اليوم       
 دقياة ف  اليوم     
, قم بتضمين الوقت الذي قضيته جالسا ف  يوم من أيام الأسبوعأيام الماضية, كم من الوقت قضيته  7خلال الـــ -7
جالسا ف  المدرسة, ف  البيت, خلال أداء الواجبات المدرسية, وأثناء وقت الفراغ, ويشمل أيضا الجلوس ف  المكتب, 
تف, لا تضمن الاستلااء أو الجلوس لمشاهدة التلفاز, العمل/اللعب عند زيارة الأصدقاء, عند الاراءة, عند الحديث بالها
 بالحاسوب, ولعب الألعاب الالكترونية ؟
 ساعة ف  اليوم                
 دقياة ف  اليوم     
سوب, بالحاأيام الماضية, ما هو عدد الأيام الت  قضيتها بالجلوس أوالاستلااء لمشاهدة التلفاز, العمل/اللعب  7خلال الـــ -8
 ولعب الألعاب الالكترونية ؟
 يوم     -2     ولا مرة    -1
 أيام 7    -4   يومان    -7
  أيام 1  -1        أيام 4  -1
   أيام 3     -.                  أيام 1   -3
 رفض الاجابة     -99                        لا يعلم             -33
 التدخين-1أذا أجاب بــ (ولا مرة, لايعلم, رفض الاجابة) انتال الى سؤال 
كم من الوقت تستغرق عادة ف  بالجلوس أوالاستلااء لمشاهدة التلفاز, العمل/اللعب بالحاسوب, ولعب الألعاب -9
 الالكترونية 
 ساعة ف  اليوم       
 اليومدقياة ف      
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 التدخيــــــن-نمط الحياة )د
 ؟  شيشة، نسوار) سيجارة ، سيجار، مدواخ،هل دخـــنت في يوم من الأيام ( -1
 31 رقم إنتقل الى السؤال                                    أبدا   -1
 _____    كم كان عمرك عندما بدات بالتدخين؟ -2 مدخن سابق   -2
 ؟ _____عدد سنوات التدخين -7
؟     _______سنة       _________ منذ متى اوقفت التدخين  -4
 شهر
؟  ما هو معدل عدد السجائر التي كنت تدخنها في اليوم الواحد -1
 العدد_____           
 ؟     العمر بالاعوام _______كم كان عمرك عندما بدات بالتدخين -1 مدخن حالي    -7
 ؟    _______ سنة  كم هو عدد السنوات التي دخنت خلالها -3
؟  العدد التي تدخنها في اليوم الواحدما هو معدل عدد السجائر  -.
 _____
خلال الاسبوع الماضي, كم مرة 
 دخنت:
النارجيلة او -11 السيجار؟                 -11 السيجارة؟                -9
 الشيشة؟         
 النسوار؟                 -21
  ولا مرة    
   
  مرة واحدة في الاسبوع        
   
  مرات في الاسبوع             7-2
   
  مرات في الاسبوع             5- 4
   
  كل يوم
   
 كم يوما خلال الايام السبعة الماضية دخن شخص ما ف  مكان مغلق بينما انت كنت هناك؟-31
  مرة واحدة في الاسبوع    -2     ولا مرة    -1
 مرات في الاسبوع 1-4    -4   مرات في الاسبوع 7-2    -7
 لا يعلم   -33     يوميا    -1
  
 كم يوما خلال الايام السبعة الماضية دخن شخص ما ف  بيتك بينما انت كنت هناك؟-11
  مرة واحدة في الاسبوع    -2     ولا مرة    -1
 مرات في الاسبوع 1-4    -4   مرات في الاسبوع 7-2    -7
 لا يعلم   -33     يوميا    -1
  
  ؟بشكل عام (ليس فاط الاسبوع الماض ) دخن السجائر داخل منزلك ف  الاسبوعيتم ت  كم مرة -51
  مرة واحدة في الاسبوع    -2     ولا مرة    -1
 مرات في الاسبوع 1-4    -4   مرات في الاسبوع 7-2    -7
 لا يعلم   -33     يوميا    -1
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 هـ )الأغذية المنزلية
 هل تضع ملح بشكل اضاف  على طعامك؟  هل تضع ملح بشكل اضاف  على طعامك؟ -1
 لا      -2                         نعم     -1 
                              
 ؟طعامالكم مرة تضيف الملح على -2
 دائما     -7          بالاسبوع) 7كثيرا (اكثر من     -2           بالاسبوع) 7احيانا (اقل من     -1 
 اسبوعيا أو يوميا-شهريا-فصليا-كم تتناول هذه الاطعمة سواء سنويا -3    
الكمية 
التي 
 تناولت
 رقم الصنف استخدام تكرار الاستخدام المقياس
   نعم  سنويا شهريا اسبوعيا يوميا فصليا
 لا  
  
لحم ضأن (مطبوخ، مشوي،        صحن 
 .....)
  1-7
لحم باري (مطبوخ، مشوي،        صحن 
 كباب، قيما)
  2-7
دجاج (مطبوخ، مشوي، تكا،        صحن 
 ....)
  7-7
  4-7 ....) سمك (مطبوخ، مال ،        صحن 
  1-7 الحليب       مل 112كوب  
  1-7 لبنه       ملعقة 
  3-7 لبن (روب)       مل 112كوب  
  .-7 أجبان       قطعة/عدد 
منتجات الحليب الأخرى        تحدد لاحقا 
 .......................
  9-7
  11-7 البيض       عدد 
عدس بأنواعه، الفاصوليا        صحن 
 واللوبيا، .....
  11-7
الخضراوات        صحن 
السلطات (طماطم، /الطازجة
 خيار، بصل، 
  21-7
الخضراوات المطبوخة (لا        صحن 
 تشمل البطاطا)
  71-7
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الفواكه الطازجة (لا تشمل        عدد 
 العصائر)
  41-7
عصائر الفواكه الطازجة:        مل 112كوب  
معلبة، ولا تشمل /طازجة
 شراب الفواكه 
  11-7
  11-7 الحلويات (الحلاوة)       صحن/عدد 
الفواكه المجففة(التمر        عدد 
والمشمش، العنب ... 
المكسرات الفول السودان  
 والفستق واللوز..
  31-7
  .1-7 خبز       عدد 
  91-7 رز        صحن 
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 و) الاياسات الحيوية
 المتفق عليها)الممرضة  حسب المعايير /يتم أخذ القياسات من قبل الممرض(  
 ؟خلال الثلاثين دقياة الماضيةهل دخنت سيجارة او شربت شاي او قهوة 
 لا    -2                       نعم    -1
 
 ضغط الدم والنبض  
 ( ثلاث مرات مع مراعاة خمس دقائق بين كل قراءة واخرى)  
  (يرجى أخذ القياسات بعد تعبئة الاستبيان واستخدام شريط القياس المناسب)
 )esluPالنبض (                  ضغط الدم الانقباض ضغط الدم الانبساطي
                القراءة الأولى: 
                                  القراءة الثانية:
                  القراءة الثالثة:
 الطول والوزن ومحيط الخصر والحوض
 يقف منتصبا وكذلك لا يلبس ملابس ثقيلة) شخصليرجى التأكد من أن ا(
 الاراءة الثانية              الاراءة الأولى                           
                     سم)   ( الطول
  
                      كجم)( الوزن
  
                      قياس الخصر (سم)
                      قياس محيط الحوض (سم)
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 فحوصات المخبرية) الز
 --------------------رقم المشارك                                                       المخبريةالفحوصات 
سنة ف  حضور احد الوالدين (ام/اب) من بعد  11الى  6سوف يتم فحص الاطفال من عمر  ملاحظة:
 الحصول على موافاة الطفل واهله.
 نسبة الغلوكوز بعد الصوم____________ .1
 الكولسترول _________________نسبة  .2
 _____________________LDL .3
 __________________LDH .1
 التريغلسريد_________________ .5
 :__________________C1AbH .6
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 12   :  /   /التاريخ
 اقرار بالموافقة
 
 من الأمراض المزمنة للوقايةوالدول المتقدمة  الناميةحول تعاون الدول  دراسة
 الأعزاء،الاهالي 
نحن اعضاء في هيئة التدريس في جامعة الامارت العربية المتحدة نخطط لاجراء دراسة هدفها اكتشاف العوامل الخطرة التي تؤدي الى 
تظهر عادة مع تقدم العمر لكن جذورها تعود الى الطفولة.نمط الحياة غير السليم مثل الاكل غبر الصجي أمراض لقلب والسكري التي 
وقلة الحركة كلها عوامل من الممكن أن تؤدي للاصابة بالسكري وامراض القلب.لذا من المهم ان يكون الاهل على وعي تام بوجود أي 
 .لبمن العوامل الجطرة الممكنة المؤدية لامراض الق
في هذه الدراسه، نحن ندعو أطفالكم مع أهاليهم ( الام والاب) لاجراء فحص طبي من الدراسة (تعاون الدول النامية والدول المتقدمة 
 .ية من الامراض المزمنة). هذه الدراسه ستساعدنا لانشاء برامج وقائية من امراض القلب والسكري في مجتمعنااللوق
القياس السريري يتضمن قياس  .استبيان باستخداملعوامل الخطره التي تؤدي الى الأمراض المزمنة سوف يتم جمع المعلومات عن ا
سوف يقوم ممرض متمرس  ضغط الدم والوزن والطول كما سيتم أخذ عينه من الدم لمعرفه. العوامل الخطره المؤذيه الى أمراض القلب.
 .لسحب الدم
 رفض مكنكمي. اختياري الدراسه هذه في مشاركه أن .الكتمان كيد سنبقى تعطونها سوف التي والمعلومات. مجانيا سيكون الطبي الفحص
 .وقت اَي قِي الانسحاب او المشاركه
 هذه الدراسة. لإتمام معنا مشاركتكم نقدر نحن
 :الطفل موافقه   :الوالده/الوالد موافقه
 الدراسة في ابنتي/ابني مشاركة على أوافق  شخصيا الموافقة على أوافق
 ———— :الابنه/الابن اسم  ——————: الاسم
 ———— :الوالده/الوالد امضاء  ————: الإمضاء
 :الفحوصات بنتائج وتزويد مستقبلا المشاركه على موافقه
 ………………………:liamE    .........................…:التوقيع
 
  :الدراسه هذه منسق او الممرض اسم
 ————:الإمضاء  —— ————: الاسم
 
 المتحدة العربيةجامعه الامارات 
 الطبيةكليه الطب والعلوم 
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Appendix 7: DM prevention questionnaire  
Adults with Pre-diabetes (Fasting PG 100-125 mg/dl or HbAIC 5.7-5.4) 
Q1. Patient Name:--------------------------------------------------------------مسلاا  
Q2. Contact address. House number----------------لزنملا مقر Street name and Number--
-------------------------عراشلا مسا مقر 
Q3. Cell Phone (from file and no need to ask the patient)------------------ لاقنلا-فتاهلا مقر  
Q4. Email Address ( of available if less than 50 years)-------------------------- ديربلا
ينورتكللاا 
Q5.house phone number:----------------------لزنملا فتاه مقر 
Q6. Patient ID (from file and no need to ask the patient)--------------------هقاطبلا مقر 
Q7.last visit Date: --------------\Dayموي---------\Monthرهش---------\Yearهنس----------- رخا
ةدايعلل ةرايز 
Q8 .what was the fasting glucose level-------, مدلا ركس لدعم Q8b A1C level-------------
يمكارتلا ركسلا لدعم 
-Q9. Date of birth or Age-------------------------------دلايملا خيرات وةا رمعلا 
Q10. Gender(from file and no need to ask the patient)  . (tick)    Male  ( )   Female 2 ( 
)سنجلا 
Q11. Marital status  1 Singleجوزتم ريغ ( )  2 marriedجوزتم ( ) 3 widowedةلمرا ( ) 4 
Divorced قلطم( ةيعامتجلاا ةلاحلا 
Q12. Occupation (Job)? هنهملا    House wife 1لزنم هبر(   ) 2Health careيحص ينهم (   ) 3 
Army\police يطرش\يركسع  (   ) 4. Office job (   )  5. Business (   ) 
6. Others jobs (specify)ىرخا نهم--------------------------------------------------------------- 
Q13. Education (tick) ( formal schooling) ميلعتلا ىوتسم 
1 2 3 4 5 6 7  ( primary)  ةيئادتبلاا     8 9 10 11 12  ( high school) هيوناثلا   ( )  ( college) 
يعماج    ( ) ( university)    (  ) no school  يما  
Risk assessment  رطاخملامييقت 
Q14 Are you physically active ( at least 30 minutes daily at work or during leisure 
time)? 
YES ( )  No (  )  لقلاا ىلع ةضايرلا سراما له71 هيفرتلل وا لمعلا للاخ ايموي عقيقد  
160 
 
 
 
 
Q15 how often do you eat vegetable or fruits?هكاوفلاو تاورضخلا لوانتت ةرم مك 
Every day ( )  موي لك   not every day (  )موي لك سيل 
Q16 do have high BPor hypertension?مدلا طغض يف عافترا نم يناعت له 
YES ( )  No (  )  
If  Yes 
Q17Are you taking medication for high BP?  مدلا طغض عافترلا ءاود لوانتت له  
YES ( )  No (  ) 
Q18 For married people only: have you ever been found to have high glucose during 
pregnancy? ( do not ask the question is the patient is single or male)  قف تاجوزتملل له:ط
 لمحلا ءانثا ركسلا ةبسن يف عافترا نم يناعت تنك 
YES ( )   No (  ) 
Q19 have your family members (parents, brothers, sisters) been diagnosed with 
diabetes? 
YES ( )  No (  )  يركسلا ضرم يف عافترا نم نوناعي )تخا خا نيدلاو ( ىلولاا ةجدلا نم ءابرقا كيدل له  
Q20 have your other relative (second degree relative grandfather, aunt, uncle, first 
cousin) been diagnosed with diabetes?         YES ( )  No (  )   ةيناثلا ةجدلا نم ءابرقا كيدل له
يركسلا ضرم يف عافترا نم نوناعي )ةلاخ همع لاخ مع ةدج دج ( 
Q21 have your doctor ever told you that you have diabetes?     YES ( )  No (  ) ماق له
يركسلا ضرم نم يناعت كناب كرابخاب كبيبط 
If yes 
Q22 if yes, how long you have been told that you have diabetes? يناعت يتلا ةدنلا يه ام
يركسلا ضرم نم اهنم 
Month-------years------- 
Q23 were you prescribed any treatment foe diabetes?    YES ( )  No (  ) ءاودلا لوانتت له
يركسلا شرمل 
Q24 if yes what type of treatment?يركسلا جلاعل هذخات يذلا جلاعلا عون ام .معن اذا 
Diet (  )ةيئاذغلا ةيمحلا Tablet (  )بوبح insulin injection ( )نيلوسنلاا ربا 
Q25 Do you have a blood sugar device checking device at you home? YES ( )  No (  
)؟لزنملاب ركسلا صحفل زاهج كيدل له 
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Q26 Do you smoke cigarettes?  Never (  ) Yes currently (  ) yes in the past (  ) نخدت له
؟ةراجيسلا 
Q27 Do you smoke shisha? Never (  ) Yes currently (  ) yes in the past (  )   نخدت له
هشيشلا 
Q28 Do you smoke Medyat? Never (  ) Yes currently (  ) yes in the past (  )   نخدت له
خاودملا 
International physical acitivty questionnaire: 
Q29 during the last 7 days, on how many days did you walk for at least 10 minutes at 
a time? 
Number of days in a week------  ةدمل يشملا ةضاير ةسراممب تمق له ةيضاملا مايا عبس يف11 
؟قئاقد-  
Q30 how long do you usually spend walking on one of these days? يف قرغتسملا تقولا
دحاولا مويلل يشملا 
Hours-------minutes----- 
Q31 During the last 7 days how many days did you spend doing moderate activates 
such as cycling or playing a game which will make you breathe somewhat harder 
than normal? 
Number of days------ ةبعل وا هضاير يا وا ةجاردلاك ةضاير ةسراممب تمق له ةيضاملا مايا عبس يف
 ثيحب طسوتم دوهجم تاذ؟ كيدل سفنتلا هعرس نم ديزت-  
Q32 how long do you usually spend doing moderate activity on of these days? 
Hours-----minutes--- دحاولا-مويلل  هضايرلا كلت ةسراممل قرغتسملا تقولا  
Q33 During the last 7 days how many days did you spend doing vigorous activates 
for at least 10 minutes at a time such as running or playing football or other game 
which will make you breathe somewhat harder than normal?   تمق له ةيضاملا مايا عبس يف
 كيدل سفنتلا هعرس نم ديزت ثيحب عيرسلا يرجلا وا ةركلا بعلك ةيساق ةضاير ةسراممب 
Number of days------ 
Q34 how long do you usually spend doing vigorous activity on of these days? 
Hours-----minutes---- دحاولا-ممل قرغتسملا تقولا  
